,words,labels,sentence_id,full sentence
113,Selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
114,content,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
115,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
116,the,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
117,tested,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
118,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
119,ranged,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
120,from,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
121,0.9,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
122,to,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
123,24.5,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
124,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
125,g.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
126,The,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
127,average,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
128,content,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
129,of,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
130,selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
131,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
132,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
133,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
134,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
135,popular,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
136,gluten,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
137,-,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
138,free,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
139,cereals,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
140,was,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
141,2.8,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
142,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
143,g,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
144,and,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
145,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
146,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
147,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
148,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
149,oat,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
150,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
151,amaranth,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
152,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
153,teff,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
154,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
155,and,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
156,quinoa,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
157,was,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
158,10.8,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
159,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
160,g.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
161,It,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
162,indicates,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
163,that,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
164,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
165,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
166,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
167,less,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
168,popular,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
169,grains,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
170,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
171,especially,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
172,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
173,oat,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
174,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
175,should,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
176,be,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
177,more,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
178,frequently,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
179,chosen,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
180,as,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
181,a,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
182,source,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
183,of,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
184,selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
185,by,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
186,people,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
187,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
188,gluten,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
189,-,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
190,free,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
191,diet,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
192,than,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
193,traditionally,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
194,consumed,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
195,gluten,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
196,-,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
197,free,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
198,grains,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
199,.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
430,In,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
431,many,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
432,cases,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
433,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
434,further,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
435,selection,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
436,goals,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
437,such,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
438,as,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
439,milk,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
440,composition,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
441,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
442,udder,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
443,morphology,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
444,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
445,somatic,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
446,cell,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
447,count,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
448,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
449,and,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
450,scrapie,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
451,resistance,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
452,have,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
453,been,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
454,implemented,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
455,.,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
579,Over,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
580,the,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
581,years,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
582,",",O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
583,doubts,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
584,have,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
585,arisen,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
586,concerning,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
587,the,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
588,use,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
589,of,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
590,milk,B,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
591,as,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
592,a,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
593,calcium,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
594,source,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
595,in,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
596,the,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
597,prevention,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
598,of,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
599,osteoporosis,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
600,",",O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
601,particularly,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
602,because,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
603,of,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
604,potential,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
605,offsetting,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
606,effects,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
607,of,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
608,protein,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
609,and,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
610,phosphorus,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
611,.,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
1154,Type,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1155,2,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1156,diabetes,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1157,is,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1158,another,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1159,global,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1160,health,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1161,threat,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1162,closely,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1163,associated,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1164,with,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1165,obesity,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1166,that,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1167,boosts,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1168,the,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1169,risk,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1170,of,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1171,cancer,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1172,driven,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1173,by,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1174,high,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1175,BMI,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1176,.,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1640,On,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1641,the,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1642,basis,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1643,of,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1644,these,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1645,data,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1646,for,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1647,average,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1648,annual,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1649,consumption,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1650,of,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1651,soybeans,B,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1652,and,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1653,related,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1654,products,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1655,",",O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1656,daily,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1657,intake,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1658,of,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1659,genistein,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1660,and,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1661,genistin,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1662,by,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1663,the,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1664,Japanese,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1665,is,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1666,calculated,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1667,to,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1668,be,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1669,1.5,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1670,-,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1671,4.1,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1672,and,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1673,6.3,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1674,-,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1675,8.3,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1676,mg,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1677,/,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1678,person,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1679,",",O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1680,respectively,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1681,.,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1795,During,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1796,"2,193,751",O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1797,person,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1798,years,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1799,of,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1800,follow,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1801,-,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1802,up,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1803,from,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1804,1995/1996,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1805,-,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1806,2000,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1807,",",O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1808,787,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1809,participants,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1810,were,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1811,diagnosed,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1812,with,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1813,head,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1814,and,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1815,neck,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1816,cancer,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1817,.,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
2057,Therefore,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2058,",",O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2059,some,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2060,of,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2061,them,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2062,are,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2063,unhealthy,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2064,foods,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2065,",",O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2066,whereas,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2067,others,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2068,do,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2069,not,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2070,affect,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2071,health,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2072,and,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2073,still,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2074,others,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2075,are,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2076,healthy,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2077,foods,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2078,.,O,63.0,"Therefore , some of them are unhealthy foods , whereas others do not affect health and still others are healthy foods ."
2183,However,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2184,",",O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2185,many,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2186,aspects,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2187,remain,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2188,to,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2189,be,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2190,investigated,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2191,and,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2192,others,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2193,are,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2194,still,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2195,to,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2196,be,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2197,clarified,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2198,.,O,68.0,"However , many aspects remain to be investigated and others are still to be clarified ."
2697,Despite,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2698,concerns,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2699,that,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2700,the,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2701,high,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2702,-,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2703,saturated,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2704,-,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2705,fat,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2706,content,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2707,of,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2708,full,B,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2709,-,I,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2710,fat,I,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2711,dairy,I,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2712,products,I,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2713,would,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2714,promote,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2715,heart,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2716,disease,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2717,",",O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2718,recent,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2719,meta,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2720,-,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2721,analyses,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2722,show,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2723,that,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2724,dairy,B,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2725,consumption,I,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2726,is,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2727,neutral,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2728,or,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2729,beneficial,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2730,for,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2731,weight,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2732,control,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2733,",",O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2734,coronary,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2735,disease,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2736,",",O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2737,diabetes,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2738,",",O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2739,hypertension,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2740,",",O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2741,and,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2742,most,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2743,cancers,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
2744,.,O,86.0,"Despite concerns that the high - saturated - fat content of full - fat dairy products would promote heart disease , recent meta - analyses show that dairy consumption is neutral or beneficial for weight control , coronary disease , diabetes , hypertension , and most cancers ."
3270,To,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3271,assess,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3272,gastric,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3273,cancer,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3274,(,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3275,GC,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3276,),O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3277,risk,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3278,in,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3279,relation,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3280,to,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3281,dietary,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3282,intake,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3283,in,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3284,Korea,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3285,",",O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3286,a,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3287,case,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3288,-,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3289,control,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3290,study,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3291,was,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3292,performed,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3293,.,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3792,The,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3793,effect,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3794,of,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3795,dietary,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3796,fats,B,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3797,(,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3798,coconut,B,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3799,oil,I,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3800,",",O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3801,butter,B,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3802,",",O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3803,traditional,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3804,stick,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3805,margarine,B,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3806,",",O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3807,soybean,B,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3808,oil,I,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3809,",",O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3810,canola,B,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3811,oil,I,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3812,),O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3813,differing,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3814,in,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3815,fatty,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3816,acid,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3817,profile,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3818,on,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3819,this,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3820,antiatherogenic,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3821,process,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3822,was,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3823,assessed,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3824,with,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3825,respect,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3826,to,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3827,plasma,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3828,lipids,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3829,;,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3830,exogenous,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3831,and,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3832,endogenous,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3833,lecithin,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3834,-,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3835,cholesterol,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3836,acyltransferase,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3837,(,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3838,LCAT,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3839,),O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3840,",",O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3841,cholesterol,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3842,ester,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3843,transfer,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3844,protein,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3845,(,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3846,CETP,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3847,),O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3848,",",O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3849,phospholipid,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3850,transfer,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3851,protein,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3852,(,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3853,PLTP,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3854,),O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3855,activities,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3856,;,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3857,and,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3858,LCAT,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3859,",",O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3860,apolipoprotein,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3861,(,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3862,apo,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3863,),O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3864,A,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3865,-,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3866,I,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3867,and,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3868,scavenger,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3869,receptor,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3870,B,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3871,class-1,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3872,(,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3873,SR,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3874,-,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3875,B1,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3876,),O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3877,mRNA,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3878,abundance,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3879,.,O,122.0,"The effect of dietary fats ( coconut oil , butter , traditional stick margarine , soybean oil , canola oil ) differing in fatty acid profile on this antiatherogenic process was assessed with respect to plasma lipids ; exogenous and endogenous lecithin - cholesterol acyltransferase ( LCAT ) , cholesterol ester transfer protein ( CETP ) , phospholipid transfer protein ( PLTP ) activities ; and LCAT , apolipoprotein ( apo ) A - I and scavenger receptor B class-1 ( SR - B1 ) mRNA abundance ."
3926,Canola,B,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3927,oil,I,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3928,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3929,relative,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3930,to,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3931,butter,B,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3932,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3933,resulted,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3934,in,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3935,higher,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3936,exogenous,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3937,LCAT,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3938,activity,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3939,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3940,and,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3941,both,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3942,soybean,B,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3943,and,I,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3944,canola,I,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3945,oils,I,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3946,significantly,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3947,increased,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3948,hepatic,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3949,apo,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3950,A,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3951,-,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3952,I,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3953,and,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3954,SR,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3955,-,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3956,B1,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3957,mRNA,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3958,abundance,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3959,.,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
4179,Brazilian,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4180,red,B,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4181,wine,I,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4182,contains,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4183,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4184,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4185,astringin,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4186,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4187,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4188,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4189,piceid,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4190,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4191,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4192,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4193,resveratrol,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4194,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4195,cis,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4196,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4197,resveratrol,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4198,(,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4199,in,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4200,high,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4201,quantity,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4202,:,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4203,5,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4204,times,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4205,more,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4206,than,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4207,the,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4208,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4209,form,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4210,),O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4211,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4212,epsilon,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4213,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4214,viniferin,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4215,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4216,and,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4217,a,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4218,compound,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4219,isolated,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4220,for,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4221,the,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4222,first,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4223,time,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4224,in,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4225,wine,B,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4226,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4227,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4228,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4229,delta,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4230,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4231,viniferin,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4232,.,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4833,We,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4834,hypothesized,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4835,that,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4836,substituting,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4837,canola,B,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4838,oil,I,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4839,(,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4840,10,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4841,%,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4842,ALA,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4843,),O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4844,for,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4845,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4846,corn,B,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4847,oil,I,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4848,(,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4849,1,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4850,%,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4851,ALA,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4852,),O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4853,in,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4854,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4855,diet,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4856,of,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4857,cancer,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4858,bearing,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4859,mice,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4860,would,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4861,slow,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4862,tumor,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4863,growth,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4864,by,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4865,increasing,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4866,n-3,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4867,fatty,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4868,acids,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4869,in,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4870,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4871,diet,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4872,.,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4873,Sixty,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4874,nude,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4875,mice,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4876,received,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4877,MDA,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4878,-,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4879,MB,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4880,231,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4881,human,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4882,breast,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4883,cancer,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4884,cells,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4885,and,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4886,were,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4887,fed,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4888,a,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4889,diet,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4890,containing,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4891,8,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4892,%,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4893,w,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4894,/,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4895,w,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4896,corn,B,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4897,oil,I,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4898,until,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4899,the,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4900,mean,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4901,tumor,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4902,volume,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4903,was,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4904,60,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4905,mm3,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
4906,.,O,155.0,Sixty nude mice received MDA - MB 231 human breast cancer cells and were fed a diet containing 8 % w / w corn oil until the mean tumor volume was 60 mm3 .
5067,Olive,B,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5068,oil,I,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5069,",",O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5070,a,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5071,potent,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5072,dietary,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5073,chemopreventive,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5074,agent,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5075,",",O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5076,control,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5077,colon,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5078,cancer,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5079,",",O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5080,however,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5081,",",O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5082,its,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5083,role,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5084,in,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5085,epigenetic,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5086,therapy,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5087,remains,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5088,unclear,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5089,.,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5115,DMH,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5116,was,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5117,used,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5118,to,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5119,induce,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5120,colon,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5121,cancer,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5122,in,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5123,rats,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5124,;,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5125,while,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5126,olive,B,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5127,oil,I,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5128,was,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5129,given,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5130,to,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5131,separate,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5132,group,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5133,of,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5134,rats,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5135,along,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5136,with,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5137,DMH,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5138,treatment,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5139,.,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5407,Several,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5408,milk,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5409,peptides,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5410,have,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5411,been,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5412,shown,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5413,to,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5414,have,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5415,antihypertensive,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5416,effects,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5417,in,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5418,animal,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5419,and,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5420,in,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5421,clinical,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5422,studies,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5423,.,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5599,Total,O,182.0,Total fluid intake was not associated with bladder cancer .
5600,fluid,B,182.0,Total fluid intake was not associated with bladder cancer .
5601,intake,I,182.0,Total fluid intake was not associated with bladder cancer .
5602,was,O,182.0,Total fluid intake was not associated with bladder cancer .
5603,not,O,182.0,Total fluid intake was not associated with bladder cancer .
5604,associated,O,182.0,Total fluid intake was not associated with bladder cancer .
5605,with,O,182.0,Total fluid intake was not associated with bladder cancer .
5606,bladder,O,182.0,Total fluid intake was not associated with bladder cancer .
5607,cancer,O,182.0,Total fluid intake was not associated with bladder cancer .
5608,.,O,182.0,Total fluid intake was not associated with bladder cancer .
5716,The,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5717,water,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5718,intake,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5719,-,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5720,bladder,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5721,cancer,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5722,association,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5723,also,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5724,seemed,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5725,to,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5726,be,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5727,modified,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5728,by,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5729,daytime,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5730,urination,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5731,frequency,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5732,with,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5733,significant,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5734,inverse,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5735,association,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5736,among,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5737,subjects,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5738,who,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5739,urinated,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5740,>,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5741,or,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5742,=,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5743,6,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5744,times,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5745,/,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5746,day,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5747,(,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5748,p,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5749,for,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5750,trend,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5751,=,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5752,0.015,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5753,),O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5754,",",O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5755,but,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5756,not,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5757,among,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5758,those,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5759,who,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5760,urinated,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5761,less,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5762,frequently,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5763,.,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
6090,Consumption,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6091,of,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6092,tomato,B,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6093,and,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6094,tomato,B,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6095,-,I,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6096,based,I,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6097,products,I,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6098,contribute,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6099,to,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6100,the,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6101,absorption,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6102,of,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6103,carotenoids,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6104,and,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6105,lycopenes,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6106,in,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6107,human,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6108,serum,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6109,.,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6450,When,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6451,consumed,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6452,within,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6453,the,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6454,DGA,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6455,recommendations,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6456,",",O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6457,100,B,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6458,%,B,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6459,fruit,I,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6460,juice,I,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6461,is,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6462,not,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6463,associated,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6464,with,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6465,overweight,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6466,/,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6467,obesity,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6468,or,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6469,childhood,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6470,dental,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6471,caries,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6472,and,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6473,does,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6474,not,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6475,compromise,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6476,fiber,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6477,intake,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6478,.,O,210.0,"When consumed within the DGA recommendations , 100 % fruit juice is not associated with overweight / obesity or childhood dental caries and does not compromise fiber intake ."
6851,More,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6852,often,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6853,",",O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6854,discordant,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6855,works,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6856,indicate,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6857,no,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6858,effect,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6859,of,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6860,dairy,B,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6861,consumption,I,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6862,on,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6863,bone,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6864,safety,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6865,.,O,223.0,"More often , discordant works indicate no effect of dairy consumption on bone safety ."
6977,As,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6978,a,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6979,general,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6980,conclusion,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6981,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6982,calcium,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6983,is,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6984,essential,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6985,for,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6986,bone,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6987,health,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6988,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6989,although,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6990,it,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6991,will,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6992,not,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6993,prevent,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6994,bone,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6995,loss,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6996,due,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6997,to,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6998,other,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6999,factors,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7000,;,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7001,in,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7002,this,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7003,context,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7004,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7005,milk,B,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7006,and,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7007,dairy,B,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7008,foods,I,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7009,are,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7010,bioavailable,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7011,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7012,relatively,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7013,inexpensive,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7014,sources,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7015,of,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7016,calcium,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7017,for,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7018,the,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7019,human,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7020,diet,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7021,.,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7061,The,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7062,purpose,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7063,of,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7064,this,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7065,study,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7066,was,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7067,to,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7068,determine,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7069,the,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7070,ideal,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7071,combination,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7072,of,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7073,coffee,B,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7074,",",O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7075,cream,B,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7076,",",O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7077,and,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7078,sugar,B,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7079,in,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7080,order,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7081,to,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7082,minimize,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7083,MG,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7084,consumption,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7085,.,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7196,On,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7197,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7198,other,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7199,hand,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7200,",",O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7201,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7202,addition,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7203,of,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7204,sugar,B,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7205,to,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7206,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7207,bold,B,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7208,coffee,I,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7209,did,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7210,not,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7211,further,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7212,increase,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7213,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7214,MG,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7215,level,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7216,in,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7217,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7218,samples,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7219,.,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7516,The,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7517,contributions,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7518,of,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7519,food,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7520,items,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7521,and,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7522,food,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7523,groups,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7524,as,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7525,risk,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7526,factors,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7527,in,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7528,a,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7529,previously,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7530,reported,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7531,case,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7532,-,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7533,control,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7534,study,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7535,of,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7536,diet,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7537,and,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7538,colo,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7539,-,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7540,rectal,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7541,cancer,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7542,have,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7543,been,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7544,analyzed,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7545,.,O,250.0,The contributions of food items and food groups as risk factors in a previously reported case - control study of diet and colo - rectal cancer have been analyzed .
7591,For,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7592,colon,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7593,cancer,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7594,",",O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7595,as,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7596,in,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7597,the,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7598,previous,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7599,analysis,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7600,",",O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7601,the,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7602,major,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7603,risk,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7604,factor,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7605,was,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7606,saturated,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7607,fat,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7608,",",O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7609,individual,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7610,food,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7611,items,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7612,or,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7613,groups,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7614,failing,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7615,to,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7616,make,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7617,a,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7618,significant,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7619,contribution,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7620,to,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7621,the,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7622,risk,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7623,.,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7624,In,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7625,particular,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7626,there,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7627,was,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7628,no,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7629,protective,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7630,effect,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7631,of,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7632,dietary,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7633,fibre,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7634,and,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7635,",",O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7636,for,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7637,cruciferous,B,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7638,vegetables,I,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7639,",",O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7640,only,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7641,a,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7642,minor,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7643,protective,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7644,effect,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7645,in,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7646,females,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7647,.,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7751,There,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7752,was,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7753,no,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7754,protective,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7755,effect,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7756,of,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7757,dietary,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7758,fibre,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7759,or,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7760,of,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7761,cruciferous,B,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7762,vegetables,I,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7763,for,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7764,rectal,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7765,cancer,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7766,",",O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7767,but,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7768,in,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7769,females,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7770,",",O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7771,there,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7772,was,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7773,a,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7774,significantly,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7775,increased,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7776,risk,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7777,for,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7778,consumption,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7779,of,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7780,beer,B,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7781,",",O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7782,though,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7783,this,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7784,was,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7785,somewhat,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7786,reduced,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7787,when,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7788,controlled,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7789,for,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7790,consumption,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7791,of,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7792,saturated,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7793,fat,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7794,.,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
8285,In,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8286,both,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8287,scenarios,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8288,",",O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8289,the,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8290,median,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8291,Tolerable,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8292,Upper,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8293,Intake,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8294,Levels,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8295,(,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8296,ULs,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8297,),O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8298,met,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8299,were,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8300,<,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8301,55,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8302,%,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8303,for,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8304,all,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8305,nutrients,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8306,.,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8781,Kurakkan,B,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8782,flour,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8783,pittu,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8784,and,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8785,wheat,B,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8786,flour,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8787,roti,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8788,were,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8789,classified,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8790,as,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8791,medium,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8792,-,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8793,GI,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8794,foods,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8795,with,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8796,GI,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8797,values,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8798,of,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8799,85+/-6,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8800,and,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8801,72+/-6,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8802,.,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
9400,No,O,309.0,"No clear associations were observed for milk , soda or juice ."
9401,clear,O,309.0,"No clear associations were observed for milk , soda or juice ."
9402,associations,O,309.0,"No clear associations were observed for milk , soda or juice ."
9403,were,O,309.0,"No clear associations were observed for milk , soda or juice ."
9404,observed,O,309.0,"No clear associations were observed for milk , soda or juice ."
9405,for,O,309.0,"No clear associations were observed for milk , soda or juice ."
9406,milk,B,309.0,"No clear associations were observed for milk , soda or juice ."
9407,",",O,309.0,"No clear associations were observed for milk , soda or juice ."
9408,soda,B,309.0,"No clear associations were observed for milk , soda or juice ."
9409,or,O,309.0,"No clear associations were observed for milk , soda or juice ."
9410,juice,B,309.0,"No clear associations were observed for milk , soda or juice ."
9411,.,O,309.0,"No clear associations were observed for milk , soda or juice ."
9628,Though,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9629,bioinformatic,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9630,analyses,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9631,revealed,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9632,that,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9633,GmFT7,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9634,had,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9635,high,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9636,similarity,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9637,with,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9638,GmFT2a,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9639,",",O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9640,ectopic,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9641,GmFT7,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9642,expression,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9643,in,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9644,Arabidopsis,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9645,could,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9646,not,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9647,promote,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9648,flowering,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9649,or,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9650,rescue,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9651,the,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9652,late,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9653,-,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9654,flowering,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9655,phenotype,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9656,of,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9657,Arabidopsis,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9658,ft-10,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9659,mutant,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9660,.,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9964,Both,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9965,epidemiological,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9966,and,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9967,laboratory,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9968,evidence,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9969,suggests,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9970,that,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9971,a,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9972,high,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9973,intake,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9974,of,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9975,total,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9976,fat,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9977,increases,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9978,susceptibility,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9979,to,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9980,cancer,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9981,of,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9982,different,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9983,sites,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9984,",",O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9985,particularly,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9986,the,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9987,breast,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9988,and,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9989,colon,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9990,.,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
10314,Occurrence,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10315,data,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10316,were,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10317,available,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10318,only,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10319,for,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10320,α,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10321,-,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10322,solanine,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10323,and,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10324,α,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10325,-,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10326,chaconine,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10327,",",O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10328,mostly,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10329,for,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10330,potatoes,B,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10331,.,O,347.0,"Occurrence data were available only for α - solanine and α - chaconine , mostly for potatoes ."
10604,The,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10605,review,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10606,aims,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10607,to,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10608,summarize,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10609,the,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10610,four,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10611,different,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10612,groups,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10613,of,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10614,plant,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10615,sources,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10616,(,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10617,nuts,B,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10618,",",O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10619,cereals,B,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10620,",",O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10621,seeds,B,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10622,and,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10623,legumes,B,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10624,),O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10625,used,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10626,for,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10627,the,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10628,preparation,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10629,of,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10630,plant,B,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10631,-,I,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10632,based,I,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10633,milk,I,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10634,beverages,I,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10635,.,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10958,In,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10959,conclusion,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10960,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10961,glucose,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10962,tolerance,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10963,status,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10964,did,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10965,not,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10966,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10967,in,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10968,general,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10969,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10970,affect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10971,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10972,predictive,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10973,effect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10974,of,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10975,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10976,dietary,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10977,patterns,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10978,.,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
11027,Obesity,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11028,is,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11029,a,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11030,major,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11031,epidemic,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11032,for,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11033,developed,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11034,countries,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11035,in,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11036,the,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11037,21st,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11038,century,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11039,.,O,370.0,Obesity is a major epidemic for developed countries in the 21st century .
11323,Thus,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11324,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11325,this,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11326,study,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11327,found,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11328,that,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11329,replacing,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11330,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11331,sugar,B,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11332,-,I,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11333,sweetened,I,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11334,soda,I,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11335,beverage,I,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11336,or,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11337,beer,B,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11338,with,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11339,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11340,serving,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11341,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11342,water,B,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11343,per,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11344,day,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11345,at,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11346,baseline,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11347,was,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11348,related,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11349,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11350,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11351,lower,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11352,incidence,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11353,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11354,obesity,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11355,and,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11356,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11357,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11358,higher,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11359,weight,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11360,loss,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11361,over,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11362,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11363,four,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11364,-,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11365,year,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11366,period,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11367,time,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11368,in,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11369,the,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11370,case,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11371,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11372,beer,B,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11373,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11374,based,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11375,on,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11376,mathematical,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11377,models,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11378,.,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11441,Increasing,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11442,evidence,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11443,indicates,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11444,that,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11445,the,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11446,synergy,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11447,among,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11448,these,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11449,components,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11450,results,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11451,in,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11452,beneficial,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11453,changes,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11454,in,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11455,intermediate,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11456,pathways,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11457,of,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11458,cardiometabolic,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11459,risk,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11460,",",O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11461,such,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11462,as,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11463,lipids,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11464,",",O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11465,insulin,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11466,sensitivity,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11467,",",O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11468,oxidative,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11469,stress,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11470,",",O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11471,inflammation,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11472,",",O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11473,and,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11474,vasoreactivity,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
11475,.,O,382.0,"Increasing evidence indicates that the synergy among these components results in beneficial changes in intermediate pathways of cardiometabolic risk , such as lipids , insulin sensitivity , oxidative stress , inflammation , and vasoreactivity ."
12124,This,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12125,sample,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12126,contained,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12127,significantly,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12128,higher,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12129,protein,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12130,and,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12131,lower,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12132,carbohydrate,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12133,than,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12134,the,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12135,wheat,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12136,sample,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12137,.,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12199,This,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12200,could,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12201,be,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12202,due,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12203,to,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12204,its,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12205,association,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12206,with,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12207,wheaty,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12208,aroma,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12209,and,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12210,flavor,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12211,attributes,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12212,rather,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12213,than,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12214,the,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12215,pea,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12216,aroma,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12217,and,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12218,flavor,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12219,attributes,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12220,of,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12221,the,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12222,other,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12223,two,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12224,breads,B,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12225,.,O,409.0,This could be due to its association with wheaty aroma and flavor attributes rather than the pea aroma and flavor attributes of the other two breads .
12420,Consumer,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12421,acceptance,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12422,tests,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12423,(,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12424,n=75,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12425,consumers,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12426,),O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12427,were,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12428,conducted,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12429,with,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12430,cottage,B,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12431,cheeses,I,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12432,with,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12433,and,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12434,without,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12435,sodium,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12436,reductions,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12437,and,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12438,under,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12439,conditions,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12440,with,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12441,and,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12442,without,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12443,health,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12444,benefits,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12445,of,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12446,sodium,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12447,reduction,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12448,.,O,416.0,Consumer acceptance tests ( n=75 consumers ) were conducted with cottage cheeses with and without sodium reductions and under conditions with and without health benefits of sodium reduction .
12668,We,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12669,based,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12670,our,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12671,work,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12672,on,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12673,an,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12674,expert,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12675,meeting,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12676,conducted,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12677,by,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12678,the,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12679,International,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12680,Agency,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12681,for,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12682,Research,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12683,on,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12684,Cancer,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12685,in,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12686,2003,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12687,.,O,423.0,We based our work on an expert meeting conducted by the International Agency for Research on Cancer in 2003 .
12885,It,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12886,is,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12887,important,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12888,to,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12889,recognize,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12890,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12891,this,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12892,is,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12893,only,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12894,a,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12895,crude,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12896,range,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12897,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12898,estimates,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12899,and,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12900,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12901,the,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12902,proportion,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12903,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12904,cancers,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12905,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12906,might,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12907,be,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12908,preventable,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12909,by,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12910,increasing,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12911,fruit,B,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12912,and,I,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12913,vegetable,I,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12914,intake,I,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12915,may,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12916,vary,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12917,beyond,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12918,this,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12919,range,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12920,for,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12921,specific,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12922,cancer,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12923,sites,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12924,and,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12925,across,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12926,different,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12927,regions,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12928,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12929,the,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12930,world,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12931,.,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
13040,Despite,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13041,a,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13042,different,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13043,methodology,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13044,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13045,reports,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13046,from,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13047,several,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13048,Asian,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13049,centres,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13050,suggest,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13051,a,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13052,similar,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13053,frequency,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13054,of,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13055,hypersensitivity,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13056,to,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13057,these,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13058,foods,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13059,in,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13060,young,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13061,children,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13062,although,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13063,hypersensitivity,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13064,to,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13065,shellfish,B,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13066,and,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13067,seafood,B,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13068,was,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13069,more,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13070,common,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13071,than,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13072,for,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13073,nuts,B,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13074,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13075,peanut,B,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13076,and,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13077,wheat,B,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13078,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13079,if,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13080,seafoods,B,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13081,are,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13082,part,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13083,of,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13084,the,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13085,staple,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13086,infant,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13087,diet,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13088,.,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13100,Milk,B,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13101,consumption,I,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13102,decreases,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13103,inflammatory,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13104,stress,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13105,in,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13106,overweight,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13107,and,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13108,obese,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13109,subjects,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13110,.,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13530,The,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13531,amounts,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13532,of,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13533,gluten,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13534,were,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13535,calculated,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13536,as,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13537,the,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13538,amount,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13539,of,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13540,cereal,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13541,protein,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13542, ,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13543,×,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13544, ,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13545,0·80,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13546,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13547,wheat,B,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13548,and,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13549,oats,B,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13550,",",O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13551,×0·65,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13552,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13553,rye,B,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13554,and,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13555,×0·50,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13556,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13557,barley,B,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13558,.,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13594,Oats,B,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13595,were,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13596,introduced,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13597,first,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13598,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13599,rapidly,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13600,outpaced,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13601,by,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13602,wheat,B,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13603,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13604,the,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13605,intake,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13606,of,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13607,which,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13608,continued,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13609,to,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13610,increase,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13611,with,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13612,age,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13613,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13614,whereas,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13615,oats,B,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13616,started,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13617,to,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13618,decrease,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13619,at,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13620,12,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13621,months,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13622,.,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
14257,Apiaceae,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14258,-,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14259,positive,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14260,patients,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14261,showed,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14262,significantly,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14263,higher,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14264,birch,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14265,pollen,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14266,-,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14267,specific,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14268,IgE,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14269,levels,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14270,than,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14271,negative,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14272,ones,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14273,(,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14274,median,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14275,13,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14276,vs,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14277,7,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14278,AU,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14279,/,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14280,ml,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14281,;,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14282,P,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14283,<,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14284,0.0001,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14285,),O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14286,.,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14855,Increased,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14856,hepatic,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14857,glucose,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14858,production,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14859,underlies,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14860,fasting,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14861,hyperglycemia,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14862,that,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14863,defines,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14864,type,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14865,2,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14866,diabetes,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14867,",",O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14868,while,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14869,increased,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14870,production,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14871,of,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14872,atherogenic,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14873,",",O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14874,large,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14875,",",O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14876,triglyceride,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14877,-,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14878,rich,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14879,",",O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14880,very,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14881,low,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14882,-,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14883,density,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14884,lipoproteins,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14885,raises,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14886,the,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14887,risk,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14888,of,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14889,cardiovascular,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14890,disease,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14891,.,O,495.0,"Increased hepatic glucose production underlies fasting hyperglycemia that defines type 2 diabetes , while increased production of atherogenic , large , triglyceride - rich , very low - density lipoproteins raises the risk of cardiovascular disease ."
14911,Metabolic,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14912,programming,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14913,of,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14914,the,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14915,liver,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14916,transcriptome,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14917,and,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14918,posttranslation,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14919,modifications,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14920,of,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14921,proteins,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14922,is,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14923,strongly,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14924,influenced,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14925,by,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14926,the,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14927,daily,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14928,rhythms,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14929,in,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14930,nutrient,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14931,intake,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14932,governed,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14933,by,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14934,the,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14935,circadian,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14936,clock,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
14937,.,O,497.0,Metabolic programming of the liver transcriptome and posttranslation modifications of proteins is strongly influenced by the daily rhythms in nutrient intake governed by the circadian clock .
16078,This,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16079,pattern,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16080,had,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16081,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16082,lowest,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16083,contribution,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16084,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16085,most,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16086,food,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16087,groups,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16088,",",O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16089,with,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16090,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16091,exception,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16092,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16093,beans,B,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16094,(,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16095,~4.0,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16096,%,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16097,),O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16098,.,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16099,The,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16100,RS,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16101,pattern,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16102,had,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16103,the,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16104,highest,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16105,contribution,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16106,of,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16107,alcohol,B,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16108,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16109,9.4,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16110,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16111,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16112,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16113,soft,B,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16114,drinks,I,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16115,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16116,9.4,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16117,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16118,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16119,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16120,white,B,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16121,bread,I,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16122,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16123,7.7,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16124,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16125,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16126,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16127,fast,B,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16128,food,I,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16129,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16130,sweets,B,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16131,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16132,and,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16133,snacks,B,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16134,.,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16565,Postprandial,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16566,plasma,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16567,glucose,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16568,and,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16569,triglyceride,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16570,concentrations,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16571,are,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16572,predictive,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16573,of,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16574,relative,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16575,cardiovascular,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16576,disease,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16577,(,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16578,CVD,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16579,),O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16580,risk,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16581,",",O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16582,and,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16583,the,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16584,pathogenesis,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16585,of,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16586,both,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16587,insulin,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16588,resistance,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16589,and,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16590,atherosclerosis,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16591,has,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16592,been,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16593,attributed,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16594,to,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16595,acute,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16596,states,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16597,of,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16598,hyperglycemia,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16599,and,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16600,hypertriglyceridemia,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16601,.,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16602,Postprandial,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16603,lipemia,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16604,and,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16605,hyperglycemia,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16606,suppress,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16607,vascular,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16608,reactivity,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16609,and,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16610,induce,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16611,endothelial,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16612,dysfunction,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16613,.,O,551.0,Postprandial lipemia and hyperglycemia suppress vascular reactivity and induce endothelial dysfunction .
16644,The,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16645,addition,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16646,of,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16647,dairy,B,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16648,products,I,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16649,to,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16650,meals,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16651,high,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16652,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16653,carbohydrates,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16654,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16655,fat,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16656,may,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16657,lessen,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16658,these,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16659,risks,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16660,through,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16661,reductions,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16662,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16663,postprandial,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16664,glucose,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16665,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16666,triglyceride,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16667,responses,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16668,.,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16691,The,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16692,current,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16693,review,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16694,evaluates,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16695,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16696,available,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16697,literature,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16698,describing,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16699,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16700,relationships,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16701,between,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16702,metabolic,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16703,dysfunction,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16704,",",O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16705,postprandial,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16706,metabolism,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16707,",",O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16708,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16709,vascular,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16710,dysfunction,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16711,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16712,discusses,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16713,the,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16714,potential,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16715,role,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16716,of,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16717,milk,B,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16718,and,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16719,dairy,B,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16720,products,I,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16721,in,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16722,attenuating,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16723,these,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16724,impairments,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16725,.,O,555.0,"The current review evaluates the available literature describing the relationships between metabolic dysfunction , postprandial metabolism , and vascular dysfunction and discusses the potential role of milk and dairy products in attenuating these impairments ."
16735,Coffee,B,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16736,contains,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16737,various,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16738,chemical,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16739,compounds,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16740,(,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16741,e.g.,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16742,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16743,caffeine,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16744,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16745,chlorogenic,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16746,acids,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16747,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16748,hydroxyhydroquinone,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16749,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16750,kahweol,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16751,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16752,cafestol,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16753,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16754,and,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16755,complex,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16756,chemical,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16757,mixtures,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16758,),O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16759,.,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16800,The,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16801,effects,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16802,of,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16803,coffee,B,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16804,and,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16805,caffeine,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16806,on,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16807,cardiovascular,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16808,diseases,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16809,remain,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16810,controversial,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16811,.,O,559.0,The effects of coffee and caffeine on cardiovascular diseases remain controversial .
16928,Different,O,565.0,Different skin test techniques using fresh fruit were compared .
16929,skin,O,565.0,Different skin test techniques using fresh fruit were compared .
16930,test,O,565.0,Different skin test techniques using fresh fruit were compared .
16931,techniques,O,565.0,Different skin test techniques using fresh fruit were compared .
16932,using,O,565.0,Different skin test techniques using fresh fruit were compared .
16933,fresh,O,565.0,Different skin test techniques using fresh fruit were compared .
16934,fruit,B,565.0,Different skin test techniques using fresh fruit were compared .
16935,were,O,565.0,Different skin test techniques using fresh fruit were compared .
16936,compared,O,565.0,Different skin test techniques using fresh fruit were compared .
16937,.,O,565.0,Different skin test techniques using fresh fruit were compared .
17303,The,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17304,animals,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17305,were,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17306,fed,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17307,either,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17308,a,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17309,commercial,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17310,laboratory,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17311,chow,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17312,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17313,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17314,study,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17315,1,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17316,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17317,",",O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17318,containing,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17319,5,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17320,%,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17321,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17322,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17323,low,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17324,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17325,saturated,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17326,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17327,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17328,1.46,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17329,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17330,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17331,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17332,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17333,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17334,cholesterol,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17335,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17336,0.03,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17337,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17338,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17339,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17340,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17341,or,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17342,a,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17343,semi,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17344,-,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17345,synthetic,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17346,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17347,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17348,study,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17349,2,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17350,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17351,set,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17352,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17353,gelatine,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17354,",",O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17355,containing,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17356,10,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17357,%,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17358,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17359,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17360,high,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17361,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17362,saturated,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17363,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17364,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17365,4,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17366,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17367,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17368,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17369,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17370,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17371,cholesterol,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17372,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17373,0.5,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17374,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17375,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17376,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17377,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17378,.,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
18519,Contrasting,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18520,",",O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18521,chocolate,B,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18522,for,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18523,dinner,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18524,prevented,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18525,re,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18526,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18527,entrainment,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18528,in,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18529,the,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18530,jet,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18531,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18532,lag,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18533,condition,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18534,and,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18535,favored,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18536,circadian,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18537,desynchrony,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18538,in,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18539,the,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18540,shift,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18541,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18542,work,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18543,models,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18544,.,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
19011,We,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19012,observed,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19013,that,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19014,FA,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19015,significantly,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19016,improved,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19017,insulin,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19018,sensitivity,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19019,and,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19020,lipid,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19021,profiles,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19022,",",O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19023,and,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19024,reduced,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19025,elevated,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19026,blood,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19027,pressure,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19028,",",O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19029,compared,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19030,to,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19031,untreated,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19032,controls,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19033,(,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19034,p,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19035,<,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19036,0.05,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19037,),O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19038,.,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19966,Moreover,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19967,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19968,substantial,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19969,experimental,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19970,studies,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19971,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19972,supported,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19973,the,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19974,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19975,role,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19976,of,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19977,fruits,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19978,against,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19979,CVDs,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19980,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19981,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19982,several,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19983,fruits,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19984,(,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19985,grape,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19986,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19987,blueberry,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19988,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19989,pomegranate,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19990,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19991,apple,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19992,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19993,hawthorn,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19994,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19995,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19996,avocado,B,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19997,),O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19998,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19999,been,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20000,widely,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20001,studied,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20002,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20003,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20004,shown,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20005,potent,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20006,cardiovascular,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20007,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20008,action,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20009,.,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
21050,This,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21051,research,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21052,uses,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21053,10,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21054,mo,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21055,of,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21056,consecutive,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21057,dairy,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21058,herd,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21059,improvement,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21060,data,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21061,from,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21062,2013,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21063,and,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21064,2014,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21065,to,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21066,estimate,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21067,milk,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21068,yield,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21069,loss,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21070,using,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21071,SCC,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21072,as,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21073,a,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21074,proxy,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21075,for,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21076,clinical,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21077,and,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21078,subclinical,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21079,mastitis,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21080,.,O,698.0,This research uses 10 mo of consecutive dairy herd improvement data from 2013 and 2014 to estimate milk yield loss using SCC as a proxy for clinical and subclinical mastitis .
21249,Results,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21250,demonstrate,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21251,the,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21252,importance,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21253,of,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21254,including,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21255,the,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21256,duration,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21257,of,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21258,months,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21259,above,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21260,a,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21261,threshold,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21262,SCC,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21263,when,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21264,estimating,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21265,milk,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21266,yield,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21267,losses,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21268,.,O,705.0,Results demonstrate the importance of including the duration of months above a threshold SCC when estimating milk yield losses .
21299,This,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21300,provides,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21301,farm,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21302,managers,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21303,with,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21304,a,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21305,method,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21306,to,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21307,evaluate,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21308,the,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21309,trade,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21310,-,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21311,off,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21312,between,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21313,treatment,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21314,and,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21315,culling,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21316,decisions,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21317,as,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21318,it,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21319,relates,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21320,to,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21321,mastitis,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21322,control,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21323,and,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21324,early,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21325,detection,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21326,.,O,707.0,This provides farm managers with a method to evaluate the trade - off between treatment and culling decisions as it relates to mastitis control and early detection .
21398,In,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21399,the,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21400,present,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21401,studies,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21402,",",O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21403,dosing,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21404,relied,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21405,on,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21406,injection,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21407,of,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21408,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21409,into,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21410,live,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21411,feeder,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21412,fish,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21413,for,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21414,oral,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21415,dosing,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21416,of,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21417,these,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21418,piscivorous,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21419,birds,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21420,",",O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21421,or,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21422,applying,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21423,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21424,to,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21425,body,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21426,contour,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21427,feathers,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21428,resulting,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21429,in,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21430,transdermal,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21431,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21432,exposure,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21433,and,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21434,oral,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21435,exposure,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21436,through,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21437,preening,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21438,.,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21473,External,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21474,oil,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21475,application,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21476,allowed,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21477,for,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21478,controlled,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21479,study,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21480,of,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21481,thermoregulatory,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21482,stress,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21483,as,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21484,well,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21485,.,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21486,Infrared,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21487,thermal,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21488,images,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21489,indicated,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21490,significantly,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21491,greater,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21492,surface,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21493,temperatures,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21494,and,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21495,heat,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21496,loss,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21497,in,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21498,treated,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21499,birds,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21500,following,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21501,external,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21502,oil,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21503,applications,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21504,;,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21505,however,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21506,",",O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21507,measurements,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21508,collected,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21509,by,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21510,coelomically,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21511,implanted,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21512,temperature,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21513,transmitters,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21514,showed,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21515,that,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21516,internal,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21517,body,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21518,temperatures,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21519,were,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21520,stable,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21521,over,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21522,the,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21523,course,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21524,of,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21525,the,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21526,study,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21527,period,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21528,.,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21591,Many,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21592,studies,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21593,have,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21594,shown,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21595,therapeutic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21596,effects,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21597,of,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21598,cinnamon,B,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21599,including,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21600,its,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21601,antimicrobial,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21602,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21603,antiviral,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21604,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21605,antifungal,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21606,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21607,antioxidant,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21608,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21609,antitumor,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21610,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21611,antihypertensive,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21612,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21613,antilipemic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21614,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21615,antidiabetic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21616,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21617,gastroprotective,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21618,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21619,and,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21620,immunomodulatory,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21621,effects,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21622,.,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
22007,Such,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22008,approaches,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22009,to,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22010,limit,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22011,microbial,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22012,growth,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22013,may,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22014,include,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22015,hydrostatic,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22016,pressures,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22017,",",O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22018,irradiation,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22019,",",O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22020,controlled,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22021,atmosphere,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22022,packaging,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22023,",",O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22024,or,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22025,the,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22026,use,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22027,of,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22028,food,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22029,additives,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22030,.,O,734.0,"Such approaches to limit microbial growth may include hydrostatic pressures , irradiation , controlled atmosphere packaging , or the use of food additives ."
22077,Biological,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22078,activities,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22079,associated,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22080,with,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22081,mango,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22082,fractions,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22083,were,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22084,assessed,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22085,in,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22086,cell,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22087,-,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22088,based,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22089,assays,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22090,to,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22091,develop,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22092,effective,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22093,extraction,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22094,and,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22095,fractionation,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22096,methodologies,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22097,and,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22098,to,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22099,define,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22100,sources,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22101,of,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22102,variability,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22103,.,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22489,However,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22490,",",O,752.0,"However , it only slightly affected human PPARgamma activity ."
22491,it,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22492,only,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22493,slightly,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22494,affected,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22495,human,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22496,PPARgamma,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22497,activity,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22498,.,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22691,Consumers,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22692,look,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22693,for,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22694,products,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22695,that,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22696,contribute,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22697,to,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22698,their,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22699,wellness,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22700,and,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22701,health,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22702,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22703,however,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22704,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22705,even,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22706,health,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22707,-,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22708,conscious,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22709,consumers,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22710,are,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22711,not,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22712,willing,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22713,to,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22714,sacrifice,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22715,organoleptic,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22716,properties,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22717,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22718,and,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22719,intense,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22720,full,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22721,-,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22722,flavor,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22723,snacks,B,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22724,remain,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22725,an,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22726,important,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22727,trend,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22728,.,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22802,This,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22803,resulted,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22804,in,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22805,frying,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22806,temperatures,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22807,of,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22808,160,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22809,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22810,180,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22811,°,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22812,C,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22813,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22814,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22815,98,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22816,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22817,118,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22818,°,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22819,C,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22820,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22821,for,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22822,atmospheric,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22823,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22824,vacuum,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22825,frying,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22826,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22827,respectively,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22828,.,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22829,Vacuum,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22830,-,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22831,fried,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22832,carrot,B,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22833,and,I,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22834,potato,I,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22835,chips,I,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22836,absorbed,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22837,about,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22838,50,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22839,%,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22840,less,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22841,oil,B,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22842,than,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22843,atmospheric,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22844,-,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22845,fried,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22846,chips,B,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22847,",",O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22848,whereas,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22849,vacuum,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22850,-,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22851,fried,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22852,apple,B,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22853,chips,I,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22854,reduced,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22855,oil,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22856,absorption,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22857,by,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22858,25,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22859,%,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22860,.,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22968,To,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22969,test,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22970,this,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22971,hypothesis,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22972,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22973,rabbits,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22974,were,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22975,fed,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22976,for,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22977,30,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22978,days,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22979,diets,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22980,containing,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22981,2,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22982,g,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22983,corn,B,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22984,oil/100,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22985,g,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22986,diet,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22987,(,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22988,low,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22989,fat,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22990,diet,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22991,),O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22992,or,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22993,low,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22994,fat,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22995,supplemented,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22996,with,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22997,16,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22998,g/100,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22999,g,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23000,diet,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23001,of,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23002,corn,B,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23003,oil,I,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23004,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23005,corn,B,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23006,oil,I,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23007,with,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23008,added,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23009,cholesterol,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23010,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23011,milk,B,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23012,fat,I,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23013,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23014,chicken,B,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23015,fat,I,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23016,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23017,beef,B,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23018,tallow,I,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23019,or,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23020,lard,B,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23021,.,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23096,The,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23097,significant,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23098,elevations,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23099,in,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23100,linoleic,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23101,acid,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23102,[,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23103,18:2(n-6,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23104,),O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23105,],O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23106,in,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23107,serum,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23108,and,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23109,LDL,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23110,may,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23111,partially,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23112,explain,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23113,the,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23114,high,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23115,oxidizability,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23116,of,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23117,LDL,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23118,in,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23119,rabbits,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23120,fed,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23121,corn,B,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23122,oil,I,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23123,.,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23165,Dietary,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23166,cholesterol,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23167,supplementation,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23168,to,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23169,the,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23170,corn,B,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23171,oil,I,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23172,diet,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23173,decreased,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23174,oxidizability,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23175,of,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23176,LDL,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23177,and,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23178,partially,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23179,protected,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23180,the,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23181,oxidized,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23182,LDL,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23183,-,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23184,mediated,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23185,endothelial,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23186,cell,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23187,dysfunction,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23188,as,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23189,compared,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23190,with,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23191,the,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23192,corn,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23193,oil,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23194,diet,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23195,group,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23196,.,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23498,In,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23499,the,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23500,present,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23501,article,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23502,",",O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23503,we,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23504,review,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23505,those,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23506,observational,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23507,studies,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23508,that,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23509,evaluated,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23510,the,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23511,association,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23512,between,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23513,yogurt,B,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23514,consumption,I,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23515,and,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23516,type,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23517,2,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23518,diabetes,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23519,.,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23567,In,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23568,addition,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23569,to,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23570,the,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23571,scientific,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23572,evidence,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23573,accumulated,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23574,from,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23575,individual,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23576,prospective,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23577,studies,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23578,",",O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23579,several,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23580,meta,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23581,-,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23582,analyses,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23583,have,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23584,shown,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23585,that,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23586,yogurt,B,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23587,consumption,I,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23588,has,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23589,a,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23590,potential,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23591,role,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23592,in,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23593,diabetes,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23594,prevention,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23595,.,O,790.0,"In addition to the scientific evidence accumulated from individual prospective studies , several meta - analyses have shown that yogurt consumption has a potential role in diabetes prevention ."
23721,Changes,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23722,in,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23723,our,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23724,understanding,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23725,of,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23726,diet,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23727,and,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23728,health,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23729,drive,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23730,changes,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23731,in,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23732,the,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23733,way,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23734,foods,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23735,are,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23736,processed,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23737,.,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
24051,Effects,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24052,of,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24053,pasteurization,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24054,",",O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24055,fat,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24056,addition,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24057,",",O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24058,and,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24059,curd,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24060,disruption,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24061,followed,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24062,by,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24063,repressing,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24064,were,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24065,studied,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24066,.,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24480,Fermented,B,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24481,milk,I,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24482,is,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24483,now,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24484,also,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24485,recognized,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24486,to,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24487,contain,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24488,highly,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24489,active,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24490,components,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24491,such,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24492,as,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24493,vitamins,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24494,",",O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24495,peptides,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24496,",",O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24497,oligosaccharides,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24498,",",O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24499,and,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24500,organic,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24501,acids,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24502,.,O,825.0,"Fermented milk is now also recognized to contain highly active components such as vitamins , peptides , oligosaccharides , and organic acids ."
24503,In,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24504,this,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24505,review,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24506,",",O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24507,the,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24508,role,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24509,of,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24510,milk,B,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24511,and,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24512,milk,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24513,components,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24514,in,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24515,improving,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24516,calcium,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24517,absorption,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24518,and,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24519,thereby,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24520,supporting,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24521,bone,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24522,health,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24523,is,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24524,discussed,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24525,.,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
25161,The,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25162,protective,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25163,effect,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25164,does,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25165,not,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25166,seem,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25167,to,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25168,be,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25169,due,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25170,to,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25171,cholesterol,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25172,-,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25173,lowering,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25174,.,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25493,Skin,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25494,prick,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25495,test,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25496,performed,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25497,with,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25498,the,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25499,formula,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25500,feed,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25501,components,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25502,showed,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25503,positive,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25504,reactions,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25505,to,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25506,cereal,B,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25507,flours,I,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25508,(,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25509,wheat,B,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25510,",",O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25511,rye,B,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25512,and,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25513,barley,B,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25514,),O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25515,and,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25516,negative,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25517,to,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25518,the,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25519,other,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25520,substances,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25521,in,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25522,these,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25523,formulas,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25524,.,O,859.0,"Skin prick test performed with the formula feed components showed positive reactions to cereal flours ( wheat , rye and barley ) and negative to the other substances in these formulas ."
25813,Gastric,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25814,proteolysis,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25815,was,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25816,not,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25817,influenced,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25818,by,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25819,the,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25820,nature,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25821,of,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25822,dietary,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25823,fats,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25824,.,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
26181,Epidemiological,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26182,and,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26183,clinical,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26184,studies,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26185,have,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26186,pointed,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26187,out,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26188,that,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26189,regular,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26190,and,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26191,moderate,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26192,wine,B,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26193,consumption,I,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26194,(,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26195,one,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26196,to,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26197,two,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26198,glasses,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26199,a,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26200,day,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26201,),O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26202,is,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26203,associated,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26204,with,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26205,decreased,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26206,incidence,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26207,of,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26208,cardiovascular,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26209,disease,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26210,(,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26211,CVD,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26212,),O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26213,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26214,hypertension,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26215,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26216,diabetes,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26217,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26218,and,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26219,certain,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26220,types,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26221,of,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26222,cancer,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26223,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26224,including,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26225,colon,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26226,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26227,basal,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26228,cell,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26229,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26230,ovarian,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26231,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26232,and,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26233,prostate,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26234,carcinoma,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26235,.,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26293,This,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26294,review,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26295,summarizes,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26296,the,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26297,main,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26298,protective,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26299,effects,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26300,on,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26301,the,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26302,cardiovascular,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26303,system,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26304,and,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26305,cancer,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26306,resulting,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26307,from,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26308,moderate,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26309,wine,B,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26310,and,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26311,beer,B,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26312,intake,I,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26313,due,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26314,mainly,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26315,to,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26316,their,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26317,common,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26318,components,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26319,",",O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26320,alcohol,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26321,and,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26322,polyphenols,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26323,.,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26579,The,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26580,assessments,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26581,supplemented,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26582,and,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26583,completed,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26584,our,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26585,understanding,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26586,of,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26587,stakeholders,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26588,',O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26589,needs,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26590,in,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26591,management,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26592,and,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26593,processing,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26594,of,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26595,milk,B,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26596,.,O,902.0,The assessments supplemented and completed our understanding of stakeholders ' needs in management and processing of milk .
26742,Continued,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26743,improvements,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26744,in,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26745,the,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26746,dairy,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26747,value,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26748,chain,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26749,depend,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26750,on,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26751,available,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26752,resources,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26753,for,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26754,education,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26755,.,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
27457,The,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27458,average,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27459,reduction,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27460,in,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27461,various,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27462,washing,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27463,solutions,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27464,ranged,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27465,from,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27466,10.21,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27467,to,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27468,79.68,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27469,%,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27470,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27471,22.60,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27472,to,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27473,89.48,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27474,%,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27475,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27476,22.95,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27477,to,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27478,94,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27479,-,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27480,21,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27481,%,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27482,and,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27483,11.24,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27484,-,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27485,70.32,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27486,%,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27487,for,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27488,the,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27489,removal,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27490,of,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27491,deltamethrin,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27492,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27493,cypermethrin,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27494,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27495,chlorpyrifos,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27496,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27497,and,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27498,endosulfan,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27499,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27500,respectively,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27501,.,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27808,A,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27809,field,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27810,survey,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27811,was,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27812,conducted,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27813,to,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27814,investigate,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27815,the,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27816,present,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27817,situation,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27818,and,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27819,health,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27820,risk,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27821,of,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27822,arsenic,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27823,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27824,As,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27825,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27826,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27827,lead,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27828,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27829,Pb,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27830,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27831,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27832,cadmium,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27833,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27834,Cd,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27835,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27836,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27837,copper,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27838,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27839,Cu,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27840,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27841,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27842,and,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27843,zinc,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27844,(,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27845,Zn,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27846,),O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27847,in,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27848,soils,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27849,and,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27850,vegetables,B,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27851,in,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27852,a,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27853,multi,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27854,-,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27855,metal,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27856,mining,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27857,area,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27858,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27859,Gejiu,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27860,",",O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27861,China,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
27862,.,O,945.0,"A field survey was conducted to investigate the present situation and health risk of arsenic ( As ) , lead ( Pb ) , cadmium ( Cd ) , copper ( Cu ) , and zinc ( Zn ) in soils and vegetables in a multi - metal mining area , Gejiu , China ."
28032,Although,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28033,the,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28034,total,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28035,and,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28036,bioavailable,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28037,Cd,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28038,were,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28039,high,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28040,in,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28041,soil,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28042,",",O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28043,its,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28044,speciation,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28045,in,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28046,vegetables,B,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28047,was,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28048,mainly,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28049,presented,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28050,as,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28051,HAc,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28052,-,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28053,extractable,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28054,fraction,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28055,",",O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28056,which,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28057,has,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28058,a,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28059,relatively,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28060,low,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28061,bioactivity,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28062,.,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28063,Lead,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28064,and,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28065,arsenic,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28066,were,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28067,imposing,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28068,a,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28069,serious,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28070,threat,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28071,on,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28072,the,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28073,local,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28074,residents,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28075,via,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28076,vegetable,B,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28077,consumption,I,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28078,.,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28776,School,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28777,meal,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28778,programs,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28779,make,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28780,fluid,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28781,milk,B,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28782,accessible,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28783,to,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28784,millions,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28785,of,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28786,children,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28787,each,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28788,day,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28789,;,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28790,however,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28791,",",O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28792,regulations,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28793,and,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28794,school,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28795,lunch,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28796,procurement,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28797,systems,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28798,in,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28799,the,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28800,United,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28801,States,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28802,sometimes,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28803,make,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28804,it,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28805,difficult,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28806,to,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28807,provide,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28808,novel,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28809,or,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28810,value,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28811,-,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28812,added,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28813,milk,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28814,products,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28815,in,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28816,these,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28817,programs,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28818,.,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
29361,However,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29362,",",O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29363,spices,B,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29364,and,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29365,herbs,B,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29366,cultivated,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29367,mainly,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29368,in,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29369,tropic,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29370,and,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29371,subtropic,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29372,areas,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29373,can,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29374,be,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29375,exposed,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29376,to,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29377,contamination,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29378,with,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29379,toxigenic,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29380,fungi,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29381,and,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29382,subsequently,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29383,mycotoxins,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29384,.,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29874,Changes,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29875,in,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29876,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29877,gene,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29878,expression,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29879,of,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29880,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29881,HA,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29882,group,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29883,were,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29884,produced,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29885,by,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29886,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29887,high,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29888,consumption,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29889,of,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29890,fat,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29891,",",O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29892,whereas,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29893,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29894,consumption,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29895,of,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29896,tomato,B,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29897,juice,I,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29898,had,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29899,different,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29900,effects,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29901,",",O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29902,depending,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29903,on,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29904,the,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29905,diet,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
29906,.,O,1012.0,"Changes in the gene expression of the HA group were produced by the high consumption of fat , whereas the consumption of tomato juice had different effects , depending on the diet ."
30400,Alongside,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30401,modest,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30402,contributions,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30403,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30404,chicken,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30405,-,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30406,keeping,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30407,to,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30408,some,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30409,improved,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30410,dietary,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30411,outcomes,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30412,",",O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30413,this,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30414,study,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30415,importantly,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30416,(,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30417,and,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30418,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30419,substantial,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30420,practical,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30421,significance,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30422,if,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30423,confirmed,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30424,),O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30425,found,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30426,no,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30427,indication,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30428,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30429,a,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30430,heightened,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30431,risk,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30432,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30433,stunting,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30434,or,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30435,greater,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30436,frequency,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30437,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30438,diarrhea,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30439,being,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30440,associated,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30441,with,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30442,chicken,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30443,-,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30444,keeping,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30445,or,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30446,the,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30447,practice,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30448,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30449,keeping,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30450,chickens,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30451,within,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30452,human,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30453,dwellings,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30454,overnight,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30455,.,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
31041,Polyphenols,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31042,are,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31043,the,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31044,most,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31045,abundant,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31046,antioxidants,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31047,in,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31048,the,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31049,diet,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31050,and,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31051,are,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31052,widespread,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31053,constituents,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31054,of,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31055,fruits,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31056,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31057,vegetables,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31058,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31059,cereals,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31060,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31061,dry,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31062,legumes,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31063,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31064,chocolate,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31065,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31066,and,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31067,beverages,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31068,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31069,such,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31070,as,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31071,tea,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31072,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31073,coffee,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31074,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31075,or,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31076,wine,B,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31077,.,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31154,The,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31155,few,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31156,clinical,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31157,studies,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31158,on,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31159,biomarkers,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31160,of,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31161,oxidative,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31162,stress,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31163,",",O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31164,cardiovascular,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31165,disease,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31166,risk,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31167,factors,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31168,",",O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31169,and,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31170,tumor,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31171,or,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31172,bone,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31173,resorption,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31174,biomarkers,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31175,have,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31176,often,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31177,led,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31178,to,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31179,contradictory,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31180,results,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31181,.,O,1054.0,"The few clinical studies on biomarkers of oxidative stress , cardiovascular disease risk factors , and tumor or bone resorption biomarkers have often led to contradictory results ."
31341,Each,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31342,lipid,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31343,fraction,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31344,from,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31345,HPLC,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31346,separation,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31347,along,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31348,with,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31349,TL,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31350,",",O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31351,TPL,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31352,",",O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31353,and,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31354,TNL,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31355,lipid,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31356,samples,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31357,from,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31358,oils,B,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31359,were,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31360,tested,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31361,in,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31362,vitro,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31363,for,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31364,their,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31365,capacity,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31366,to,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31367,induce,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31368,or,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31369,to,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31370,inhibit,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31371,washed,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31372,rabbit,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31373,platelet,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31374,aggregation,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31375,.,O,1060.0,"Each lipid fraction from HPLC separation along with TL , TPL , and TNL lipid samples from oils were tested in vitro for their capacity to induce or to inhibit washed rabbit platelet aggregation ."
31835,Regardless,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31836,of,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31837,ethnic,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31838,group,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31839,or,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31840,energy,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31841,adjustment,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31842,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31843,high,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31844,and,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31845,frequent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31846,vegetable,B,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31847,consumption,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31848,(,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31849,particularly,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31850,dark,B,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31851,green,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31852,vegetables,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31853,),O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31854,was,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31855,protective,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31856,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31857,consistent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31858,with,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31859,20,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31860,-,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31861,50,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31862,%,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31863,reductions,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31864,in,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31865,risk,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31866,.,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
32042,Tea,B,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32043,",",O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32044,red,B,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32045,wine,I,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32046,and,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32047,cocoa,B,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32048,are,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32049,good,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32050,sources,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32051,of,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32052,flavanols,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32053,and,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32054,these,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32055,highly,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32056,consumed,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32057,foods,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32058,might,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32059,contribute,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32060,to,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32061,prevent,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32062,diabetes,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32063,.,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32436,The,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32437,allergenic,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32438,proteins,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32439,existing,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32440,in,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32441,the,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32442,buckwheat,B,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32443,seeds,I,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32444,and,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32445,their,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32446,derivatives,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32447,were,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32448,reviewed,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32449,with,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32450,respect,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32451,to,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32452,their,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32453,chemical,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32454,and,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32455,biochemical,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32456,characteristics,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32457,as,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32458,well,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32459,as,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32460,the,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32461,physiological,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32462,reactions,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32463,after,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32464,digestion,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32465,.,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
33351,),O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33352,and,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33353,recipes,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33354,of,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33355,bamboo,B,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33356,shoots,I,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33357,(,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33358,bamboo,B,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33359,beer,I,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33360,",",O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33361,bamboo,B,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33362,cookies,I,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33363,),O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33364,are,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33365,consumed,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33366,worldwide,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33367,.,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33506,are,O,1141.0,are now gaining importance .
33507,now,O,1141.0,are now gaining importance .
33508,gaining,O,1141.0,are now gaining importance .
33509,importance,O,1141.0,are now gaining importance .
33510,.,O,1141.0,are now gaining importance .
33597,Mitochondrial,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33598,ATPase,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33599,activity,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33600,",",O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33601,alpha,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33602,-,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33603,glycerophosphate,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33604,and,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33605,malate,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33606,-,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33607,aspartate,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33608,shuttle,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33609,activity,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33610,",",O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33611,and,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33612,succinate-,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33613,or,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33614,pyruvate,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33615,-,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33616,supported,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33617,respiration,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33618,were,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33619,determined,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33620,.,O,1146.0,"Mitochondrial ATPase activity , alpha - glycerophosphate and malate - aspartate shuttle activity , and succinate- or pyruvate - supported respiration were determined ."
33645,ATPase,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33646,activity,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33647,and,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33648,the,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33649,activity,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33650,of,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33651,the,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33652,malate,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33653,-,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33654,aspartate,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33655,shuttle,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33656,were,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33657,not,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33658,affected,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33659,by,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33660,diet,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33661,.,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33688,Succinate,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33689,-,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33690,supported,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33691,state,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33692,3,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33693,respiration,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33694,was,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33695,not,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33696,affected,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33697,by,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33698,diet,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33699,",",O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33700,whereas,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33701,succinate,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33702,-,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33703,supported,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33704,state,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33705,4,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33706,respiration,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33707,was,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33708,higher,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33709,in,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33710,mitochondria,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33711,from,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33712,rats,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33713,fed,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33714,coconut,B,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33715,oil,I,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33716,than,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33717,in,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33718,rats,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33719,fed,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33720,corn,B,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33721,oil,I,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33722,.,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33723,Evidence,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33724,of,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33725,uncoupling,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33726,of,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33727,pyruvate,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33728,-,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33729,supported,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33730,respiration,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33731,from,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33732,ATP,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33733,synthesis,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33734,was,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33735,observed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33736,in,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33737,mitochondria,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33738,from,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33739,rats,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33740,fed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33741,coconut,B,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33742,oil,I,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33743,but,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33744,not,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33745,in,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33746,rats,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33747,fed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33748,corn,B,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33749,oil,I,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33750,.,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33821,The,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33822,amount,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33823,and,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33824,source,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33825,of,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33826,fat,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33827,was,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33828,varied,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33829,in,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33830,diets,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33831,fed,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33832,to,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33833,anemic,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33834,rats,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33835,for,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33836,assaying,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33837,the,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33838,bioavailability,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33839,of,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33840,iron,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33841,from,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33842,turkey,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33843,meat,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33844,.,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33951,Differences,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33952,in,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33953,liver,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33954,iron,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33955,concentrations,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33956,among,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33957,treatments,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33958,were,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33959,minimal,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33960,even,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33961,when,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33962,the,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33963,low,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33964,-,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33965,iron,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33966,",",O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33967,basal,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33968,diet,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33969,treatment,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33970,is,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33971,included,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33972,in,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33973,the,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33974,comparisons,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
33975,.,O,1159.0,"Differences in liver iron concentrations among treatments were minimal even when the low - iron , basal diet treatment is included in the comparisons ."
34194,The,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34195,food,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34196,that,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34197,was,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34198,most,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34199,closely,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34200,correlated,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34201,with,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34202,the,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34203,mortality,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34204,rate,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34205,of,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34206,prostatic,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34207,cancer,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34208,was,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34209,milk,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34210,(,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34211,r,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34212,=,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34213,0.766,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34214,),O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34215,",",O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34216,followed,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34217,by,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34218,coffee,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34219,",",O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34220,cheese,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34221,and,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34222,animal,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34223,fats,I,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34224,.,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
35048,Food,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35049,manufacturers,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35050,have,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35051,the,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35052,responsibility,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35053,to,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35054,declare,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35055,the,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35056,presence,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35057,of,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35058,walnuts,B,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35059,on,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35060,packaged,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35061,foods,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35062,even,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35063,when,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35064,trace,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35065,residues,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35066,may,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35067,be,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35068,present,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35069,from,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35070,the,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35071,use,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35072,of,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35073,shared,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35074,equipment,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35075,or,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35076,the,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35077,adventitious,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35078,contamination,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35079,of,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35080,ingredients,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35081,.,O,1195.0,Food manufacturers have the responsibility to declare the presence of walnuts on packaged foods even when trace residues may be present from the use of shared equipment or the adventitious contamination of ingredients .
35185,The,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35186,performance,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35187,of,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35188,the,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35189,ELISA,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35190,was,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35191,validated,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35192,by,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35193,testing,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35194,known,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35195,amounts,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35196,of,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35197,walnut,B,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35198,(,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35199,0,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35200,to,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35201,100,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35202,ppm,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35203,),O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35204,either,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35205,spiked,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35206,into,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35207,or,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35208,manufactured,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35209,into,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35210,milk,B,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35211,chocolate,I,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35212,",",O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35213,cookies,B,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35214,",",O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35215,muffins,B,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35216,",",O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35217,or,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35218,ice,B,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35219,cream,I,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
35220,.,O,1199.0,"The performance of the ELISA was validated by testing known amounts of walnut ( 0 to 100 ppm ) either spiked into or manufactured into milk chocolate , cookies , muffins , or ice cream ."
36650,The,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36651,plasticity,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36652,of,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36653,cancer,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36654,patterns,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36655,implicates,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36656,environmental,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36657,factors,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36658,as,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36659,determinants,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36660,of,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36661,cancer,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36662,",",O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36663,and,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36664,nutrition,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36665,influences,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36666,key,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36667,cellular,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36668,and,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36669,molecular,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36670,processes,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36671,that,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36672,characterise,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36673,cancer,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36674,.,O,1254.0,"The plasticity of cancer patterns implicates environmental factors as determinants of cancer , and nutrition influences key cellular and molecular processes that characterise cancer ."
36992,Among,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36993,their,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36994,bioactive,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36995,components,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36996,",",O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36997,flavonoids,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36998,have,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
36999,been,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37000,found,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37001,to,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37002,be,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37003,active,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37004,against,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37005,liver,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37006,dysfunction,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37007,and,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37008,damage,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37009,caused,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37010,by,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37011,liver,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37012,diseases,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37013,.,O,1266.0,"Among their bioactive components , flavonoids have been found to be active against liver dysfunction and damage caused by liver diseases ."
37244,The,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37245,Reference,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37246,Doses,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37247,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37248,in,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37249,terms,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37250,of,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37251,mg,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37252,of,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37253,total,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37254,protein,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37255,from,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37256,the,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37257,allergenic,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37258,food,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37259,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37260,were,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37261,based,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37262,upon,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37263,either,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37264,the,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37265,ED01,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37266,(,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37267,for,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37268,peanut,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37269,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37270,cow,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37271,'s,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37272,milk,I,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37273,),O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37274,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37275,the,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37276,95,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37277,%,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37278,lower,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37279,confidence,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37280,interval,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37281,of,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37282,the,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37283,ED05,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37284,(,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37285,for,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37286,wheat,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37287,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37288,soybean,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37289,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37290,cashew,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37291,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37292,shrimp,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37293,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37294,sesame,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37295,seed,I,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37296,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37297,mustard,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37298,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37299,and,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37300,lupine,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37301,),O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37302,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37303,or,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37304,both,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37305,(,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37306,egg,B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37307,",",B,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37308,hazelnut,I,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37309,),O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37310,using,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37311,all,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37312,appropriate,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37313,statistical,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37314,dose,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37315,-,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37316,distribution,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37317,models,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37318,.,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37386,The,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37387,calcium,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37388,economy,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37389,is,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37390,a,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37391,dynamic,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37392,state,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37393,influenced,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37394,by,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37395,fluxes,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37396,in,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37397,dietary,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37398,calcium,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37399,intake,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37400,",",O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37401,intestinal,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37402,calcium,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37403,absorption,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37404,",",O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37405,and,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37406,renal,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37407,calcium,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37408,conservation,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37409,.,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37410,The,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37411,relationship,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37412,of,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37413,selected,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37414,bone,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37415,-,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37416,related,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37417,nutrients,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37418,to,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37419,these,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37420,calcium,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37421,fluxes,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37422,exhibits,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37423,both,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37424,constructive,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37425,and,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37426,destructive,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37427,interactions,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37428,that,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37429,affect,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37430,the,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37431,overall,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37432,state,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37433,of,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37434,calcium,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37435,balance,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37436,.,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37886,Rats,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37887,fed,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37888,a,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37889,diet,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37890,based,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37891,on,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37892,beef,B,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37893,",",O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37894,pork,B,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37895,",",O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37896,or,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37897,chicken,B,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37898,meat,I,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37899,had,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37900,less,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37901,fecal,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37902,NOC,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37903,than,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37904,controls,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37905,(,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37906,most,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37907,p,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37908,<,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37909,0.01,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37910,),O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37911,.,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37953,In,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37954,contrast,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37955,",",O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37956,the,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37957,bacon,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37958,-,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37959,based,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37960,diet,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37961,consistently,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37962,reduced,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37963,the,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37964,number,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37965,of,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37966,large,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37967,ACF,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37968,per,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37969,rat,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37970,and,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37971,the,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37972,ACF,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37973,multiplicity,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37974,in,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37975,the,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37976,three,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37977,promotion,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37978,studies,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37979,by,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37980,12,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37981,%,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37982,",",O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37983,17,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37984,%,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37985,",",O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37986,and,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37987,20,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37988,%,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37989,(,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37990,all,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37991,p,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37992,<,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37993,0.01,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37994,),O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37995,.,O,1303.0,"In contrast , the bacon - based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12 % , 17 % , and 20 % ( all p < 0.01 ) ."
37996,Results,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37997,suggest,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37998,that,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37999,NOC,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38000,from,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38001,dietary,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38002,bacon,B,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38003,would,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38004,not,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38005,enhance,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38006,colon,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38007,carcinogenesis,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38008,in,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38009,rats,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38010,.,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38546,β,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38547,-,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38548,Carotene,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38549,",",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38550,total,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38551,phenolics,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38552,and,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38553,gallic,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38554,acid,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38555,contents,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38556,and,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38557,the,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38558,antioxidant,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38559,capacity,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38560,",",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38561,measured,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38562,by,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38563,the,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38564,ferric,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38565,reducing,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38566,/,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38567,antioxidant,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38568,power,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38569,and,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38570,the,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38571,"2,2",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38572,-,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38573,"diphenyl-1,1",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38574,-,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38575,picrylhydrazyl,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38576,radical,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38577,scavenging,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38578,assays,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38579,",",O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38580,were,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38581,analyzed,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38582,in,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38583,each,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38584,aqueous,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38585,extract,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38586,.,O,1325.0,"β - Carotene , total phenolics and gallic acid contents and the antioxidant capacity , measured by the ferric reducing / antioxidant power and the 2,2 - diphenyl-1,1 - picrylhydrazyl radical scavenging assays , were analyzed in each aqueous extract ."
38925,Inverse,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38926,associations,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38927,were,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38928,found,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38929,for,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38930,consumption,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38931,of,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38932,wine,B,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38933,and,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38934,liquor,B,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38935,",",O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38936,but,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38937,not,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38938,beer,B,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
38939,.,O,1338.0,"Inverse associations were found for consumption of wine and liquor , but not beer ."
39021,Crossed,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39022,line,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39023,immunoelectrophoresis,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39024,(,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39025,CLIE,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39026,),O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39027,was,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39028,used,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39029,to,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39030,show,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39031,that,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39032,a,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39033,minor,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39034,allergen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39035,present,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39036,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39037,birch,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39038,pollen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39039,and,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39040,another,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39041,present,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39042,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39043,timothy,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39044,pollen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39045,shared,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39046,common,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39047,epitopes,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39048,with,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39049,antigens,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39050,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39051,apple,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39052,",",O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39053,carrot,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39054,and,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39055,celery,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39056,tuber,I,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39057,.,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39095,In,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39096,crossed,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39097,immunoelectrophoresis,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39098,(,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39099,CIE,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39100,),O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39101,of,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39102,samples,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39103,of,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39104,apple,B,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39105,",",O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39106,carrot,B,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39107,or,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39108,celery,B,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39109,extracts,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39110,towards,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39111,antibodies,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39112,against,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39113,birch,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39114,pollen,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39115,",",O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39116,grass,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39117,pollen,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39118,or,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39119,mugwort,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39120,pollen,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39121,",",O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39122,four,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39123,to,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39124,14,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39125,distinct,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39126,precipitates,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39127,were,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39128,observed,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39129,and,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39130,shown,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39131,to,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39132,be,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39133,specific,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39134,.,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39135,In,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39136,crossed,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39137,radioimmunoelectrophoresis,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39138,(,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39139,CRIE,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39140,),O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39141,none,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39142,of,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39143,the,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39144,precipitates,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39145,could,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39146,be,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39147,shown,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39148,to,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39149,act,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39150,as,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39151,an,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39152,allergen,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39153,.,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39294,We,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39295,also,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39296,discuss,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39297,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39298,major,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39299,contribution,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39300,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39301,obesity,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39302,and,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39303,alcohol,B,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39304,to,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39305,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39306,ten,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39307,most,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39308,common,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39309,cancers,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39310,as,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39311,well,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39312,as,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39313,measures,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39314,outlined,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39315,by,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39316,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39317,departing,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39318,Chief,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39319,Medical,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39320,Officer,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39321,to,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39322,combat,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39323,rising,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39324,levels,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39325,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39326,obesity,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39327,-,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39328,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39329,highest,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39330,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39331,any,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39332,country,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39333,in,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39334,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39335,west,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39336,.,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39495,Understanding,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39496,of,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39497,the,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39498,harm,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39499,to,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39500,health,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39501,from,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39502,lifestyle,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39503,causes,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39504,among,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39505,the,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39506,general,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39507,population,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39508,is,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39509,low,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39510,",",O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39511,with,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39512,a,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39513,poor,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39514,knowledge,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39515,of,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39516,alcohol,B,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39517,consumption,I,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39518,and,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39519,dietary,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39520,guidelines,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39521,.,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39522,The,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39523,Lancet,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39524,Commission,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39525,has,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39526,serious,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39527,doubts,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39528,about,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39529,whether,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39530,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39531,initiatives,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39532,described,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39533,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39534,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39535,Prevention,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39536,Green,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39537,Paper,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39538,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39539,with,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39540,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39541,onus,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39542,placed,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39543,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39544,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39545,individual,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39546,based,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39547,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39548,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39549,use,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39550,of,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39551,information,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39552,technology,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39553,and,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39554,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39555,latest,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39556,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39557,behavioural,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39558,science,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39559,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39560,will,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39561,be,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39562,effective,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39563,.,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39806,Although,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39807,cholesterol,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39808,oxidation,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39809,products,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39810,were,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39811,not,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39812,accumulated,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39813,in,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39814,serum,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39815,",",O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39816,significant,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39817,amounts,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39818,were,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39819,accumulated,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39820,in,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39821,liver,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39822,only,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39823,when,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39824,ghee,B,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39825,was,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39826,fed,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39827,as,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39828,a,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39829,sole,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39830,source,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39831,of,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39832,fat,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39833,at,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39834,a,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39835,10,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39836,%,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39837,level,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
39838,.,O,1369.0,"Although cholesterol oxidation products were not accumulated in serum , significant amounts were accumulated in liver only when ghee was fed as a sole source of fat at a 10 % level ."
40151,In,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40152,conclusion,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40153,",",O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40154,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40155,middle,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40156,-,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40157,aged,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40158,and,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40159,elderly,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40160,moderately,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40161,hypercholesterolemic,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40162,subjects,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40163,",",O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40164,the,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40165,consumption,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40166,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40167,reduced,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40168,-,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40169,fat,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40170,diets,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40171,enriched,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40172,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40173,animal,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40174,fat,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40175,or,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40176,vegetable,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40177,oils,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40178,with,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40179,a,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40180,relatively,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40181,wide,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40182,range,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40183,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40184,fatty,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40185,acid,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40186,profiles,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40187,did,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40188,not,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40189,alter,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40190,the,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40191,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40192,vitro,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40193,susceptibility,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40194,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40195,LDL,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40196,to,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40197,oxidation,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40198,.,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40484,Weight,O,1388.0,Weight was closely associated with skinfold thickness .
40485,was,O,1388.0,Weight was closely associated with skinfold thickness .
40486,closely,O,1388.0,Weight was closely associated with skinfold thickness .
40487,associated,O,1388.0,Weight was closely associated with skinfold thickness .
40488,with,O,1388.0,Weight was closely associated with skinfold thickness .
40489,skinfold,O,1388.0,Weight was closely associated with skinfold thickness .
40490,thickness,O,1388.0,Weight was closely associated with skinfold thickness .
40491,.,O,1388.0,Weight was closely associated with skinfold thickness .
40809,The,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40810,differences,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40811,in,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40812,concentrations,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40813,of,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40814,luminal,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40815,surfactants,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40816,in,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40817,fecal,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40818,water,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40819,of,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40820,rats,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40821,fed,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40822,the,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40823,three,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40824,fat,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40825,diets,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40826,resulted,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40827,in,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40828,a,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40829,fat,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40830,type,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40831,-,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40832,dependent,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40833,cytotoxicity,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40834,of,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40835,fecal,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40836,water,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40837,",",O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40838,with,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40839,that,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40840,of,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40841,palm,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40842,oil,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40843,-,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40844,fed,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40845,rats,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40846,the,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40847,most,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40848,cytotoxic,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40849,.,O,1399.0,"The differences in concentrations of luminal surfactants in fecal water of rats fed the three fat diets resulted in a fat type - dependent cytotoxicity of fecal water , with that of palm oil - fed rats the most cytotoxic ."
40899,The,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40900,concentration,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40901,of,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40902,surfactants,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40903,in,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40904,fecal,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40905,water,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40906,and,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40907,cytotoxicity,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40908,were,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40909,correlated,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40910,by,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40911,multiple,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40912,regression,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40913,analysis,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40914,(,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40915,R,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40916,=,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40917,0.89,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40918,),O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40919,.,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
41071,They,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41072,were,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41073,recruited,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41074,from,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41075,Hordaland,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41076,county,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41077,of,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41078,western,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41079,Norway,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41080,in,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41081,1992,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41082,-,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41083,1993,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41084,.,O,1408.0,They were recruited from Hordaland county of western Norway in 1992 - 1993 .
41228,The,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41229,combination,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41230,of,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41231,cigarette,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41232,smoking,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41233,and,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41234,high,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41235,coffee,B,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41236,intake,I,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41237,was,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41238,associated,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41239,with,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41240,particularly,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41241,high,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41242,tHcy,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41243,concentrations,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41244,.,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41404,Glycemic,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41405,indices,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41406,for,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41407,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41408,rice,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41409,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41410,38,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41411,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41412,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41413,6,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41414,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41415,and,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41416,almond,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41417,meals,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41418,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41419,55,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41420,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41421,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41422,7,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41423,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41424,were,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41425,less,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41426,than,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41427,for,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41428,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41429,potato,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41430,meal,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41431,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41432,94,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41433,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41434,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41435,11,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41436,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41437,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41438,P,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41439,<,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41440,0.003,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41441,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41442,",",O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41443,as,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41444,were,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41445,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41446,postprandial,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41447,areas,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41448,under,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41449,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41450,insulin,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41451,concentration,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41452,time,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41453,curve,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41454,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41455,P,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41456,<,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41457,0.001,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41458,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41459,.,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
42000,This,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42001,cross,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42002,-,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42003,sectional,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42004,study,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42005,used,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42006,the,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42007,database,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42008,compiled,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42009,in,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42010,Taiwan,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42011,between,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42012,2001,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42013,to,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42014,2010,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42015,.,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42805,Overall,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42806,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42807,we,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42808,recommend,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42809,breast,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42810,cancer,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42811,patients,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42812,consume,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42813,a,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42814,diet,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42815,naturally,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42816,high,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42817,in,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42818,flavonol,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42819,polyphenols,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42820,including,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42821,tea,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42822,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42823,vegetables,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42824,(,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42825,onion,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42826,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42827,broccoli,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42828,),O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42829,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42830,and,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42831,fruit,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42832,(,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42833,apples,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42834,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42835,citrus,B,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42836,),O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42837,.,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
43364,More,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43365,studies,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43366,are,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43367,required,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43368,powered,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43369,for,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43370,primary,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43371,clinical,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43372,outcomes,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43373,together,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43374,with,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43375,the,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43376,development,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43377,of,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43378,standardized,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43379,product,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43380,formulations,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43381,that,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43382,optimize,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43383,the,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43384,dose,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43385,of,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43386,polyphenols,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43387,within,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43388,a,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43389,palatable,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43390,and,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43391,energy,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43392,-,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43393,restricted,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43394,product,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43395,.,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43438,We,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43439,investigated,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43440,associations,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43441,of,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43442,rice,B,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43443,intake,I,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43444,",",O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43445,a,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43446,marker,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43447,of,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43448,arsenic,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43449,exposure,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43450,",",O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43451,with,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43452,subclinical,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43453,cardiovascular,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43454,disease,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43455,(,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43456,CVD,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43457,),O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43458,markers,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43459,in,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43460,a,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43461,multiethnic,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43462,population,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43463,.,O,1492.0,"We investigated associations of rice intake , a marker of arsenic exposure , with subclinical cardiovascular disease ( CVD ) markers in a multiethnic population ."
43761,A,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43762,diet,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43763,rich,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43764,in,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43765,fruits,B,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43766,",",O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43767,vegetables,B,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43768,and,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43769,minimally,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43770,refined,B,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43771,cereals,I,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43772,is,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43773,associated,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43774,with,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43775,lower,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43776,risk,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43777,for,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43778,chronic,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43779,degenerative,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43780,diseases,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43781,.,O,1504.0,"A diet rich in fruits , vegetables and minimally refined cereals is associated with lower risk for chronic degenerative diseases ."
43929,These,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43930,data,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43931,are,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43932,in,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43933,accordance,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43934,with,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43935,our,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43936,present,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43937,extended,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43938,analysis,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43939,of,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43940,an,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43941,earlier,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43942,report,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43943,on,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43944,nut,B,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43945,intake,I,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43946,and,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43947,death,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43948,attributed,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43949,to,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43950,various,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43951,diseases,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43952,in,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43953,the,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43954,Iowa,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43955,Women,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43956,'s,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43957,Health,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43958,Study,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43959,.,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
44193,In,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44194,analyses,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44195,focusing,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44196,on,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44197,nutrients,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44198,",",O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44199,rather,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44200,than,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44201,foods,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44202,",",O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44203,polyunsaturated,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44204,fats,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44205,were,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44206,positively,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44207,and,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44208,vitamin,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44209,E,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44210,inversely,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44211,associated,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44212,with,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44213,prostate,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44214,cancer,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44215,.,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44283,The,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44284,commonest,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44285,foods,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44286,causing,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44287,reactions,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44288,were,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44289,wheat,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44290,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44291,78,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44292,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44293,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44294,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44295,orange,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44296,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44297,65,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44298,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44299,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44300,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44301,eggs,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44302,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44303,45,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44304,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44305,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44306,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44307,tea,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44308,and,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44309,coffee,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44310,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44311,40,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44312,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44313,each,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44314,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44315,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44316,chocolate,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44317,and,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44318,milk,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44319,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44320,37,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44321,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44322,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44323,each,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44324,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44325,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44326,beef,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44327,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44328,35,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44329,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44330,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44331,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44332,and,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44333,corn,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44334,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44335,cane,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44336,sugar,I,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44337,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44338,and,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44339,yeast,B,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44340,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44341,33,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44342,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44343,each,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44344,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44345,.,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44346,When,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44347,an,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44348,average,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44349,of,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44350,ten,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44351,common,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44352,foods,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44353,were,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44354,avoided,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44355,there,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44356,was,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44357,a,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44358,dramatic,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44359,fall,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44360,in,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44361,the,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44362,number,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44363,of,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44364,headaches,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44365,per,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44366,month,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44367,",",O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44368,85,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44369,%,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44370,of,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44371,patients,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44372,becoming,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44373,headache,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44374,-,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44375,free,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44376,.,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44716,High,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44717,intake,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44718,of,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44719,red,B,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44720,meat,I,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44721,or,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44722,processed,B,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44723,meat,I,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44724,is,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44725,associated,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44726,with,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44727,increased,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44728,risk,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44729,of,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44730,colon,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44731,cancer,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44732,.,O,1542.0,High intake of red meat or processed meat is associated with increased risk of colon cancer .
44758,We,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44759,speculated,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44760,that,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44761,a,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44762,diet,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44763,containing,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44764,beef,B,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44765,or,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44766,bacon,B,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44767,would,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44768,increase,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44769,and,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44770,a,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44771,diet,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44772,containing,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44773,chicken,B,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44774,would,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44775,decrease,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44776,colon,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44777,carcinogenesis,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44778,in,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44779,rats,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44780,.,O,1544.0,We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats .
44872,Meat,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44873,diets,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44874,contained,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44875,30,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44876,%,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44877,or,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44878,60,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44879,%,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44880,freeze,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44881,-,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44882,dried,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44883,fried,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44884,meat,B,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44885,.,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
45138,Dairy,B,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45139,products,I,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45140,are,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45141,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45142,main,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45143,source,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45144,of,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45145,calcium,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45146,(,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45147,Ca,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45148,),O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45149,",",O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45150,but,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45151,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45152,loss,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45153,of,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45154,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45155,consumption,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45156,habit,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45157,contributes,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45158,to,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45159,low,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45160,consumption,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45161,in,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45162,adulthood,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45163,",",O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45164,which,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45165,leads,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45166,to,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45167,osteoporosis,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45168,and,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45169,increased,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45170,fracture,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45171,risk,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45172,.,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45272,Intestinal,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45273,Ca,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45274,absorption,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45275,was,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45276,not,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45277,different,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45278,between,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45279,both,B,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45280,milks,I,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45281,and,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45282,an,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45283,increase,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45284,in,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45285,urinary,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45286,Ca,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45287,excretion,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45288,was,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45289,observed,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45290,in,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45291,humans,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45292,.,O,1565.0,Intestinal Ca absorption was not different between both milks and an increase in urinary Ca excretion was observed in humans .
45316,It,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45317,has,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45318,been,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45319,suggested,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45320,that,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45321,diet,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45322,may,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45323,influence,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45324,the,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45325,risk,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45326,of,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45327,melanoma,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45328,",",O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45329,but,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45330,few,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45331,studies,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45332,are,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45333,available,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45334,on,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45335,this,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45336,topic,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45337,.,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45382,Dietary,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45383,habits,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45384,were,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45385,established,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45386,through,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45387,a,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45388,self,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45389,-,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45390,administered,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45391,semi,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45392,-,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45393,quantitative,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45394,food,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45395,frequency,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45396,questionnaire,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45397,.,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45525,Conversely,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45526,",",O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45527,an,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45528,inverse,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45529,association,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45530,with,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45531,disease,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45532,risk,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45533,was,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45534,found,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45535,for,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45536,the,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45537,intake,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45538,of,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45539,legumes,B,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45540,(,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45541,OR,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45542,=,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45543,0.77,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45544,;,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45545,95,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45546,%,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45547,CI,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45548,0.52,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45549,-,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45550,1.13,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45551,),O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45552,",",O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45553,olive,B,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45554,oil,I,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45555,(,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45556,OR,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45557,=,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45558,0.77,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45559,;,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45560,95,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45561,%,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45562,CI,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45563,0.51,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45564,-,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45565,1.16,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45566,),O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45567,",",O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45568,eggs,B,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45569,(,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45570,OR,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45571,=,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45572,0.58,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45573,;,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45574,95,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45575,%,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45576,CI,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45577,0.41,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45578,-,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45579,0.82,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45580,),O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45581,",",O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45582,and,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45583,onion,B,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45584,and,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45585,garlic,B,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45586,(,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45587,OR,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45588,=,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45589,0.80,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45590,;,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45591,95,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45592,%,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45593,CI,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45594,0.52,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45595,-,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45596,1.14,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45597,),O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45598,.,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45702,This,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45703,glycolipids,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45704,fraction,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45705,was,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45706,an,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45707,inhibitor,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45708,of,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45709,DNA,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45710,polymerase,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45711,alpha,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45712,(,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45713,pol,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45714,alpha,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45715,),O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45716,in,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45717,vitro,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45718,and,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45719,also,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45720,the,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45721,proliferation,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45722,of,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45723,human,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45724,cancer,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45725,cells,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45726,.,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
46117,Functional,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46118,foods,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46119,that,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46120,contain,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46121,significant,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46122,amounts,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46123,of,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46124,bioactive,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46125,components,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46126,may,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46127,provide,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46128,desirable,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46129,health,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46130,benefits,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46131,beyond,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46132,basic,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46133,nutrition,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46134,and,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46135,play,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46136,important,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46137,roles,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46138,in,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46139,the,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46140,prevention,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46141,of,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46142,chronic,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46143,diseases,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46144,.,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46373,In,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46374,particular,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46375,",",O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46376,rates,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46377,of,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46378,breast,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46379,and,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46380,prostate,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46381,cancers,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46382,remain,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46383,high,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46384,among,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46385,Adventist,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46386,populations,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46387,despite,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46388,an,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46389,overall,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46390,healthy,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46391,lifestyle,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46392,and,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46393,long,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46394,life,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46395,expectancy,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46396,.,O,1603.0,"In particular , rates of breast and prostate cancers remain high among Adventist populations despite an overall healthy lifestyle and long life expectancy ."
46734,Dietary,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46735,oxalate,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46736,can,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46737,contribute,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46738,considerably,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46739,to,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46740,the,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46741,amount,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46742,of,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46743,urinary,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46744,oxalate,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46745,excretion,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46746,.,O,1616.0,Dietary oxalate can contribute considerably to the amount of urinary oxalate excretion .
46791,A,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46792,high,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46793,total,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46794,oxalate,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46795,content,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46796,(,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46797,>,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46798,50,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46799,mg/100,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46800,g,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46801,),O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46802,was,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46803,found,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46804,in,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46805,whole,B,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46806,grain,I,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46807,wheat,I,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46808,species,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46809,Triticum,B,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46810,durum,I,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46811,(,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46812,76.6,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46813,mg/100,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46814,g,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46815,),O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46816,",",O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46817,Triticum,B,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46818,sativum,I,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46819,(,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46820,71.2,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46821,mg/100,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46822,g,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46823,),O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46824,",",O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46825,and,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46826,Triticum,B,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46827,aestivum,I,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46828,(,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46829,53.3,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46830,mg/100,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46831,g,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46832,),O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46833,.,O,1618.0,"A high total oxalate content ( > 50 mg/100 g ) was found in whole grain wheat species Triticum durum ( 76.6 mg/100 g ) , Triticum sativum ( 71.2 mg/100 g ) , and Triticum aestivum ( 53.3 mg/100 g ) ."
46877,The,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46878,highest,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46879,oxalate,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46880,content,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46881,was,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46882,demonstrated,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46883,for,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46884,wheat,B,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46885,bran,I,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46886,(,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46887,457.4,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46888,mg/100,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46889,g,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46890,),O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46891,.,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46974,Epidemiological,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46975,studies,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46976,suggest,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46977,that,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46978,the,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46979,consumption,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46980,of,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46981,tea,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46982,flavonoids,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46983,may,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46984,be,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46985,associated,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46986,with,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46987,reduced,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46988,risk,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46989,of,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46990,coronary,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46991,heart,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46992,disease,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46993,",",O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46994,stroke,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46995,and,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46996,cancer,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46997,-,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46998,related,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46999,deaths,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
47000,.,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
47323,Among,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47324,traditional,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47325,treatments,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47326,",",O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47327,dietary,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47328,habits,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47329,represent,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47330,one,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47331,of,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47332,the,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47333,most,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47334,difficult,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47335,and,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47336,controversial,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47337,aspects,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47338,to,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47339,implement,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47340,in,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47341,handling,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47342,metabolic,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47343,disturbances,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47344,.,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47798,Avoiding,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47799,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47800,high,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47801,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47802,fat,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47803,/,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47804,low,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47805,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47806,fibre,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47807,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47808,and,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47809,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47810,high,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47811,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47812,sugar,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47813,',O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47814,dietary,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47815,components,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47816,may,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47817,reduce,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47818,the,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47819,risk,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47820,of,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47821,cardiovascular,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47822,events,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47823,and,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47824,all,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47825,-,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47826,cause,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47827,mortality,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47828,in,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47829,older,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47830,adults,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47831,.,O,1652.0,Avoiding ' high - fat / low - fibre ' and ' high - sugar ' dietary components may reduce the risk of cardiovascular events and all - cause mortality in older adults .
47956,The,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47957,serum,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47958,insulin,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47959,area,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47960,response,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47961,was,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47962,3.6,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47963,-,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47964,fold,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47965,greater,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47966,following,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47967,ingestion,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47968,of,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47969,cottage,B,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47970,cheese,I,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47971,compared,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47972,with,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47973,egg,B,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47974,white,I,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47975,(,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47976,309,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47977,v,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47978,86,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47979,pmol,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47980,/,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47981,L.h,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47982,),O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47983,.,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
48100,Following,O,1662.0,"Following ingestion of glucose , it was negative ."
48101,ingestion,O,1662.0,"Following ingestion of glucose , it was negative ."
48102,of,O,1662.0,"Following ingestion of glucose , it was negative ."
48103,glucose,O,1662.0,"Following ingestion of glucose , it was negative ."
48104,",",O,1662.0,"Following ingestion of glucose , it was negative ."
48105,it,O,1662.0,"Following ingestion of glucose , it was negative ."
48106,was,O,1662.0,"Following ingestion of glucose , it was negative ."
48107,negative,O,1662.0,"Following ingestion of glucose , it was negative ."
48108,.,O,1662.0,"Following ingestion of glucose , it was negative ."
49063,The,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49064,Mediterranean,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49065,dietary,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49066,pattern,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49067,is,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49068,an,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49069,example,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49070,of,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49071,a,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49072,prudent,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49073,choice,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49074,of,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49075,lifestyle,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49076,and,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49077,scientifically,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49078,accepted,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49079,to,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49080,help,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49081,preserve,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49082,human,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49083,health,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49084,by,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49085,protecting,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49086,against,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49087,major,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49088,chronic,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49089,and,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49090,inflammatory,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49091,diseases,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49092,.,O,1695.0,The Mediterranean dietary pattern is an example of a prudent choice of lifestyle and scientifically accepted to help preserve human health by protecting against major chronic and inflammatory diseases .
49406,Subsequently,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49407,",",O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49408,milk,B,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49409,samples,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49410,were,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49411,taken,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49412,on,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49413,a,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49414,biweekly,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49415,basis,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49416,for,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49417,measurement,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49418,of,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49419,the,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49420,qSCC,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49421,.,O,1705.0,"Subsequently , milk samples were taken on a biweekly basis for measurement of the qSCC ."
49565,The,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49566,main,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49567,operators,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49568,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49569,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49570,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49571,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49572,sector,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49573,are,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49574,continuously,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49575,involved,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49576,in,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49577,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49578,development,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49579,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49580,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49581,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49582,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49583,mechanical,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49584,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49585,process,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49586,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49587,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49588,common,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49589,aim,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49590,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49591,increasing,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49592,both,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49593,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49594,quality,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49595,and,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49596,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49597,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49598,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49599,yield,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49600,coupled,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49601,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49602,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49603,potential,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49604,enhancement,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49605,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49606,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49607,working,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49608,efficiency,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49609,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49610,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49611,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49612,mill,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49613,.,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49808,Human,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49809,clinical,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49810,trials,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49811,have,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49812,demonstrated,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49813,the,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49814,cardiovascular,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49815,protective,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49816,properties,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49817,of,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49818,peanuts,B,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49819,and,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49820,peanut,B,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49821,oil,I,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49822,in,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49823,decreasing,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49824,total,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49825,and,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49826,low,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49827,density,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49828,lipoprotein,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49829,cholesterol,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49830,(,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49831,LDL,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49832,-,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49833,C,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49834,),O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49835,without,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49836,reducing,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49837,high,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49838,density,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49839,lipoprotein,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49840,cholesterol,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49841,(,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49842,HDL,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49843,-,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49844,C,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49845,),O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
49846,.,O,1718.0,Human clinical trials have demonstrated the cardiovascular protective properties of peanuts and peanut oil in decreasing total and low density lipoprotein cholesterol ( LDL - C ) without reducing high density lipoprotein cholesterol ( HDL - C ) .
51085,Confirmatory,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51086,factor,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51087,analysis,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51088,with,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51089,the,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51090,16,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51091,items,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51092,that,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51093,had,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51094,factor,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51095,loadings,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51096,of,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51097,at,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51098,least,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51099,0.60,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51100,validated,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51101,the,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51102,four,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51103,dietary,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51104,patterns,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51105,.,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51488,Aqueous,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51489,/,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51490,alcohol,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51491,-,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51492,soluble,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51493,prolamins,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51494,(,B,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51495,kafirins,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51496,),O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51497,from,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51498,different,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51499,sorghum,B,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51500,varieties,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51501,",",O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51502,including,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51503,pure,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51504,lines,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51505,and,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51506,hybrids,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51507,",",O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51508,were,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51509,evaluated,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51510,by,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51511,SDS,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51512,-,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51513,PAGE,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51514,and,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51515,HPLC,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51516,analyses,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51517,as,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51518,well,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51519,as,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51520,an,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51521,established,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51522,enzyme,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51523,-,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51524,linked,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51525,immunosorbent,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51526,assay,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51527,(,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51528,ELISA,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51529,),O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51530,based,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51531,on,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51532,the,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51533,R5,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51534,antibody,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51535,.,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51865,Since,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51866,January,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51867,2000,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51868,the,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51869,Chilean,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51870,Ministry,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51871,of,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51872,Health,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51873,has,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51874,required,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51875,the,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51876,fortification,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51877,of,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51878,wheat,B,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51879,flour,I,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51880,with,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51881,folic,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51882,acid,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51883,(,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51884,FA,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51885,),O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51886,at,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51887,a,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51888,concentration,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51889,of,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51890,2.2,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51891,mg,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51892,FA,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51893,/,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51894,kg,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51895,in,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51896,order,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51897,to,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51898,reduce,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51899,the,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51900,risk,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51901,of,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51902,neural,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51903,tube,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51904,defects,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51905,(,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51906,NTD,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51907,),O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51908,in,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51909,newborns,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
51910,.,O,1779.0,Since January 2000 the Chilean Ministry of Health has required the fortification of wheat flour with folic acid ( FA ) at a concentration of 2.2 mg FA / kg in order to reduce the risk of neural tube defects ( NTD ) in newborns .
52335,Particularly,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52336,with,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52337,green,B,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52338,tea,I,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52339,",",O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52340,the,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52341,doses,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52342,consumed,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52343,do,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52344,get,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52345,into,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52346,a,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52347,perceived,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52348,protective,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52349,range,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52350,in,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52351,a,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52352,significant,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52353,subset,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52354,of,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52355,the,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52356,population,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52357,.,O,1795.0,"Particularly with green tea , the doses consumed do get into a perceived protective range in a significant subset of the population ."
52375,There,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52376,is,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52377,no,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52378,consistent,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52379,adjustment,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52380,for,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52381,important,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52382,potential,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52383,confounders,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52384,of,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52385,any,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52386,tea,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52387,relationship,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52388,",",O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52389,such,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52390,as,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52391,coffee,B,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52392,and,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52393,alcohol,B,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52394,consumption,I,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52395,and,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52396,physical,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52397,activity,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52398,levels,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52399,.,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52814,Effects,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52815,of,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52816,spice,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52817,extracts,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52818,on,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52819,the,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52820,viability,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52821,of,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52822,88,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52823,anaerobic,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52824,and,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52825,facultative,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52826,isolates,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52827,from,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52828,intestinal,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52829,microbiota,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52830,were,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52831,determined,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52832,by,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52833,using,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52834,Brucella,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52835,agar,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52836,plates,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52837,containing,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52838,serial,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52839,dilutions,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52840,of,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52841,extracts,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52842,.,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
53308,Furthermore,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53309,",",O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53310,the,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53311,estimation,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53312,of,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53313,the,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53314,GI,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53315,of,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53316,a,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53317,mixed,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53318,meal,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53319,by,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53320,calculation,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53321,is,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53322,imprecise,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53323,.,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53901,Almond,B,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53902,is,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53903,among,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53904,the,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53905,most,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53906,popular,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53907,tree,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53908,nuts,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53909,worldwide,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53910,and,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53911,also,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53912,the,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53913,most,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53914,nut,B,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53915,cultivated,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53916,in,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53917,Spain,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53918,.,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
54160,However,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54161,",",O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54162,consumption,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54163,of,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54164,butter,B,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54165,and,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54166,yogurt,B,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54167,had,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54168,no,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54169,associations,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54170,with,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54171,the,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54172,risk,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54173,.,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54334,Some,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54335,42.3,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54336,%,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54337,had,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54338,family,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54339,history,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54340,of,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54341,atopia,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54342,",",O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54343,lower,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54344,than,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54345,in,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54346,the,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54347,control,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54348,group,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54349,(,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54350,P,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54351,<,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54352,0.05,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54353,),O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54354,",",O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54355,while,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54356,the,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54357,prevalence,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54358,of,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54359,asthma,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54360,and,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54361,urticaria,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54362,was,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54363,significantly,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54364,higher,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54365,(,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54366,P,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54367,<,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54368,0.05,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54369,),O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54370,.,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54504,We,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54505,concluded,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54506,that,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54507,mugwort,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54508,hay,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54509,fever,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54510,can,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54511,be,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54512,associated,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54513,with,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54514,the,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54515,Compositae,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54516,family,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54517,of,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54518,foods,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54519,",",O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54520,but,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54521,that,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54522,it,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54523,is,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54524,not,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54525,normally,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54526,associated,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54527,with,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54528,other,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54529,foods,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54530,.,O,1882.0,"We concluded that mugwort hay fever can be associated with the Compositae family of foods , but that it is not normally associated with other foods ."
54617,For,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54618,colon,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54619,cancer,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54620,",",O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54621,no,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54622,statistically,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54623,significant,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54624,associations,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54625,with,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54626,total,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54627,vegetable,B,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54628,intake,I,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54629,or,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54630,total,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54631,fruit,B,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54632,intake,I,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54633,were,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54634,found,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54635,.,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
55055,No,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55056,myosmine,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55057,was,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55058,detectable,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55059,in,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55060,other,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55061,vegetables,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55062,and,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55063,fruits,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55064,such,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55065,as,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55066,lettuce,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55067,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55068,spinach,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55069,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55070,cucumber,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55071,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55072,onion,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55073,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55074,banana,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55075,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55076,tangerines,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55077,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55078,and,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55079,grapes,B,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55080,.,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55229,Preliminary,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55230,clinical,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55231,trials,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55232,provided,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55233,evidence,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55234,that,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55235,resveratrol,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55236,had,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55237,anti,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55238,-,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55239,diabetic,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55240,activity,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55241,in,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55242,humans,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55243,by,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55244,improving,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55245,glycemic,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55246,control,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55247,in,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55248,subjects,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55249,with,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55250,insulin,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55251,resistance,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55252,.,O,1909.0,Preliminary clinical trials provided evidence that resveratrol had anti - diabetic activity in humans by improving glycemic control in subjects with insulin resistance .
55383,A,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55384,past,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55385,history,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55386,of,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55387,heart,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55388,disease,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55389,was,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55390,associated,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55391,with,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55392,the,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55393,choice,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55394,of,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55395,polyunsaturated,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55396,margarine,B,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55397,",",O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55398,low,B,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55399,fat,I,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55400,spread,I,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55401,",",O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55402,or,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55403,no,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55404,spread,B,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55405,at,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55406,all,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55407,;,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55408,this,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55409,was,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55410,most,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55411,apparent,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55412,in,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55413,men,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55414,.,O,1915.0,"A past history of heart disease was associated with the choice of polyunsaturated margarine , low fat spread , or no spread at all ; this was most apparent in men ."
55483,In,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55484,both,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55485,sexes,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55486,",",O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55487,the,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55488,non,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55489,-,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55490,manual,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55491,groups,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55492,consumed,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55493,less,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55494,spread,B,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55495,than,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55496,the,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55497,manual,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55498,at,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55499,comparable,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55500,ages,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55501,.,O,1919.0,"In both sexes , the non - manual groups consumed less spread than the manual at comparable ages ."
55514,The,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55515,amount,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55516,of,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55517,spread,B,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55518,consumed,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55519,was,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55520,not,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55521,associated,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55522,with,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55523,body,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55524,mass,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55525,index,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55526,",",O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55527,a,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55528,past,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55529,history,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55530,or,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55531,family,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55532,history,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55533,of,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55534,heart,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55535,disease,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55536,or,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55537,previously,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55538,diagnosed,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55539,hypertension,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55540,.,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55616,We,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55617,hypothesised,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55618,that,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55619,the,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55620,ameliorating,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55621,effect,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55622,of,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55623,Yukihikari,B,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55624,on,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55625,atopic,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55626,dermatitis,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55627,is,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55628,associated,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55629,with,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55630,the,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55631,gut,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55632,microbiota,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55633,.,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
56326,Because,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56327,of,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56328,several,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56329,study,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56330,limitations,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56331,",",O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56332,results,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56333,should,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56334,be,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56335,considered,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56336,preliminary,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56337,.,O,1943.0,"Because of several study limitations , results should be considered preliminary ."
56798,Proteins,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56799,play,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56800,a,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56801,crucial,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56802,role,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56803,in,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56804,metabolism,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56805,",",O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56806,in,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56807,maintaining,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56808,fluid,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56809,and,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56810,acid,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56811,-,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56812,base,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56813,balance,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56814,and,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56815,antibody,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56816,synthesis,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56817,.,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
57115,However,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57116,",",O,1972.0,"However , the way red meat is cooked and preserved matters ."
57117,the,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57118,way,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57119,red,B,1972.0,"However , the way red meat is cooked and preserved matters ."
57120,meat,I,1972.0,"However , the way red meat is cooked and preserved matters ."
57121,is,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57122,cooked,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57123,and,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57124,preserved,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57125,matters,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57126,.,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57548,We,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57549,recruited,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57550,65,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57551,Saharawi,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57552,type,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57553,II,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57554,diabetic,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57555,women,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57556,taking,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57557,orally,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57558,glucose,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57559,-,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57560,lowering,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57561,drugs,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57562,only,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57563,.,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57809,The,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57810,postprandial,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57811,PG,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57812,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57813,SI,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57814,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57815,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57816,CP,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57817,responses,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57818,to,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57819,two,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57820,of,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57821,the,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57822,test,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57823,breakfasts,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57824,(,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57825,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57826,A,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57827,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57828,eggs,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57829,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57830,toasted,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57831,wholemeal,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57832,bread,I,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57833,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57834,orange,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57835,juice,I,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57836,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57837,margarine,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57838,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57839,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57840,milk,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57841,;,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57842,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57843,B,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57844,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57845,wheatflake,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57846,biscuits,I,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57847,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57848,toasted,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57849,wholemeal,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57850,bread,I,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57851,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57852,milk,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57853,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57854,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57855,margarine,B,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57856,),O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57857,were,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57858,similar,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57859,(,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57860,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57861,A,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57862,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57863,104.3,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57864,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57865,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57866,23.0,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57867,mg,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57868,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57869,h,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57870,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57871,dl-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57872,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57873,5996,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57874,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57875,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57876,1108,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57877,microU,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57878,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57879,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57880,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57881,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57882,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57883,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57884,89.8,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57885,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57886,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57887,25.4,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57888,pmol,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57889,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57890,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57891,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57892,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57893,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57894,respectively,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57895,;,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57896,meal,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57897,B,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57898,:,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57899,104.9,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57900,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57901,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57902,21.6,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57903,mg,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57904,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57905,h,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57906,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57907,dl-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57908,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57909,6268,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57910,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57911,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57912,1161,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57913,microU,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57914,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57915,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57916,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57917,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57918,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57919,and,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57920,99.8,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57921,+,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57922,/-,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57923,26.4,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57924,pmol,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57925,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57926,min,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57927,X,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57928,ml-1,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57929,",",O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57930,respectively,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57931,),O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
57932,.,O,2000.0,"The postprandial PG , SI , and CP responses to two of the test breakfasts ( meal A : eggs , toasted wholemeal bread , orange juice , margarine , and milk ; meal B : wheatflake biscuits , toasted wholemeal bread , milk , and margarine ) were similar ( meal A : 104.3 + /- 23.0 mg X h X dl-1 , 5996 + /- 1108 microU X min X ml-1 , and 89.8 + /- 25.4 pmol X min X ml-1 , respectively ; meal B : 104.9 + /- 21.6 mg X h X dl-1 , 6268 + /- 1161 microU X min X ml-1 , and 99.8 + /- 26.4 pmol X min X ml-1 , respectively ) ."
58209,RWF,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58210,and,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58211,RWE,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58212,had,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58213,significantly,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58214,higher,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58215,insulin,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58216,response,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58217,",",O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58218,but,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58219,no,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58220,significant,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58221,increase,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58222,was,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58223,observed,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58224,in,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58225,RWT,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58226,and,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58227,RWC,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58228,when,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58229,compared,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58230,with,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58231,the,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58232,control,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58233,(,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58234,P<0·05,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58235,),O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58236,.,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58859,Beer,B,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58860,explained,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58861,a,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58862,large,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58863,proportion,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58864,of,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58865,variation,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58866,in,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58867,GI,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58868,in,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58869,a,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58870,Finnish,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58871,and,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58872,an,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58873,American,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58874,study,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
58875,.,O,2034.0,Beer explained a large proportion of variation in GI in a Finnish and an American study .
59121,Next,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59122,to,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59123,potatoes,B,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59124,",",O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59125,bread,B,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59126,",",O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59127,sugar,B,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59128,and,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59129,sugar,B,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59130,-,B,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59131,sweetened,B,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59132,beverages,I,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59133,",",O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59134,beer,B,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59135,captured,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59136,a,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59137,considerable,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59138,proportion,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59139,of,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59140,between,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59141,-,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59142,person,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59143,variability,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59144,in,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59145,GI,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59146,and,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59147,GL,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59148,in,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59149,the,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59150,Dutch,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59151,diet,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59152,.,O,2047.0,"Next to potatoes , bread , sugar and sugar - sweetened beverages , beer captured a considerable proportion of between - person variability in GI and GL in the Dutch diet ."
59263,Based,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59264,on,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59265,clinical,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59266,values,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59267,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59268,additional,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59269,amounts,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59270,of,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59271,garlic,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59272,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59273,onion,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59274,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59275,tomato,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59276,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59277,shiitake,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59278,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59279,rice,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59280,bran,I,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59281,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59282,kale,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59283,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59284,blueberry,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59285,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59286,pineapples,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59287,",",O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59288,and/or,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59289,turmeric,B,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59290,powder,I,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59291,were,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59292,provided,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59293,in,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59294,regular,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59295,meals,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59296,.,O,2051.0,"Based on clinical values , additional amounts of garlic , onion , tomato , shiitake , rice bran , kale , blueberry , pineapples , and/or turmeric powder were provided in regular meals ."
59381,In,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59382,conclusion,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59383,",",O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59384,personalized,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59385,diets,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59386,with,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59387,supplemented,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59388,functional,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59389,ingredients,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59390,improved,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59391,antioxidant,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59392,status,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59393,and/or,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59394,anticoagulant,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59395,activity,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59396,in,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59397,cancer,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59398,patients,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59399,undergoing,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59400,chemotherapy,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59401,and,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59402,in,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59403,remission,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59404,.,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59486,Olive,B,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59487,and,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59488,olive,B,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59489,oil,I,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59490,may,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59491,have,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59492,a,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59493,role,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59494,in,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59495,the,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59496,prevention,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59497,of,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59498,coronary,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59499,heart,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59500,disease,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59501,and,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59502,certain,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59503,cancers,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59504,because,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59505,of,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59506,their,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59507,high,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59508,levels,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59509,of,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59510,monosaturated,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59511,fatty,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59512,acids,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59513,and,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59514,phenolic,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59515,compounds,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59516,.,O,2059.0,Olive and olive oil may have a role in the prevention of coronary heart disease and certain cancers because of their high levels of monosaturated fatty acids and phenolic compounds .
59677,Nitrite,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59678,curing,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59679,of,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59680,all,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59681,meats,B,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59682,lowered,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59683,lipid,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59684,and,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59685,protein,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59686,oxidation,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59687,to,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59688,the,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59689,level,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59690,of,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59691,oxidation,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59692,in,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59693,uncured,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59694,chicken,B,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59695,.,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
60349,Hazard,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60350,ratio,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60351,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60352,HR,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60353,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60354,estimates,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60355,for,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60356,consuming,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60357,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60358,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60359,drink,B,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60360,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60361,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60362,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60363,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60364,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60365,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60366,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60367,drink,B,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60368,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60369,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60370,but,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60371,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60372,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60373,drink,B,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60374,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60375,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60376,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60377,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60378,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60379,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60380,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60381,drink,B,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60382,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60383,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60384,were,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60385,0.89,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60386,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60387,95,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60388,%,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60389,confidence,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60390,interval,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60391,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60392,0.74,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60393,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60394,1.07,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60395,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60396,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60397,0.99,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60398,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60399,0.83,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60400,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60401,1.17,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60402,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60403,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60404,0.88,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60405,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60406,0.70,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60407,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60408,1.12,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60409,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60410,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60411,respectively,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60412,.,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60497,Neither,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60498,red,B,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60499,wine,I,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60500,nor,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60501,total,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60502,alcohol,B,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60503,consumption,I,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60504,were,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60505,associated,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60506,with,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60507,prostate,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60508,cancer,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60509,risk,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60510,in,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60511,this,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60512,population,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60513,of,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60514,moderate,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60515,drinkers,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
60516,.,O,2095.0,Neither red wine nor total alcohol consumption were associated with prostate cancer risk in this population of moderate drinkers .
61093,However,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61094,",",O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61095,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61096,molecular,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61097,mechanisms,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61098,responsible,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61099,for,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61100,this,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61101,preventive,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61102,activity,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61103,and,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61104,whether,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61105,cocoa,B,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61106,exerts,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61107,potential,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61108,beneficial,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61109,effects,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61110,on,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61111,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61112,insulin,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61113,signaling,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61114,pathway,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61115,in,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61116,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61117,liver,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61118,remain,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61119,largely,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61120,unknown,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61121,.,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61349,Many,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61350,countries,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61351,set,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61352,quantitative,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61353,targets,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61354,for,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61355,added,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61356,sugars,B,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61357,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61358,justifying,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61359,this,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61360,by,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61361,expressing,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61362,concern,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61363,about,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61364,the,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61365,likely,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61366,impact,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61367,of,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61368,sugar,B,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61369,on,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61370,weight,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61371,control,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61372,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61373,dental,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61374,health,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61375,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61376,diet,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61377,quality,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61378,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61379,or,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61380,metabolic,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61381,syndrome,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61382,.,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61603,Ginger,B,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61604,(,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61605,Zingiber,B,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61606,officinale,I,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61607,Roscoe,I,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61608,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61609,Zingiberacae,B,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61610,),O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61611,is,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61612,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61613,medicinal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61614,plant,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61615,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61616,has,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61617,been,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61618,widely,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61619,used,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61620,in,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61621,Chinese,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61622,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61623,Ayurvedic,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61624,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61625,Tibb,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61626,-,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61627,Unani,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61628,herbal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61629,medicines,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61630,all,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61631,over,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61632,the,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61633,world,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61634,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61635,since,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61636,antiquity,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61637,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61638,for,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61639,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61640,wide,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61641,array,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61642,of,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61643,unrelated,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61644,ailments,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61645,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61646,include,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61647,arthritis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61648,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61649,rheumatism,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61650,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61651,sprains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61652,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61653,muscular,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61654,aches,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61655,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61656,pains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61657,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61658,sore,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61659,throats,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61660,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61661,cramps,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61662,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61663,constipation,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61664,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61665,indigestion,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61666,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61667,vomiting,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61668,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61669,hypertension,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61670,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61671,dementia,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61672,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61673,fever,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61674,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61675,infectious,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61676,diseases,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61677,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61678,helminthiasis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61679,.,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61854,Breast,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61855,cancer,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61856,is,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61857,the,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61858,most,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61859,common,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61860,cancer,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61861,among,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61862,females,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61863,worldwide,O,2146.0,Breast cancer is the most common cancer among females worldwide .
61864,.,O,2146.0,Breast cancer is the most common cancer among females worldwide .
62144,A,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62145,lower,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62146,risk,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62147,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62148,colon,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62149,cancer,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62150,was,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62151,observed,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62152,with,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62153,higher,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62154,self,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62155,-,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62156,reported,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62157,consumption,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62158,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62159,fruit,B,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62160,and,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62161,vegetable,B,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62162,combined,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62163,(,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62164,HR,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62165,Q4,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62166,vs.,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62167,Q1,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62168,0.87,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62169,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62170,95,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62171,%,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62172,CI,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62173,0.75,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62174,-,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62175,1.01,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62176,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62177,p,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62178,for,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62179,trend,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62180,0.02,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62181,),O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62182,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62183,but,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62184,no,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62185,consistent,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62186,association,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62187,was,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62188,observed,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62189,for,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62190,separate,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62191,consumption,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62192,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62193,fruits,B,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62194,and,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62195,vegetables,B,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62196,.,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62248,Although,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62249,a,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62250,lower,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62251,risk,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62252,of,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62253,colon,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62254,cancer,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62255,is,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62256,suggested,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62257,with,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62258,high,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62259,consumption,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62260,of,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62261,fruit,B,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62262,and,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62263,vegetables,B,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62264,",",O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62265,this,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62266,study,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62267,does,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62268,not,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62269,support,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62270,a,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62271,clear,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62272,inverse,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62273,association,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62274,between,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62275,fruit,B,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62276,and,I,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62277,vegetable,I,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62278,consumption,I,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62279,and,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62280,colon,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62281,or,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62282,rectal,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62283,cancer,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62284,beyond,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62285,a,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62286,follow,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62287,-,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62288,up,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62289,of,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62290,more,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62291,than,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62292,10,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62293,years,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62294,.,O,2160.0,"Although a lower risk of colon cancer is suggested with high consumption of fruit and vegetables , this study does not support a clear inverse association between fruit and vegetable consumption and colon or rectal cancer beyond a follow - up of more than 10 years ."
62418,Much,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62419,higher,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62420,RAST,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62421,uptakes,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62422,were,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62423,obtained,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62424,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62425,sera,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62426,from,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62427,four,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62428,asthmatic,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62429,bakers,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62430,when,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62431,tested,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62432,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62433,wheat,B,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62434,and,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62435,its,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62436,close,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62437,relatives,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62438,",",O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62439,but,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62440,there,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62441,was,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62442,still,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62443,reasonably,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62444,high,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62445,reactivity,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62446,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62447,more,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62448,distantly,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62449,related,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62450,cereals,B,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62451,.,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62780,When,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62781,extracts,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62782,from,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62783,nonthermally,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62784,and,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62785,thermally,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62786,processed,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62787,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62788,were,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62789,subjected,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62790,to,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62791,an,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62792,RBL,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62793,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62794,cell,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62795,mediator,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62796,release,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62797,assay,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62798,with,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62799,these,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62800,sera,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62801,",",O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62802,an,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62803,inverse,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62804,ranking,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62805,was,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62806,obtained,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62807,with,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62808,anti,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62809,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62810,heated,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62811,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62812,IgE,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62813,and,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62814,anti,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62815,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62816,native,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62817,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62818,IgE,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62819,",",O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62820,respectively,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62821,.,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
63171,Although,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63172,associations,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63173,between,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63174,fruit,B,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63175,and,I,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63176,vegetable,I,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63177,intake,I,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63178,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63179,both,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63180,ESCC,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63181,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63182,EAC,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63183,have,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63184,been,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63185,found,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63186,in,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63187,multiple,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63188,ecological,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63189,and,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63190,case,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63191,-,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63192,control,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63193,studies,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63194,",",O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63195,few,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63196,prospective,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63197,studies,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63198,have,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63199,investigated,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63200,these,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63201,associations,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
63202,.,O,2193.0,"Although associations between fruit and vegetable intake and both ESCC and EAC have been found in multiple ecological and case - control studies , few prospective studies have investigated these associations ."
64211,This,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64212,article,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64213,provides,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64214,an,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64215,overview,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64216,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64217,the,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64218,health,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64219,benefits,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64220,associated,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64221,with,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64222,fruit,B,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64223,and,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64224,vegetable,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64225,consumption,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64226,for,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64227,each,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64228,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64229,these,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64230,conditions,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64231,",",O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64232,including,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64233,brief,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64234,discussions,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64235,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64236,underlying,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64237,protective,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64238,mechanisms,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64239,",",O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64240,identifies,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64241,key,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64242,scientific,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64243,findings,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64244,regarding,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64245,the,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64246,health,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64247,benefits,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64248,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64249,fruit,B,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64250,and,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64251,vegetable,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64252,consumption,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64253,",",O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64254,and,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64255,outlines,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64256,applications,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64257,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64258,these,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64259,findings,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64260,for,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64261,dietetics,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64262,professionals,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64263,.,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64461,Fifteen,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64462,Norwegian,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64463,Red,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64464,calves,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64465,",",O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64466,9,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64467,to,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64468,27,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64469,d,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64470,of,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64471,age,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64472,",",O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64473,weighing,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64474,between,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64475,45.5,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64476,and,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64477,71.0,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64478,kg,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64479,",",O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64480,were,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64481,tested,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64482,according,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64483,to,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64484,the,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64485,response,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64486,surface,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64487,pathway,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64488,design,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64489,.,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64592,The,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64593,minimum,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64594,milk,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64595,temperature,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64596,was,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64597,estimated,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64598,to,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64599,be,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64600,8,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64601,°,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64602,C,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64603,.,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
65024,A,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65025,dietary,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65026,history,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65027,questionnaire,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65028,was,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65029,used,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65030,to,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65031,determine,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65032,the,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65033,usual,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65034,eating,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65035,habits,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65036,during,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65037,the,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65038,year,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65039,preceding,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65040,diagnosis,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65041,for,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65042,cases,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65043,",",O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65044,or,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65045,preceding,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65046,interview,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65047,for,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65048,controls,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65049,.,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65495,The,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65496,aim,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65497,of,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65498,this,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65499,study,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65500,was,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65501,to,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65502,verify,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65503,the,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65504,clinical,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65505,significance,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65506,of,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65507,the,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65508,skin,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65509,prick,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65510,test,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65511,(,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65512,SPT,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65513,),O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65514,and,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65515,CAP,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65516,-,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65517,FEIA,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65518,CAP,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65519,-,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65520,System,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65521,IgE,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65522,fluozoenzyme,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65523,immunosorbent,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65524,assay,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65525,(,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65526,Pharmacia,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65527,Diagnostic,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65528,",",O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65529,Uppsala,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65530,",",O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65531,Sweden,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65532,),O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65533,positivities,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65534,to,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65535,corn,B,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65536,and,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65537,to,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65538,identify,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65539,the,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65540,presence,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65541,of,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65542,IgE,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65543,-,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65544,binding,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65545,proteins,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65546,in,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65547,the,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65548,corn,B,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65549,flour,I,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65550,salt,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65551,-,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65552,insoluble,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65553,protein,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65554,fractions,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65555,(,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65556,comprising,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65557,up,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65558,to,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65559,96,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65560,%,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65561,of,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65562,the,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65563,total,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65564,protein,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65565,),O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65566,using,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65567,sera,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65568,of,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65569,patients,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65570,with,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65571,DBPCFC,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65572,-,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65573,documented,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65574,food,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65575,allergy,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65576,to,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65577,corn,B,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65578,.,O,2285.0,"The aim of this study was to verify the clinical significance of the skin prick test ( SPT ) and CAP - FEIA CAP - System IgE fluozoenzyme immunosorbent assay ( Pharmacia Diagnostic , Uppsala , Sweden ) positivities to corn and to identify the presence of IgE - binding proteins in the corn flour salt - insoluble protein fractions ( comprising up to 96 % of the total protein ) using sera of patients with DBPCFC - documented food allergy to corn ."
65813,Soybean,B,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65814,oil,I,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65815,consumption,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65816,is,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65817,increasing,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65818,worldwide,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65819,and,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65820,parallels,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65821,a,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65822,rise,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65823,in,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65824,obesity,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65825,.,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
66425,Furthermore,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66426,",",O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66427,strawberry,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66428,extracts,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66429,have,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66430,been,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66431,shown,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66432,to,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66433,inhibit,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66434,COX,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66435,enzymes,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66436,in,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66437,vitro,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66438,",",O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66439,which,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66440,would,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66441,modulate,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66442,the,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66443,inflammatory,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66444,process,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66445,.,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66904,Red,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66905,wine,I,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66906,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66907,liquor,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66908,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66909,and,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66910,beer,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66911,were,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66912,not,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66913,associated,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66914,with,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66915,prostate,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66916,cancer,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66917,nor,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66918,was,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66919,total,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66920,alcohol,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66921,consumed,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66922,at,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66923,ages,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66924,18,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66925,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66926,30,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66927,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66928,and,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66929,45,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66930,.,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
67397,Included,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67398,were,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67399,464,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67400,cases,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67401,(,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67402,90,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67403,%,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67404,of,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67405,eligible,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67406,),O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67407,and,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67408,480,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67409,controls,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67410,(,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67411,87,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67412,%,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67413,of,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67414,eligible,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67415,),O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67416,.,O,2354.0,Included were 464 cases ( 90 % of eligible ) and 480 controls ( 87 % of eligible ) .
67591,Tomatoes,B,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67592,are,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67593,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67594,fourth,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67595,most,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67596,commonly,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67597,consumed,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67598,fresh,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67599,vegetable,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67600,and,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67601,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67602,most,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67603,frequently,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67604,consumed,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67605,canned,B,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67606,vegetable,I,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67607,in,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67608,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67609,American,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67610,diet,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67611,.,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67936,The,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67937,importance,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67938,of,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67939,exploiting,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67940,these,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67941,grains,B,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67942,for,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67943,the,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67944,elaboration,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67945,of,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67946,healthy,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67947,and,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67948,nutritious,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67949,foods,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67950,has,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67951,forced,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67952,food,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67953,producers,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67954,to,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67955,develop,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67956,novel,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67957,adequate,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67958,strategies,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67959,for,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67960,their,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67961,processing,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
67962,.,O,2373.0,The importance of exploiting these grains for the elaboration of healthy and nutritious foods has forced food producers to develop novel adequate strategies for their processing .
68455,No,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68456,association,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68457,was,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68458,observed,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68459,between,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68460,egg,B,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68461,consumption,I,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68462,and,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68463,risk,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68464,of,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68465,type,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68466,2,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68467,diabetes,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68468,.,O,2389.0,No association was observed between egg consumption and risk of type 2 diabetes .
68975,The,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68976,results,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68977,demonstrate,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68978,that,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68979,small,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68980,reductions,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68981,in,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68982,discretionary,B,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68983,food,I,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68984,consumption,I,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68985,are,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68986,likely,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68987,to,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68988,have,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68989,substantial,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68990,health,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68991,benefits,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68992,at,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68993,the,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68994,population,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68995,level,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68996,.,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
69413,Insulinemic,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69414,indexes,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69415,do,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69416,not,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69417,improve,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69418,discrimination,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69419,between,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69420,foods,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69421,taken,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69422,alone,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69423,in,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69424,type,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69425,2,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69426,diabetics,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69427,:,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69428,they,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69429,only,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69430,discriminate,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69431,between,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69432,foods,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69433,during,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69434,mixed,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69435,meals,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69436,",",O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69437,similarly,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69438,to,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69439,glycemic,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69440,indexes,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69441,.,O,2419.0,"Insulinemic indexes do not improve discrimination between foods taken alone in type 2 diabetics : they only discriminate between foods during mixed meals , similarly to glycemic indexes ."
69558,Meat,B,2424.0,Meat is sometimes added .
69559,is,O,2424.0,Meat is sometimes added .
69560,sometimes,O,2424.0,Meat is sometimes added .
69561,added,O,2424.0,Meat is sometimes added .
69562,.,O,2424.0,Meat is sometimes added .
69618,The,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69619,proposed,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69620,long,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69621,-,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69622,term,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69623,measure,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69624,by,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69625,the,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69626,Federal,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69627,government,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69628,of,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69629,Nigeria,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69630,for,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69631,the,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69632,resolution,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69633,of,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69634,these,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69635,various,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69636,types,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69637,of,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69638,malnutrition,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69639,is,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69640,dietary,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69641,diversification,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69642,.,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
70603,To,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70604,explore,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70605,further,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70606,the,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70607,possible,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70608,confounding,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70609,of,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70610,the,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70611,milk,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70612,-,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70613,ovarian,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70614,cancer,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70615,association,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70616,by,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70617,the,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70618,animal,B,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70619,fat,I,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70620,content,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70621,of,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70622,milk,B,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70623,",",O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70624,the,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70625,authors,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70626,performed,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70627,a,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70628,case,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70629,-,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70630,control,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70631,study,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70632,of,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70633,303,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70634,ovarian,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70635,cancer,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70636,cases,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70637,and,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70638,606,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70639,age,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70640,-,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70641,matched,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70642,nonmalignant,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70643,-,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70644,disease,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70645,controls,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70646,seen,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70647,between,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70648,1982,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70649,and,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70650,1988,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70651,at,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70652,Roswell,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70653,Park,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70654,Memorial,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70655,Institute,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70656,in,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70657,Buffalo,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70658,",",O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70659,New,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70660,York,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
70661,.,O,2461.0,"To explore further the possible confounding of the milk - ovarian cancer association by the animal fat content of milk , the authors performed a case - control study of 303 ovarian cancer cases and 606 age - matched nonmalignant - disease controls seen between 1982 and 1988 at Roswell Park Memorial Institute in Buffalo , New York ."
71319,Moreover,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71320,",",O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71321,recent,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71322,results,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71323,suggest,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71324,that,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71325,bacterial,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71326,and,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71327,fungal,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71328,metabolites,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71329,produced,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71330,by,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71331,cocobiota,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71332,have,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71333,a,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71334,significant,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71335,anti,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71336,-,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71337,infective,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71338,potential,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71339,.,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71470,Factor,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71471,analysis,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71472,with,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71473,principal,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71474,component,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71475,method,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71476,was,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71477,applied,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71478,to,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71479,ascertain,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71480,dietary,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71481,patterns,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
71482,.,O,2486.0,Factor analysis with principal component method was applied to ascertain dietary patterns .
72397,Patients,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72398,following,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72399,a,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72400,"""",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72401,Western,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72402,"""",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72403,diet,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72404,had,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72405,lower,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72406,chances,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72407,to,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72408,improve,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72409,in,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72410,physical,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72411,functioning,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72412,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72413,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72414,=,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72415,0.45,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72416,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72417,0.21,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72418,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72419,0.99,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72420,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72421,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72422,",",O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72423,constipation,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72424,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72425,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72426,=,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72427,0.30,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72428,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72429,0.13,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72430,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72431,0.72,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72432,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72433,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72434,and,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72435,diarrhea,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72436,(,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72437,OR,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72438,:,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72439,0.44,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72440,[,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72441,0.20,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72442,-,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72443,0.98,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72444,],O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72445,),O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72446,over,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72447,time,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72448,.,O,2517.0,"Patients following a "" Western "" diet had lower chances to improve in physical functioning ( OR = 0.45 [ 0.21 - 0.99 ] ) , constipation ( OR = 0.30 [ 0.13 - 0.72 ] ) and diarrhea ( OR : 0.44 [ 0.20 - 0.98 ] ) over time ."
72597,Other,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72598,minerals,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72599,were,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72600,zinc,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72601,(,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72602,0.39,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72603,g,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72604,/,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72605,kg,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72606,),O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72607,",",O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72608,manganese,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72609,(,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72610,0.15,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72611,g,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72612,/,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72613,kg,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72614,),O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72615,and,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72616,iron,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72617,(,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72618,0.14,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72619,g,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72620,/,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72621,kg,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72622,),O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72623,.,O,2523.0,"Other minerals were zinc ( 0.39 g / kg ) , manganese ( 0.15 g / kg ) and iron ( 0.14 g / kg ) ."
72648,Among,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72649,the,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72650,minerals,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72651,analysed,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72652,",",O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72653,the,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72654,leaves,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72655,of,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72656,M.,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72657,balsamina,I,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72658,had,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72659,higher,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72660,values,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72661,than,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72662,those,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72663,reported,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72664,for,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72665,the,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72666,exotic,B,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72667,vegetables,I,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72668,",",O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72669,except,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72670,for,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72671,sodium,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72672,.,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72844,Mean,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72845,(,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72846,SD,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72847,),O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72848,age,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72849,",",O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72850,weight,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72851,and,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72852,BMI,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72853,of,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72854,the,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72855,population,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72856,were,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72857,51,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72858,±,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72859,10,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72860,year,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72861,",",O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72862,94,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72863,±,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72864,18,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72865,kg,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72866,and,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72867,32.4,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72868,±,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72869,5.7,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72870,kg,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72871,/,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72872,m2,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72873,",",O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72874,respectively,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72875,.,O,2530.0,"Mean ( SD ) age , weight and BMI of the population were 51 ± 10 year , 94 ± 18 kg and 32.4 ± 5.7 kg / m2 , respectively ."
72970,Yoghurt,B,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72971,consumption,I,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72972,(,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72973,g,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72974,/,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72975,day,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72976,),O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72977,was,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72978,inversely,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72979,associated,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72980,with,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72981,%,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72982,body,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72983,fat,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72984,",",O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72985,abdominal,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72986,fat,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72987,",",O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72988,WC,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72989,and,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72990,HC,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72991,(,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72992,all,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72993,p,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72994,<,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72995,0.05,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72996,),O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72997,",",O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72998,while,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
72999,reduced,B,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73000,fat,I,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73001,milk,I,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73002,consumption,I,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73003,was,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73004,inversely,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73005,associated,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73006,with,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73007,BMI,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73008,",",O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73009,WC,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73010,",",O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73011,HC,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73012,and,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73013,%,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73014,body,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73015,fat,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73016,(,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73017,all,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73018,p,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73019,<,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73020,0.05,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73021,),O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73022,.,O,2534.0,"Yoghurt consumption ( g / day ) was inversely associated with % body fat , abdominal fat , WC and HC ( all p < 0.05 ) , while reduced fat milk consumption was inversely associated with BMI , WC , HC and % body fat ( all p < 0.05 ) ."
73048,Garlic,B,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73049,has,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73050,long,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73051,been,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73052,the,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73053,focus,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73054,of,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73055,experimental,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73056,and,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73057,clinical,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73058,attentions,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73059,due,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73060,to,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73061,its,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73062,promising,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73063,lipid,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73064,-,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73065,lowering,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73066,effects,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73067,.,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73528,Other,O,2554.0,Other associations were not significant after false discovery correction .
73529,associations,O,2554.0,Other associations were not significant after false discovery correction .
73530,were,O,2554.0,Other associations were not significant after false discovery correction .
73531,not,O,2554.0,Other associations were not significant after false discovery correction .
73532,significant,O,2554.0,Other associations were not significant after false discovery correction .
73533,after,O,2554.0,Other associations were not significant after false discovery correction .
73534,false,O,2554.0,Other associations were not significant after false discovery correction .
73535,discovery,O,2554.0,Other associations were not significant after false discovery correction .
73536,correction,O,2554.0,Other associations were not significant after false discovery correction .
73537,.,O,2554.0,Other associations were not significant after false discovery correction .
73620,The,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73621,purpose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73622,of,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73623,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73624,study,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73625,was,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73626,to,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73627,1,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73628,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73629,systematically,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73630,study,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73631,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73632,insulin,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73633,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73634,to,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73635,several,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73636,different,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73637,high,B,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73638,-,I,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73639,starch,I,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73640,foods,I,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73641,",",O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73642,2,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73643,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73644,determine,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73645,whether,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73646,this,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73647,insulin,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73648,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73649,could,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73650,be,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73651,predicted,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73652,by,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73653,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73654,glucose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73655,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73656,",",O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73657,and,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73658,3,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73659,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73660,determine,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73661,whether,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73662,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73663,glucose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73664,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73665,could,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73666,be,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73667,predicted,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73668,by,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73669,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73670,physical,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73671,structure,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73672,and,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73673,digestibility,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73674,of,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73675,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73676,ingested,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73677,carbohydrate,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73678,.,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73926,Perinatal,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73927,outcomes,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73928,were,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73929,collected,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73930,at,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73931,delivery,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73932,with,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73933,birth,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73934,weight,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73935,data,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73936,calculated,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73937,into,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73938,percentiles,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73939,to,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73940,assess,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73941,small,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73942,and,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73943,large,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73944,for,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73945,gestational,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73946,age,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73947,and,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73948,preterm,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73949,delivery,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73950,at,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73951,<,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73952,37,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73953,wk,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73954,.,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
74357,Skin,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74358,prick,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74359,tests,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74360,(,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74361,SPT,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74362,),O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74363,for,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74364,the,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74365,more,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74366,important,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74367,inhalant,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74368,allergens,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74369,and,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74370,foods,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74371,were,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74372,performed,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74373,on,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74374,all,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74375,children,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74376,.,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74560,Associated,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74561,fruit,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74562,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74563,specific,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74564,IgE,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74565,(,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74566,SPT,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74567,and/or,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74568,RAST,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74569,),O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74570,were,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74571,found,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74572,in,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74573,all,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74574,latex,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74575,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74576,symptomatic,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74577,children,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74578,and,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74579,in,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74580,2/5,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74581,latex,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74582,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74583,asymptomatic,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74584,children,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74585,.,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
76985,In,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76986,this,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76987,high,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76988,-,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76989,risk,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76990,area,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76991,",",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76992,where,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76993,the,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76994,frequency,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76995,of,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76996,esophageal,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76997,cancer,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76998,is,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
76999,higher,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77000,among,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77001,females,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77002,than,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77003,among,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77004,males,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77005,",",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77006,a,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77007,special,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77008,diet,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77009,known,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77010,as,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77011,"""",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77012,majoweh,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77013,"""",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77014,or,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77015,"""",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77016,majum,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77017,"""",O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77018,is,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77019,given,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77020,to,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77021,pregnant,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77022,women,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77023,.,O,2673.0,"In this high - risk area , where the frequency of esophageal cancer is higher among females than among males , a special diet known as "" majoweh "" or "" majum "" is given to pregnant women ."
77024,This,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77025,food,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77026,is,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77027,a,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77028,crushed,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77029,mixture,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77030,of,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77031,sour,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77032,pomegranate,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77033,seeds,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77034,",",O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77035,black,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77036,pepper,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77037,",",O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77038,dried,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77039,raisins,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77040,",",O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77041,and,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77042,occasionally,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77043,garlic,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77044,;,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77045,this,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77046,combination,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77047,irritates,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77048,the,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77049,esophagus,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77050,because,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77051,of,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77052,the,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77053,hot,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77054,black,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77055,pepper,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77056,and,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77057,the,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77058,sharp,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77059,",",O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77060,crushed,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77061,pomegranate,B,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77062,seeds,I,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77063,.,O,2674.0,"This food is a crushed mixture of sour pomegranate seeds , black pepper , dried raisins , and occasionally garlic ; this combination irritates the esophagus because of the hot black pepper and the sharp , crushed pomegranate seeds ."
77116,Very,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77117,little,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77118,fruit,B,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77119,and,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77120,vegetables,B,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77121,are,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77122,consumed,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77123,by,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77124,the,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77125,Turkomans,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77126,of,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77127,the,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77128,high,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77129,-,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77130,risk,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77131,region,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77132,",",O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77133,whereas,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77134,inhabitants,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77135,in,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77136,the,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77137,low,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77138,-,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77139,risk,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77140,area,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77141,keep,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77142,vegetables,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77143,and,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77144,citrus,B,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77145,fruits,I,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77146,as,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77147,an,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77148,important,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77149,part,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77150,of,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77151,their,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77152,usual,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77153,diets,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77154,.,O,2677.0,"Very little fruit and vegetables are consumed by the Turkomans of the high - risk region , whereas inhabitants in the low - risk area keep vegetables and citrus fruits as an important part of their usual diets ."
77187,But,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77188,",",O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77189,environmental,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77190,contamination,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77191,due,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77192,to,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77193,drugs,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77194,or,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77195,medicines,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77196,used,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77197,for,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77198,different,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77199,purposes,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77200,in,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77201,humans,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77202,and,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77203,animals,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77204,goes,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77205,unseen,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77206,largely,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77207,and,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77208,can,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77209,affect,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77210,the,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77211,health,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77212,of,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77213,living,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77214,system,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77215,severely,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77216,.,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77318,These,O,2684.0,These drugs are not eliminated even by water treatment plant .
77319,drugs,O,2684.0,These drugs are not eliminated even by water treatment plant .
77320,are,O,2684.0,These drugs are not eliminated even by water treatment plant .
77321,not,O,2684.0,These drugs are not eliminated even by water treatment plant .
77322,eliminated,O,2684.0,These drugs are not eliminated even by water treatment plant .
77323,even,O,2684.0,These drugs are not eliminated even by water treatment plant .
77324,by,O,2684.0,These drugs are not eliminated even by water treatment plant .
77325,water,O,2684.0,These drugs are not eliminated even by water treatment plant .
77326,treatment,O,2684.0,These drugs are not eliminated even by water treatment plant .
77327,plant,O,2684.0,These drugs are not eliminated even by water treatment plant .
77328,.,O,2684.0,These drugs are not eliminated even by water treatment plant .
77672,The,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77673,typical,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77674,Japanese,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77675,diet,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77676,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77677,characterized,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77678,by,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77679,plant,B,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77680,food,I,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77681,and,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77682,fish,B,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77683,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77684,well,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77685,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77686,modest,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77687,Westernized,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77688,diet,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77689,such,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77690,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77691,meat,B,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77692,",",O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77693,milk,B,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77694,and,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77695,dairy,B,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77696,products,I,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77697,might,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77698,be,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77699,associated,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77700,with,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77701,longevity,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77702,in,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77703,Japan,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77704,.,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77855,In,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77856,stratified,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77857,analyses,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77858,",",O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77859,among,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77860,men,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77861,coffee,B,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77862,consumption,I,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77863,was,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77864,inversely,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77865,related,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77866,to,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77867,ESCC,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77868,(,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77869,HR,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77870,for,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77871,comparison,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77872,of,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77873,extreme,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77874,tertiles,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77875,0.42,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77876,",",O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77877,95,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77878,%,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77879,CI,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77880,0.20,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77881,-,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77882,0.88,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77883,;,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77884,p,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77885,-,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77886,trend=0.022,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77887,),O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77888,",",O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77889,but,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77890,not,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77891,among,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77892,women,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77893,.,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
78209,In,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78210,conclusion,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78211,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78212,a,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78213,typical,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78214,Western,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78215,diet,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78216,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78217,which,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78218,is,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78219,high,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78220,in,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78221,meats,B,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78222,and,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78223,low,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78224,in,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78225,vegetables,B,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78226,",",O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78227,may,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78228,be,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78229,positively,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78230,associated,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78231,with,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78232,ovarian,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78233,cancer,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78234,incidence,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78235,.,O,2712.0,"In conclusion , a typical Western diet , which is high in meats and low in vegetables , may be positively associated with ovarian cancer incidence ."
78392,The,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78393,risk,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78394,of,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78395,TNBC,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78396,was,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78397,negatively,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78398,associated,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78399,with,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78400,a,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78401,healthy,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78402,dietary,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78403,pattern,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78404,involving,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78405,consumption,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78406,of,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78407,seafood,B,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78408,and,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78409,vegetables,B,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78410,",",O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78411,and,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78412,positively,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78413,associated,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78414,with,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78415,a,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78416,dietary,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78417,pattern,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78418,of,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78419,consuming,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78420,grains,B,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78421,",",O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78422,meats,B,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78423,",",O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78424,and,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78425,eggs,B,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78426,.,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78480,The,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78481,present,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78482,study,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78483,is,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78484,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78485,first,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78486,to,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78487,show,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78488,a,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78489,negative,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78490,association,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78491,between,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78492,risk,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78493,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78494,TNBC,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78495,and,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78496,a,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78497,healthy,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78498,dietary,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78499,pattern,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78500,in,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78501,women,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78502,with,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78503,dense,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78504,breasts,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78505,and,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78506,suggests,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78507,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78508,importance,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78509,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78510,diet,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78511,in,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78512,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78513,prevention,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78514,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78515,TNBC,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78516,.,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78546,We,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78547,evaluated,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78548,the,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78549,consumption,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78550,of,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78551,coffee,B,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78552,and,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78553,other,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78554,beverages,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78555,and,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78556,food,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78557,containing,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78558,caffeine,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78559,in,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78560,relation,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78561,to,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78562,the,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78563,incidence,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78564,of,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78565,diabetes,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78566,.,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78613,At,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78614,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78615,follow,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78616,-,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78617,up,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78618,survey,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78619,in,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78620,2002,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78621,",",O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78622,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78623,development,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78624,of,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78625,diabetes,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78626,and,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78627,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78628,time,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78629,of,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78630,diagnosis,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78631,were,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78632,reported,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78633,.,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
79137,It,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79138,has,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79139,been,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79140,demonstrated,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79141,that,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79142,raisins,B,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79143,possess,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79144,a,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79145,low,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79146,-,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79147,to,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79148,-,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79149,moderate,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79150,glycemic,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79151,index,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79152,",",O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79153,which,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79154,makes,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79155,them,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79156,a,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79157,healthy,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79158,snack,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79159,.,O,2741.0,"It has been demonstrated that raisins possess a low - to - moderate glycemic index , which makes them a healthy snack ."
79320,Milk,B,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79321,and,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79322,fermented,B,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79323,milk,I,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79324,consumption,I,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79325,has,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79326,been,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79327,linked,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79328,to,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79329,health,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79330,and,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79331,mortality,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79332,but,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79333,the,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79334,association,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79335,with,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79336,Parkinson,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79337,'s,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79338,disease,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79339,(,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79340,PD,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79341,),O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79342,is,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79343,uncertain,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79344,.,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79433,During,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79434,a,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79435,mean,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79436,follow,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79437,-,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79438,up,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79439,of,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79440,14.9,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79441,years,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79442,",",O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79443,1251,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79444,PD,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79445,cases,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79446,were,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79447,identified,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79448,in,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79449,the,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79450,cohort,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79451,.,O,2754.0,"During a mean follow - up of 14.9 years , 1251 PD cases were identified in the cohort ."
79930,Red,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79931,foods,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79932,contain,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79933,lycopene,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79934,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79935,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79936,pigment,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79937,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79938,tomatoes,B,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79939,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79940,which,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79941,is,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79942,localized,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79943,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79944,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79945,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79946,gland,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79947,and,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79948,may,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79949,be,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79950,involved,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79951,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79952,maintaining,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79953,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79954,health,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79955,.,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79956,Yellow,B,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79957,-,I,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79958,green,I,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79959,vegetables,I,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79960,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79961,such,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79962,as,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79963,corn,B,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79964,and,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79965,leafy,B,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79966,greens,I,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79967,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79968,contain,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79969,lutein,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79970,and,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79971,zeaxanthin,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79972,",",O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79973,which,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79974,are,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79975,localized,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79976,in,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79977,the,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79978,retina,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79979,where,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79980,age,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79981,-,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79982,related,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79983,macular,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79984,degeneration,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79985,occurs,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
79986,.,O,2769.0,"Yellow - green vegetables , such as corn and leafy greens , contain lutein and zeaxanthin , which are localized in the retina where age - related macular degeneration occurs ."
80497,A,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80498,case,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80499,-,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80500,control,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80501,study,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80502,was,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80503,conducted,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80504,including,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80505,"1,170",O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80506,histologically,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80507,confirmed,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80508,cases,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80509,and,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80510,"2,525",O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80511,group,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80512,-,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80513,matched,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80514,visitor,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80515,controls,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80516,from,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80517,the,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80518,largest,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80519,cancer,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80520,hospital,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80521,in,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80522,India,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80523,.,O,2786.0,"A case - control study was conducted including 1,170 histologically confirmed cases and 2,525 group - matched visitor controls from the largest cancer hospital in India ."
80627,High,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80628,consumption,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80629,of,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80630,mustard,B,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80631,oil,I,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80632,was,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80633,associated,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80634,with,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80635,GBC,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80636,risk,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80637,in,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80638,both,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80639,high-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80640,and,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80641,low,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80642,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80643,risk,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80644,regions,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80645,(,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80646,OR,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80647,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80648,1.33,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80649,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80650,95,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80651,%,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80652,CI,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80653,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80654,0.99,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80655,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80656,1.78,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80657,;,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80658,OR,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80659,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80660,3.01,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80661,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80662,95,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80663,%,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80664,CI,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80665,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80666,1.66,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80667,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80668,5.45,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80669,),O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80670,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80671,respectively,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80672,.,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80827,However,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80828,",",O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80829,comparisons,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80830,across,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80831,nuts,B,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80832,(,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80833,walnuts,B,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80834,",",O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80835,almonds,B,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80836,and,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80837,pistachios,B,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80838,),O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80839,with,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80840,varying,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80841,physical,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80842,properties,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80843,do,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80844,not,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80845,support,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80846,this,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80847,view,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80848,.,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
81512,This,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81513,implies,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81514,that,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81515,fat,B,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81516,and,I,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81517,sugar,I,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81518,addition,I,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81519,could,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81520,be,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81521,avoided,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81522,in,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81523,foods,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81524,for,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81525,children,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81526,without,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81527,having,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81528,an,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81529,impact,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81530,on,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81531,palatability,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81532,",",O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81533,allowing,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81534,the,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81535,energy,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81536,density,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81537,of,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81538,children,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81539,'s,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81540,diet,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81541,to,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81542,be,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81543,limited,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81544,.,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81671,Specificities,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81672,and,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81673,positive,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81674,predictive,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81675,accuracies,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81676,were,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81677,low,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81678,for,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81679,all,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81680,allergens,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81681,and,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81682,tests,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81683,.,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81684,Changing,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81685,the,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81686,cutoff,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81687,levels,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81688,did,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81689,not,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81690,improve,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81691,the,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81692,ability,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81693,of,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81694,the,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81695,tests,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81696,to,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81697,predict,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81698,clinical,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81699,allergy,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
81700,.,O,2831.0,Changing the cutoff levels did not improve the ability of the tests to predict clinical allergy .
82037,In,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82038,some,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82039,cases,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82040,",",O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82041,supplements,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82042,or,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82043,fortified,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82044,foods,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82045,can,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82046,provide,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82047,useful,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82048,amounts,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82049,of,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82050,important,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82051,nutrients,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82052,.,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82132,Furthermore,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82133,",",O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82134,vegetarians,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82135,tend,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82136,to,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82137,have,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82138,a,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82139,lower,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82140,body,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82141,mass,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82142,index,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82143,and,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82144,lower,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82145,overall,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82146,cancer,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82147,rates,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82148,.,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82243,Wine,B,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82244,may,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82245,cause,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82246,stomach,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82247,irritation,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82248,due,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82249,to,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82250,its,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82251,stimulatory,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82252,effect,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82253,on,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82254,gastric,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82255,acid,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82256,secretion,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82257,",",O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82258,although,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82259,the,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82260,mechanisms,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82261,by,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82262,which,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82263,wine,B,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82264,or,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82265,components,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82266,thereof,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82267,activate,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82268,pathways,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82269,of,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82270,gastric,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82271,acid,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82272,secretion,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82273,are,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82274,poorly,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82275,understood,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82276,.,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82893,Rats,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82894,were,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82895,made,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82896,moderately,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82897,anemic,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82898,(,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82899,Hb,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82900,7.8,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82901,+,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82902,/-,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82903,0.7,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82904,g,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82905,/,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82906,dL,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82907,),O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82908,by,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82909,feeding,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82910,an,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82911,iron,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82912,-,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82913,deficient,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82914,diet,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82915,and,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82916,were,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82917,then,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82918,fed,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82919,one,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82920,of,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82921,the,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82922,16,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82923,experimental,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82924,diets,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82925,.,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82926,Test,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82927,meals,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82928,(,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82929,100,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82930,micrograms,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82931,Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82932,),O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82933,labeled,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82934,with,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82935,59Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82936,were,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82937,fed,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82938,after,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82939,5,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82940,d,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82941,and,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82942,59Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82943,absorption,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82944,determined,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82945,by,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82946,whole,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82947,-,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82948,body,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82949,counting,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82950,.,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
83201,The,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83202,risk,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83203,odds,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83204,ratios,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83205,(,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83206,ORs,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83207,),O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83208,for,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83209,observing,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83210,values,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83211,above,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83212,the,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83213,50th,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83214,percentile,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83215,were,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83216,elevated,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83217,for,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83218,mercury,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83219,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83220,fish,B,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83221,consumption,I,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83222,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83223,uranium,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83224,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83225,milk,B,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83226,consumption,I,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83227,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83228,lead,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83229,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83230,female,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83231,sex,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83232,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83233,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83234,aluminum,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83235,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83236,mineral,B,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83237,water,I,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83238,consumption,I,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83239,.,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83904,We,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83905,found,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83906,that,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83907,increasing,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83908,concentrations,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83909,of,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83910,inulin,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83911,and,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83912,corn,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83913,dextrin,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83914,reduced,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83915,the,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83916,flowability,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83917,of,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83918,cheese,B,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83919,in,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83920,the,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83921,melting,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83922,test,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83923,and,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83924,can,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83925,thus,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83926,be,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83927,used,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83928,to,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83929,inhibit,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83930,flow,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83931,during,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83932,heating,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83933,.,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
84226,Consumption,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84227,of,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84228,fruit,B,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84229,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84230,fats,B,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84231,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84232,fish,B,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84233,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84234,and,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84235,fluids,B,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84236,was,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84237,substantially,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84238,less,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84239,than,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84240,recommended,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84241,.,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84426,At,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84427,the,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84428,end,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84429,of,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84430,each,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84431,study,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84432,period,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84433,",",O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84434,faeces,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84435,of,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84436,twelve,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84437,volunteers,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84438,were,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84439,collected,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84440,for,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84441,chemical,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84442,analyses,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84443,and,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84444,use,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84445,in,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84446,cell,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84447,-,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84448,culture,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84449,systems,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84450,.,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84564,Faecal,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84565,water,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84566,pH,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84567,decreased,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84568,only,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84569,after,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84570,carrot,B,2934.0,Faecal water pH decreased only after carrot juice consumption .
84571,juice,I,2934.0,Faecal water pH decreased only after carrot juice consumption .
84572,consumption,I,2934.0,Faecal water pH decreased only after carrot juice consumption .
84573,.,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84593,In,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84594,summary,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84595,",",O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84596,in,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84597,the,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84598,present,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84599,study,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84600,",",O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84601,2,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84602,-,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84603,week,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84604,interventions,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84605,with,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84606,carotenoid,B,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84607,-,I,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84608,rich,I,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84609,juices,I,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84610,led,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84611,only,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84612,to,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84613,minor,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84614,changes,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84615,in,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84616,investigated,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84617,luminal,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84618,biomarkers,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84619,relevant,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84620,to,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84621,colon,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84622,carcinogenesis,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84623,.,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84900,Adherence,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84901,to,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84902,a,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84903,diet,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84904,comprising,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84905,mostly,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84906,fruits,B,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84907,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84908,vegetables,B,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84909,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84910,fish,B,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84911,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84912,and,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84913,olive,B,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84914,/,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84915,sunflower,I,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84916,oil,I,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84917,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84918,along,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84919,with,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84920,avoidance,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84921,of,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84922,Western,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84923,-,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84924,type,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84925,foods,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84926,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84927,may,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84928,contribute,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84929,to,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84930,a,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84931,substantial,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84932,reduction,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84933,in,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84934,postmenopausal,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84935,breast,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84936,cancer,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84937,risk,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84938,.,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
85125,Higher,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85126,meat,B,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85127,intakes,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85128,were,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85129,significantly,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85130,and,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85131,positively,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85132,correlated,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85133,with,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85134,cancers,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85135,of,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85136,the,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85137,colon,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85138,",",O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85139,rectum,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85140,",",O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85141,prostate,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85142,",",O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85143,and,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85144,female,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85145,breast,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85146,.,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85481,In,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85482,adolescents,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85483,",",O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85484,eating,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85485,disorders,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85486,and,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85487,insulin,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85488,misuse,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85489,for,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85490,weight,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85491,control,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85492,purposes,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85493,are,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85494,concrete,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85495,and,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85496,difficult,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85497,problems,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85498,to,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85499,deal,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85500,with,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85501,.,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85520,Appropriate,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85521,nutritional,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85522,education,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85523,helps,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85524,children,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85525,with,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85526,diabetes,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85527,to,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85528,find,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85529,this,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85530,balance,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85531,and,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85532,enjoy,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85533,a,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85534,better,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85535,quality,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85536,of,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85537,life,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85538,.,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85716,Three,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85717,consistent,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85718,roles,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85719,can,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85720,be,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85721,identified,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85722,:,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85723,1,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85724,),O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85725,to,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85726,treat,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85727,emaciated,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85728,patients,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85729,to,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85730,gain,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85731,weight,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85732,;,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85733,2,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85734,),O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85735,to,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85736,stimulate,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85737,nervous,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85738,systems,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85739,of,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85740,apathetic,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85741,",",O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85742,exhausted,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85743,or,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85744,feeble,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85745,patients,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85746,;,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85747,and,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85748,3,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85749,),O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85750,to,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85751,improve,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85752,digestion,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85753,and,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85754,elimination,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85755,where,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85756,cacao,B,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85757,/,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85758,chocolate,I,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85759,countered,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85760,the,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85761,effects,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85762,of,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85763,stagnant,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85764,or,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85765,weak,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85766,stomachs,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85767,",",O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85768,stimulated,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85769,kidneys,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85770,and,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85771,improved,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85772,bowel,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85773,function,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85774,.,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85775,Additional,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85776,medical,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85777,complaints,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85778,treated,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85779,with,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85780,chocolate,B,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85781,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85782,cacao,I,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85783,have,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85784,included,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85785,anemia,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85786,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85787,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85788,appetite,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85789,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85790,mental,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85791,fatigue,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85792,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85793,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85794,breast,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85795,milk,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85796,production,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85797,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85798,consumption,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85799,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85800,tuberculosis,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85801,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85802,fever,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85803,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85804,gout,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85805,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85806,kidney,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85807,stones,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85808,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85809,reduced,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85810,longevity,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85811,and,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85812,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85813,sexual,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85814,appetite,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85815,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85816,low,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85817,virility,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85818,.,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
86209,Therefore,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86210,",",O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86211,we,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86212,considered,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86213,it,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86214,important,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86215,to,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86216,determine,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86217,if,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86218,other,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86219,common,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86220,dietary,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86221,proteins,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86222,also,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86223,strongly,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86224,stimulate,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86225,an,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86226,increase,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86227,in,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86228,insulin,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86229,concentration,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86230,when,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86231,given,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86232,with,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86233,glucose,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86234,.,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86407,The,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86408,peripheral,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86409,glucagon,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86410,concentration,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86411,was,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86412,decreased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86413,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86414,ingestion,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86415,of,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86416,glucose,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86417,alone,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86418,and,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86419,increased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86420,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86421,all,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86422,the,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86423,meals,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86424,containing,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86425,protein,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86426,.,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86519,Personal,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86520,interviews,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86521,with,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86522,"1,016",O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86523,histologically,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86524,confirmed,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86525,GC,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86526,cases,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86527,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86528,"1,159",O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86529,population,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86530,controls,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86531,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86532,similar,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86533,age,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86534,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86535,sex,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86536,revealed,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86537,that,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86538,the,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86539,patients,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86540,were,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86541,more,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86542,often,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86543,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86544,lower,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86545,social,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86546,class,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86547,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86548,resident,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86549,in,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86550,rural,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86551,areas,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86552,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86553,more,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86554,frequently,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86555,reported,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86556,a,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86557,familial,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86558,history,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86559,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86560,gastric,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86561,(,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86562,but,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86563,not,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86564,other,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86565,),O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86566,cancer,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86567,.,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86814,People,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86815,with,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86816,diabetes,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86817,are,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86818,at,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86819,higher,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86820,risk,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86821,of,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86822,fatal,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86823,thromboembolic,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86824,accidents,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86825,in,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86826,the,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86827,cerebral,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86828,and,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86829,coronary,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86830,circulations,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86831,",",O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86832,especially,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86833,stroke,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86834,and,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86835,ischemic,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86836,heart,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86837,disease,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86838,.,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86899,Rats,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86900,were,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86901,rendered,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86902,diabetic,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86903,by,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86904,intraperitoneal,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86905,streptozotocin,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86906,(,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86907,65,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86908,mg,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86909,/,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86910,kg,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86911,),O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86912,",",O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86913,and,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86914,then,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86915,camel,B,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86916,milk,I,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86917,or,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86918,bovine,B,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86919,milk,I,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86920,was,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86921,administered,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86922,orally,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86923,for,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86924,8,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86925,wk,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86926,.,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86927,We,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86928,evaluated,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86929,the,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86930,changes,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86931,in,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86932,body,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86933,weight,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86934,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86935,fasting,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86936,blood,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86937,glucose,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86938,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86939,glucose,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86940,tolerance,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86941,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86942,blood,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86943,coagulation,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86944,profile,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86945,",",O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86946,and,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86947,platelet,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86948,function,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
86949,.,O,3012.0,"We evaluated the changes in body weight , fasting blood glucose , glucose tolerance , blood coagulation profile , and platelet function ."
87146,To,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87147,compare,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87148,the,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87149,metabolic,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87150,effect,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87151,of,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87152,coingestion,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87153,of,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87154,saturated,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87155,and,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87156,monounsaturated,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87157,fats,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87158,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87159,potato,B,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87160,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87161,12,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87162,subjects,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87163,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87164,non,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87165,-,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87166,insulin,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87167,-,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87168,dependent,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87169,diabetes,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87170,mellitus,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87171,(,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87172,NIDDM,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87173,),O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87174,received,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87175,300,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87176,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87177,mashed,B,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87178,potato,I,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87179,alone,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87180,or,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87181,in,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87182,combination,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87183,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87184,40,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87185,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87186,olive,B,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87187,oil,I,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87188,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87189,80,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87190,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87191,olive,B,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87192,oil,I,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87193,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87194,50,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87195,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87196,butter,B,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87197,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87198,or,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87199,100,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87200,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87201,butter,B,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87202,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87203,respectively,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87204,.,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87601,At,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87602,all,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87603,study,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87604,time,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87605,points,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87606,",",O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87607,patients,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87608,categorized,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87609,as,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87610,high,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87611,ONS,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87612,consumers,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87613,(,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87614,>,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87615,15,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87616,%,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87617,of,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87618,total,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87619,daily,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87620,calories,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87621,from,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87622,ONS,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87623,),O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87624,had,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87625,higher,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87626,intakes,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87627,of,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87628,micronutrients,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87629,(,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87630,P,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87631,<,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87632,0.003,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87633,),O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87634,.,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
88336,Women,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88337,with,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88338,toxemia,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88339,were,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88340,identified,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88341,",",O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88342,and,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88343,women,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88344,without,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88345,toxemia,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88346,served,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88347,as,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88348,controls,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88349,.,O,3060.0,"Women with toxemia were identified , and women without toxemia served as controls ."
88350,The,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88351,toxemia,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88352,group,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88353,generally,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88354,consumed,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88355,lesser,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88356,amounts,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88357,of,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88358,vitamins,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88359,and,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88360,minerals,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88361,than,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88362,the,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88363,controls,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88364,.,O,3061.0,The toxemia group generally consumed lesser amounts of vitamins and minerals than the controls .
88561,Six,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88562,multiparous,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88563,Holstein,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88564,cows,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88565,",",O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88566,averaging,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88567,49,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88568,kg,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88569,of,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88570,milk,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88571,/,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88572,d,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88573,",",O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88574,were,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88575,used,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88576,in,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88577,a,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88578,6,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88579,×,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88580,6,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88581,Latin,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88582,square,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88583,design,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88584,with,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88585,14,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88586,-,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88587,d,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88588,periods,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88589,.,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88752,We,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88753,discovered,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88754,no,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88755,effect,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88756,of,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88757,treatment,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88758,on,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88759,mammary,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88760,plasma,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88761,flow,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88762,",",O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88763,and,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88764,the,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88765,increase,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88766,in,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88767,milk,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88768,protein,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88769,yield,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88770,with,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88771,glucose,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88772,infusion,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88773,was,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88774,brought,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88775,about,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88776,by,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88777,greater,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88778,mammary,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88779,AA,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88780,clearance,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88781,rate,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88782,.,O,3075.0,"We discovered no effect of treatment on mammary plasma flow , and the increase in milk protein yield with glucose infusion was brought about by greater mammary AA clearance rate ."
88864,In,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88865,conclusion,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88866,",",O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88867,glucose,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88868,has,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88869,a,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88870,major,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88871,effect,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88872,on,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88873,stimulating,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88874,milk,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88875,protein,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88876,synthesis,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88877,",",O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88878,and,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88879,the,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88880,mammary,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88881,gland,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88882,has,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88883,the,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88884,ability,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88885,to,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88886,increase,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88887,its,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88888,supply,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88889,of,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88890,nutrients,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88891,to,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88892,match,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88893,its,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88894,synthetic,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88895,capacity,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
88896,.,O,3079.0,"In conclusion , glucose has a major effect on stimulating milk protein synthesis , and the mammary gland has the ability to increase its supply of nutrients to match its synthetic capacity ."
89974,Chocolate,B,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89975,ice,I,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89976,cream,I,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89977,is,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89978,commonly,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89979,formulated,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89980,with,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89981,higher,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89982,sugar,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89983,levels,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89984,than,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89985,nonchocolate,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89986,flavors,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89987,to,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89988,compensate,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89989,for,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89990,the,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89991,inherent,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89992,bitterness,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89993,of,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89994,cocoa,B,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89995,.,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89996,Bitterness,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89997,",",O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89998,however,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89999,",",O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90000,is,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90001,an,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90002,integral,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90003,part,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90004,of,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90005,the,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90006,complex,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90007,flavor,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90008,of,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90009,chocolate,B,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90010,.,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90035,Once,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90036,a,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90037,strategy,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90038,for,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90039,balancing,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90040,undesirable,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90041,bitterness,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90042,and,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90043,health,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90044,concerns,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90045,regarding,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90046,added,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90047,sugars,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90048,has,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90049,been,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90050,developed,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90051,",",O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90052,the,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90053,task,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90054,becomes,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90055,determining,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90056,whether,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90057,that,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90058,product,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90059,will,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90060,be,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90061,acceptable,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90062,to,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90063,the,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90064,consumer,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90065,.,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90160,Untrained,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90161,chocolate,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90162,ice,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90163,cream,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90164,consumers,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90165,participated,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90166,in,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90167,a,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90168,large,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90169,-,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90170,scale,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90171,sensory,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90172,test,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90173,by,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90174,indicating,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90175,their,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90176,preferences,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90177,for,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90178,blinded,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90179,pairs,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90180,of,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90181,unspiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90182,and,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90183,spiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90184,samples,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90185,",",O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90186,where,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90187,the,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90188,spiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90189,sample,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90190,had,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90191,increasing,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90192,levels,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90193,of,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90194,the,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90195,added,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90196,bitterant,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90197,.,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90307,The,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90308,consumption,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90309,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90310,dairy,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90311,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90312,including,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90313,milk,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90314,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90315,cheese,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90316,and,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90317,yogurt,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90318,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90319,has,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90320,been,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90321,associated,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90322,with,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90323,better,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90324,quality,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90325,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90326,diet,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90327,and,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90328,reduced,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90329,risk,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90330,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90331,cardiovascular,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90332,disease,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90333,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90334,the,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90335,leading,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90336,cause,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90337,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90338,death,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90339,globally,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90340,.,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90413,Data,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90414,pertaining,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90415,to,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90416,dairy,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90417,fat,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90418,were,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90419,inconclusive,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90420,",",O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90421,but,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90422,point,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90423,to,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90424,a,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90425,potential,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90426,protective,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90427,effect,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90428,of,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90429,full,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90430,-,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90431,fat,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90432,milk,B,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90433,",",O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90434,cheese,B,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90435,",",O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90436,and,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90437,yogurt,B,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90438,on,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90439,risk,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90440,of,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90441,cardiovascular,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90442,disease,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90443,.,O,3133.0,"Data pertaining to dairy fat were inconclusive , but point to a potential protective effect of full - fat milk , cheese , and yogurt on risk of cardiovascular disease ."
90597,The,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90598,droplet,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90599,size,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90600,of,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90601,the,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90602,film,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90603,suspension,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90604,increased,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90605,with,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90606,increasing,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90607,oil,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90608,concentration,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90609,both,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90610,in,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90611,trehalose,B,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90612,and,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90613,allose,B,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90614,",",O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90615,which,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90616,blended,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90617,with,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90618,oil,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90619,.,O,3138.0,"The droplet size of the film suspension increased with increasing oil concentration both in trehalose and allose , which blended with oil ."
90920,Variables,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90921,with,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90922,factor,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90923,loadings,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90924,having,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90925,absolute,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90926,values,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90927,of,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90928,0.3,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90929,or,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90930,greater,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90931,were,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90932,used,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90933,in,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90934,interpreting,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90935,the,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90936,factors,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90937,.,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
91200,In,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91201,the,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91202,fourteen,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91203,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91204,week,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91205,study,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91206,",",O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91207,an,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91208,adjustment,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91209,period,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91210,of,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91211,three,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91212,weeks,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91213,was,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91214,followed,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91215,by,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91216,two,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91217,consecutive,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91218,experimental,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91219,periods,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91220,of,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91221,four,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91222,weeks,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91223,each,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91224,",",O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91225,then,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91226,by,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91227,a,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91228,three,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91229,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91230,week,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91231,follow,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91232,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91233,up,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91234,period,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91235,.,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91269,Five,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91270,participants,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91271,ate,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91272,polyunsaturated,B,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91273,beef,I,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91274,and,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91275,dairy,B,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91276,products,I,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91277,during,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91278,the,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91279,first,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91280,experimental,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91281,period,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91282,and,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91283,their,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91284,saturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91285,counterparts,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91286,in,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91287,the,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91288,second,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91289,;,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91290,six,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91291,participants,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91292,ate,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91293,saturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91294,products,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91295,first,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91296,",",O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91297,then,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91298,polyunsaturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91299,.,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91820,Information,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91821,about,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91822,constituents,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91823,of,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91824,milk,B,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91825,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91826,visual,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91827,alterations,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91828,can,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91829,be,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91830,used,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91831,for,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91832,management,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91833,support,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91834,in,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91835,improving,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91836,mastitis,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91837,detection,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91838,",",O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91839,monitoring,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91840,fertility,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91841,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91842,reproduction,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91843,",",O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91844,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91845,adapting,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91846,individual,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91847,diets,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91848,.,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91849,Numerous,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91850,sensors,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91851,that,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91852,gather,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91853,this,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91854,information,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91855,are,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91856,either,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91857,currently,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91858,available,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91859,or,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91860,in,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91861,development,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91862,.,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
92461,Obesity,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92462,is,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92463,associated,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92464,with,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92465,increased,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92466,risk,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92467,for,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92468,chronic,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92469,diseases,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92470,",",O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92471,and,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92472,affects,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92473,both,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92474,developed,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92475,and,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92476,developing,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92477,nations,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92478,.,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92527,Obesity,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92528,is,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92529,often,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92530,accompanied,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92531,by,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92532,chronic,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92533,",",O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92534,low,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92535,-,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92536,grade,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92537,inflammation,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92538,perpetuated,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92539,by,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92540,adipose,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92541,tissue,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92542,and,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92543,the,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92544,gut,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92545,.,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92618,While,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92619,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92620,evidence,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92621,suggests,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92622,that,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92623,yogurt,B,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92624,consumption,I,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92625,is,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92626,beneficial,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92627,for,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92628,obese,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92629,individuals,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92630,",",O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92631,randomized,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92632,-,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92633,controlled,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92634,trials,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92635,are,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92636,needed,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92637,to,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92638,further,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92639,support,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92640,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92641,hypothesis,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92642,.,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92856,In,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92857,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92858,domain,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92859,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92860,nutrition,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92861,",",O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92862,exploring,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92863,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92864,diet,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92865,-,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92866,health,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92867,linkages,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92868,is,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92869,major,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92870,area,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92871,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92872,research,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92873,.,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
93154,The,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93155,role,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93156,of,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93157,coffee,B,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93158,and,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93159,total,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93160,methylxanthine,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93161,intake,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93162,from,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93163,coffee,B,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93164,",",O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93165,tea,B,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93166,",",O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93167,cola,B,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93168,",",O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93169,chocolate,B,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93170,",",O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93171,and,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93172,cocoa,B,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93173,drinks,I,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93174,was,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93175,evaluated,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93176,in,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93177,the,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93178,BC,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93179,patients,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93180,as,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93181,compared,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93182,to,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93183,that,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93184,in,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93185,two,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93186,matched,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93187,control,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93188,populations,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93189,[,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93190,surgical,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93191,controls,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93192,(,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93193,SC,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93194,),O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93195,and,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93196,neighborhood,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93197,controls,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93198,(,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93199,NC,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93200,),O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93201,],O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93202,.,O,3233.0,"The role of coffee and total methylxanthine intake from coffee , tea , cola , chocolate , and cocoa drinks was evaluated in the BC patients as compared to that in two matched control populations [ surgical controls ( SC ) and neighborhood controls ( NC ) ] ."
93293,This,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93294,association,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93295,was,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93296,observed,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93297,in,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93298,all,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93299,3,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93300,ethnic,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93301,subgroups,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93302,studied,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93303,.,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93343,In,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93344,addition,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93345,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93346,when,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93347,the,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93348,consumption,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93349,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93350,methylxanthine,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93351,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93352,BC,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93353,patients,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93354,was,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93355,compared,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93356,to,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93357,that,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93358,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93359,benign,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93360,breast,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93361,patients,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93362,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93363,adjusted,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93364,by,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93365,age,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93366,and,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93367,ethnic,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93368,group,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93369,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93370,a,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93371,diminished,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93372,risk,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93373,was,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93374,found,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93375,(,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93376,odds,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93377,ratio,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93378,for,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93379,BC,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93380,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93381,the,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93382,highest,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93383,level,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93384,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93385,methylxanthine,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93386,vs.,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93387,lowest,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93388,level,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93389,=,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93390,0.59,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93391,),O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93392,.,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93704,Specific,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93705,IgE,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93706,to,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93707,olive,B,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93708,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93709,grass,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93710,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93711,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93712,weed,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93713,pollens,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93714,were,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93715,10.92,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93716,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93717,6.17,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93718,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93719,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93720,2.4,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93721,AU,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93722,/,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93723,ml,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93724,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93725,respectively,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93726,.,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93789,Specific,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93790,IgE,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93791,to,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93792,olive,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93793,pollen,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93794,was,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93795,not,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93796,inhibited,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93797,by,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93798,carrot,B,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93799,.,O,3256.0,Specific IgE to olive pollen was not inhibited by carrot .
93850,With,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93851,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93852,high,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93853,prevalence,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93854,of,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93855,obesity,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93856,and,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93857,type,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93858,2,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93859,diabetes,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93860,",",O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93861,abnormalities,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93862,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93863,carbohydrate,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93864,metabolism,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93865,are,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93866,common,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93867,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93868,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93869,general,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93870,population,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93871,and,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93872,obtaining,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93873,glycemic,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93874,control,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93875,is,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93876,important,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93877,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93878,reducing,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93879,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93880,complications,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93881,of,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93882,diabetes,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93883,.,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
94365,In,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94366,the,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94367,ascending,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94368,aorta,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94369,",",O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94370,lesion,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94371,size,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94372,doubled,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94373,in,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94374,animals,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94375,fed,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94376,on,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94377,coconut,B,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94378,oil,I,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94379,but,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94380,stabilized,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94381,in,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94382,those,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94383,fed,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94384,on,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94385,olive,B,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94386,oil,I,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94387,.,O,3274.0,"In the ascending aorta , lesion size doubled in animals fed on coconut oil but stabilized in those fed on olive oil ."
94909,The,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94910,types,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94911,of,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94912,vegetables,B,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94913,or,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94914,fruit,B,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94915,that,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94916,most,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94917,often,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94918,appear,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94919,to,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94920,be,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94921,protective,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94922,against,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94923,cancer,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94924,are,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94925,raw,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94926,vegetables,B,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94927,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94928,followed,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94929,by,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94930,allium,B,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94931,vegetables,I,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94932,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94933,carrots,B,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94934,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94935,green,B,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94936,vegetables,I,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94937,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94938,cruciferous,B,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94939,vegetables,I,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94940,",",O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94941,and,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94942,tomatoes,B,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
94943,.,O,3291.0,"The types of vegetables or fruit that most often appear to be protective against cancer are raw vegetables , followed by allium vegetables , carrots , green vegetables , cruciferous vegetables , and tomatoes ."
95100,Many,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95101,people,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95102,erroneously,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95103,believe,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95104,they,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95105,are,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95106,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95107,intolerant,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95108,or,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95109,develop,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95110,gastrointestinal,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95111,symptoms,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95112,after,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95113,intake,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95114,of,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95115,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95116,.,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95157,This,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95158,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95159,in,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95160,turn,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95161,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95162,can,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95163,increase,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95164,the,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95165,risk,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95166,of,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95167,major,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95168,chronic,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95169,diseases,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95170,such,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95171,as,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95172,osteoporosis,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95173,(,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95174,porous,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95175,bones,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95176,),O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95177,and,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95178,hypertension,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95179,.,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95423,By,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95424,contrast,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95425,",",O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95426,in,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95427,the,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95428,celery,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95429,-,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95430,mugwort,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95431,sensitive,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95432,patients,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95433,(,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95434,n,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95435,=,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95436,6,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95437,),O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95438,the,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95439,celery,B,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95440,RASTs,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95441,with,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95442,heated,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95443,celery,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95444,extracts,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95445,remained,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95446,clearly,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95447,positive,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95448,and,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95449,high,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95450,RAST,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95451,values,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95452,to,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95453,stick,B,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95454,celery,I,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95455,could,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95456,be,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95457,found,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95458,.,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
96110,The,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96111,knowledge,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96112,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96113,uranium,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96114,concentration,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96115,",",O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96116,in,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96117,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96118,products,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96119,entering,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96120,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96121,human,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96122,diet,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96123,is,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96124,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96125,extreme,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96126,importance,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96127,because,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96128,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96129,their,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96130,chemical,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96131,hazard,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96132,to,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96133,health,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96134,.,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96968,PCSs,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96969,have,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96970,shown,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96971,that,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96972,the,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96973,consumption,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96974,of,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96975,cheese,B,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96976,",",O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96977,despite,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96978,its,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96979,high,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96980,saturated,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96981,fat,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96982,content,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96983,",",O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96984,is,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96985,not,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96986,associated,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96987,with,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96988,expected,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96989,hypercholesterolemia,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96990,and,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96991,an,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96992,increased,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96993,cardiovascular,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96994,risk,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
96995,.,O,3358.0,"PCSs have shown that the consumption of cheese , despite its high saturated fat content , is not associated with expected hypercholesterolemia and an increased cardiovascular risk ."
97074,In,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97075,conclusion,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97076,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97077,the,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97078,intake,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97079,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97080,fermented,B,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97081,foods,I,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97082,containing,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97083,probiotics,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97084,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97085,particularly,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97086,yogurt,B,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97087,and,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97088,cheese,B,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97089,(,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97090,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97091,an,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97092,undetermined,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97093,type,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97094,),O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97095,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97096,opens,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97097,up,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97098,new,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97099,opportunities,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97100,for,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97101,the,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97102,management,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97103,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97104,cardiometabolic,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97105,risk,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97106,factors,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97107,.,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97163,Many,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97164,lectins,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97165,resist,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97166,digestion,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97167,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97168,survive,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97169,gut,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97170,passage,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97171,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97172,and,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97173,bind,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97174,to,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97175,gastrointestinal,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97176,cells,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97177,and/or,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97178,enter,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97179,the,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97180,circulation,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97181,intact,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97182,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97183,maintaining,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97184,full,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97185,biological,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97186,activity,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97187,.,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97270,They,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97271,also,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97272,affect,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97273,the,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97274,immune,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97275,system,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97276,by,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97277,altering,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97278,the,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97279,production,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97280,of,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97281,various,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97282,interleukins,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97283,",",O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97284,or,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97285,by,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97286,activating,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97287,certain,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97288,protein,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97289,kinases,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97290,.,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97747,Published,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97748,trials,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97749,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97750,the,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97751,benefits,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97752,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97753,grape,B,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97754,and,I,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97755,blueberry,I,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97756,juice,I,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97757,in,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97758,the,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97759,treatment,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97760,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97761,small,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97762,numbers,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97763,of,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97764,cognitively,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97765,impaired,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97766,persons,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97767,have,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97768,recently,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97769,appeared,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97770,.,O,3388.0,Published trials of the benefits of grape and blueberry juice in the treatment of small numbers of cognitively impaired persons have recently appeared .
97787,A,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97788,grape,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97789,polyphenol,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97790,found,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97791,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97792,grapes,B,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97793,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97794,resveratrol,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97795,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97796,now,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97797,being,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97798,studied,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97799,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97800,humans,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97801,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97802,and,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97803,one,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97804,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97805,grapes,B,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97806,and,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97807,blueberries,B,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97808,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97809,pterostilbene,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97810,",",O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97811,have,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97812,been,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97813,found,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97814,to,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97815,improve,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97816,cognition,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97817,in,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97818,rodents,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97819,.,O,3390.0,"A grape polyphenol found in grapes , resveratrol , now being studied in humans , and one in grapes and blueberries , pterostilbene , have been found to improve cognition in rodents ."
97907,276,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97908,(,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97909,24,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97910,%,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97911,),O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97912,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97913,the,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97914,patients,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97915,reported,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97916,some,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97917,kind,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97918,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97919,allergic,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97920,symptoms,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97921,on,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97922,eating,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97923,or,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97924,handling,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97925,various,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97926,foods,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97927,",",O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97928,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97929,which,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97930,hazel,B,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97931,nut,I,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97932,",",O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97933,apple,B,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97934,and,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97935,shell,B,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97936,fish,I,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97937,were,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97938,the,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97939,most,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97940,often,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97941,named,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97942,.,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
98005,A,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98006,correlation,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98007,was,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98008,found,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98009,too,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98010,between,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98011,acetylsalicylic,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98012,acid,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98013,intolerance,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98014,and,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98015,FS,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98016,with,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98017,some,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98018,foods,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98019,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98020,e.g.,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98021,nuts,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98022,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98023,strawberry,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98024,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98025,almond,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98026,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98027,green,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98028,pepper,I,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98029,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98030,hip,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98031,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98032,chocolate,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98033,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98034,egg,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98035,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98036,cabbage,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98037,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98038,milk,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98039,and,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98040,wine,B,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98041,.,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98042,The,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98043,connection,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98044,between,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98045,birch,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98046,pollen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98047,allergy,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98048,and,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98049,FS,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98050,is,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98051,probably,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98052,explained,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98053,by,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98054,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98055,structural,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98056,relationship,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98057,between,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98058,birch,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98059,pollen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98060,allergen,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98061,and,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98062,some,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98063,allergens,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98064,of,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98065,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98066,foodstuffs,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98067,",",O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98068,whereas,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98069,the,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98070,high,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98071,incidence,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98072,of,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98073,FS,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98074,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98075,acetylsalicylic,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98076,acid,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98077,-,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98078,intolerant,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98079,patients,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98080,is,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98081,probably,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98082,explained,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98083,by,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98084,additives,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98085,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98086,foods,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98087,as,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98088,well,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98089,as,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98090,salicylates,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98091,or,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98092,benzoates,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98093,naturally,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98094,occurring,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98095,in,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98096,some,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98097,food,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98098,.,O,3398.0,"The connection between birch pollen allergy and FS is probably explained by the structural relationship between birch pollen allergen and some allergens of the foodstuffs , whereas the high incidence of FS in acetylsalicylic acid - intolerant patients is probably explained by additives in foods as well as salicylates or benzoates naturally occurring in some food ."
98422,Information,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98423,on,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98424,coffee,B,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98425,and,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98426,green,B,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98427,tea,I,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98428,consumption,I,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98429,and,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98430,other,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98431,lifestyle,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98432,factors,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98433,was,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98434,collected,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98435,via,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98436,a,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98437,self,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98438,-,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98439,administered,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98440,questionnaire,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98441,.,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98442,Consumption,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98443,of,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98444,three,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98445,or,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98446,more,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98447,cups,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98448,of,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98449,coffee,B,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98450,per,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98451,day,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98452,had,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98453,a,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98454,significant,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98455,inverse,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98456,association,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98457,with,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98458,UADT,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98459,cancer,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98460,[,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98461,odds,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98462,ratio,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98463,(,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98464,OR,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98465,),O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98466,0.73,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98467,",",O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98468,95,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98469,%,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98470,confidence,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98471,interval,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98472,(,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98473,CI,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98474,),O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98475,0.55,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98476,-,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98477,0.96,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98478,],O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98479,.,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
99619,The,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99620,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99621,infusion,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99622,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99623,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99624,alter,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99625,concentrations,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99626,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99627,vitamin,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99628,C,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99629,in,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99630,plasma,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99631,or,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99632,milk,B,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99633,",",O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99634,suggesting,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99635,that,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99636,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99637,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99638,model,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99639,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99640,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99641,produce,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99642,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99643,same,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99644,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99645,as,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99646,a,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99647,bacterial,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99648,infection,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99649,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99650,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99651,mammary,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99652,gland,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99653,with,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99654,respect,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99655,to,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99656,antioxidant,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99657,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99658,.,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99977,The,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99978,objective,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99979,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99980,this,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99981,review,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99982,was,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99983,to,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99984,give,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99985,an,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99986,overview,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99987,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99988,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99989,state,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99990,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99991,art,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99992,epidemiological,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99993,evidence,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99994,concerning,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99995,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99996,relationship,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99997,between,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99998,olive,B,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99999,oil,I,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100000,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100001,key,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100002,public,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100003,health,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100004,outcomes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100005,including,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100006,mortality,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100007,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100008,CVD,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100009,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100010,diabetes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100011,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100012,metabolic,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100013,syndrome,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100014,(,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100015,MetS,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100016,),O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100017,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100018,obesity,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100019,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100020,cancer,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100021,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100022,with,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100023,a,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100024,particular,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100025,focus,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100026,on,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100027,recent,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100028,results,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100029,from,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100030,cohort,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100031,studies,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100032,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100033,dietary,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100034,intervention,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100035,trials,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100036,.,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100465,In,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100466,2011,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100467,",",O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100468,the,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100469,first,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100470,iteration,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100471,of,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100472,our,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100473,allergen,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100474,threshold,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100475,database,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100476,(,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100477,ATDB,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100478,),O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100479,was,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100480,established,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100481,based,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100482,on,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100483,individual,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100484,NOAELs,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100485,and,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100486,LOAELs,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100487,from,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100488,oral,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100489,food,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100490,challenge,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100491,in,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100492,roughly,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100493,1750,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100494,allergic,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100495,individuals,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100496,.,O,3481.0,"In 2011 , the first iteration of our allergen threshold database ( ATDB ) was established based on individual NOAELs and LOAELs from oral food challenge in roughly 1750 allergic individuals ."
100987,Obesity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100988,is,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100989,associated,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100990,with,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100991,increased,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100992,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100993,of,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100994,the,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100995,renin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100996,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100997,angiotensin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100998,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100999,aldosterone,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101000,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101001,sympathetic,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101002,nervous,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101003,systems,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101004,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101005,possibly,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101006,other,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101007,mineralcorticoid,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101008,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101009,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101010,insulin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101011,resistance,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101012,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101013,salt,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101014,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101015,sensitive,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101016,hypertension,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101017,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101018,excess,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101019,salt,B,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101020,intake,I,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101021,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101022,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101023,reduced,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101024,kidney,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101025,function,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101026,.,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101070,Less,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101071,-,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101072,conclusive,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101073,studies,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101074,suggest,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101075,that,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101076,amino,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101077,acids,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101078,",",O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101079,tea,B,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101080,",",O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101081,green,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101082,coffee,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101083,bean,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101084,extract,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101085,",",O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101086,dark,B,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101087,chocolate,I,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101088,",",O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101089,and,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101090,foods,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101091,high,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101092,in,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101093,nitrates,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101094,may,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101095,reduce,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101096,blood,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101097,pressure,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101098,.,O,3508.0,"Less - conclusive studies suggest that amino acids , tea , green coffee bean extract , dark chocolate , and foods high in nitrates may reduce blood pressure ."
101443,Lymphoid,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101444,cancers,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101445,were,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101446,analyzed,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101447,by,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101448,multiple,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101449,polytomous,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101450,regression,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101451,.,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101662,About,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101663,50,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101664,%,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101665,of,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101666,total,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101667,dietary,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101668,calcium,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101669,was,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101670,supplied,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101671,by,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101672,milk,B,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101673,and,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101674,milk,B,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101675,products,I,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101676,.,O,3527.0,About 50 % of total dietary calcium was supplied by milk and milk products .
101699,The,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101700,remaining,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101701,30,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101702,%,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101703,of,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101704,calcium,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101705,was,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101706,provided,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101707,by,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101708,grains,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101709,and,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101710,grain,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101711,products,I,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101712,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101713,meat,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101714,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101715,poultry,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101716,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101717,fish,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101718,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101719,vegetables,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101720,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101721,fruits,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101722,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101723,eggs,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101724,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101725,legumes,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101726,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101727,nuts,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101728,",",O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101729,and,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101730,seeds,B,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101731,.,O,3529.0,"The remaining 30 % of calcium was provided by grains and grain products , meat , poultry , fish , vegetables , fruits , eggs , legumes , nuts , and seeds ."
101919,The,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101920,total,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101921,number,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101922,of,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101923,positive,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101924,responses,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101925,and,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101926,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101927,number,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101928,of,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101929,positive,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101930,responses,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101931,on,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101932,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101933,E,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101934,subscale,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101935,began,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101936,increasing,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101937,after,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101938,tasting,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101939,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101940,90,B,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101941,%,B,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101942,cocoa,I,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101943,chocolate,I,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101944,",",O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101945,whereas,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101946,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101947,number,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101948,of,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101949,positive,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101950,responses,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101951,on,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101952,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101953,MBG,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101954,and,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101955,M,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101956,subscales,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101957,began,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101958,increasing,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101959,after,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101960,tasting,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101961,the,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101962,85,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101963,%,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101964,cocoa,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101965,chocolate,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101966,sample,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
101967,.,O,3537.0,"The total number of positive responses and the number of positive responses on the E subscale began increasing after tasting the 90 % cocoa chocolate , whereas the number of positive responses on the MBG and M subscales began increasing after tasting the 85 % cocoa chocolate sample ."
102175,This,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102176,review,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102177,summarizes,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102178,comprehensive,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102179,recent,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102180,findings,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102181,on,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102182,the,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102183,beneficial,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102184,actions,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102185,of,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102186,cocoa,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102187,-,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102188,driven,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102189,phytochemicals,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102190,in,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102191,molecular,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102192,mechanisms,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102193,of,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102194,human,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102195,health,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102196,.,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102568,High,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102569,salt,B,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102570,intake,I,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102571,is,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102572,a,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102573,major,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102574,risk,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102575,factor,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102576,of,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102577,hypertension,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102578,and,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102579,cardiovascular,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102580,disease,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102581,.,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102582,Improving,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102583,knowledge,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102584,",",O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102585,attitudes,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102586,",",O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102587,and,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102588,practices,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102589,(,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102590,KAP,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102591,),O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102592,related,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102593,to,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102594,salt,B,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102595,intake,I,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102596,in,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102597,the,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102598,general,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102599,population,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102600,is,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102601,a,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102602,key,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102603,component,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102604,of,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102605,salt,B,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102606,reduction,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102607,strategies,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102608,.,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102670,Socio,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102671,-,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102672,demographic,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102673,and,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102674,food,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102675,consumption,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102676,were,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102677,assessed,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102678,using,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102679,a,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102680,structured,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102681,closed,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102682,-,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102683,ended,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102684,questionnaire,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102685,administered,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102686,by,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102687,survey,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102688,officers,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
102689,.,O,3563.0,Socio - demographic and food consumption were assessed using a structured closed - ended questionnaire administered by survey officers .
103438,Preference,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103439,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103440,exclusive,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103441,consumption,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103442,of,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103443,reduced,B,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103444,-,I,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103445,fat,I,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103446,milk,I,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103447,was,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103448,linked,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103449,to,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103450,significant,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103451,risk,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103452,reduction,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103453,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103454,oral,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103455,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103456,cervical,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103457,cancers,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103458,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103459,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103460,drinking,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103461,only,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103462,whole,B,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103463,milk,I,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103464,was,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103465,linked,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103466,to,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103467,significant,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103468,risk,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103469,increases,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103470,for,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103471,cancers,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103472,of,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103473,the,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103474,oral,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103475,cavity,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103476,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103477,stomach,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103478,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103479,rectum,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103480,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103481,lung,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103482,",",O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103483,and,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103484,breast,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103485,.,O,3590.0,"Preference for exclusive consumption of reduced - fat milk was linked to significant risk reduction for oral and cervical cancers , and drinking only whole milk was linked to significant risk increases for cancers of the oral cavity , stomach , rectum , lung , and breast ."
103533,During,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103534,the,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103535,past,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103536,20,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103537,years,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103538,",",O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103539,many,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103540,studies,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103541,have,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103542,focused,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103543,on,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103544,polyphenol,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103545,compounds,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103546,for,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103547,their,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103548,potential,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103549,beneficial,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103550,health,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103551,effects,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103552,.,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103553,Flavonoids,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103554,represent,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103555,a,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103556,large,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103557,class,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103558,of,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103559,phenolic,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103560,compounds,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103561,found,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103562,in,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103563,fruits,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103564,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103565,vegetables,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103566,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103567,nuts,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103568,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103569,grains,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103570,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103571,cocoa,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103572,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103573,tea,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103574,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103575,and,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103576,other,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103577,beverages,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103578,.,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103742,The,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103743,aim,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103744,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103745,this,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103746,paper,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103747,is,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103748,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103749,provide,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103750,an,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103751,up,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103752,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103753,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103754,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103755,date,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103756,review,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103757,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103758,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103759,latest,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103760,studies,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103761,which,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103762,investigated,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103763,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103764,health,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103765,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103766,promoting,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103767,components,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103768,forming,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103769,upon,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103770,fermentation,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103771,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103772,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103773,main,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103774,food,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103775,matrices,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103776,",",O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103777,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103778,order,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103779,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103780,contribute,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103781,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103782,understanding,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103783,their,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103784,important,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103785,role,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103786,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103787,healthy,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103788,diets,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103789,and,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103790,relevance,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103791,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103792,national,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103793,dietary,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103794,recommendations,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103795,worldwide,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103796,.,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
104016,Two,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104017,isomers,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104018,predominate,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104019,in,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104020,the,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104021,synthetic,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104022,preparation,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104023,",",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104024,"c9,t11",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104025,and,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104026,"t10,c12",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104027,.,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104050,The,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104051,inhibition,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104052,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104053,mammary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104054,tumours,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104055,in,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104056,rats,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104057,is,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104058,effective,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104059,regardless,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104060,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104061,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104062,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104063,carcinogen,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104064,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104065,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104066,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104067,amount,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104068,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104069,dietary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104070,fat,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104071,.,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104086,When,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104087,young,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104088,animals,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104089,(,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104090,mice,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104091,",",O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104092,pigs,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104093,),O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104094,are,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104095,placed,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104096,on,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104097,CLA,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104098,-,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104099,containing,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104100,diets,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104101,after,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104102,weaning,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104103,they,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104104,accumulate,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104105,more,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104106,body,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104107,protein,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104108,and,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104109,less,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104110,fat,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104111,.,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104112,Since,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104113,CLA,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104114,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104115,derived,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104116,from,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104117,the,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104118,milk,B,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104119,of,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104120,ruminant,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104121,animals,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104122,and,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104123,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104124,found,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104125,primarily,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104126,in,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104127,their,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104128,meat,B,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104129,and,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104130,in,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104131,products,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104132,derived,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104133,from,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104134,their,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104135,milk,B,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104136,there,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104137,is,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104138,a,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104139,concerted,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104140,world,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104141,-,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104142,wide,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104143,effort,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104144,to,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104145,increase,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104146,CLA,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104147,content,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104148,of,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104149,milk,B,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104150,by,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104151,dietary,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104152,means,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104153,.,O,3619.0,Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world - wide effort to increase CLA content of milk by dietary means .
104154,Its,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104155,effect,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104156,on,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104157,growth,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104158,(,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104159,less,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104160,fat,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104161,",",O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104162,more,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104163,protein,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104164,),O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104165,is,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104166,also,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104167,a,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104168,subject,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104169,of,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104170,active,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104171,research,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104172,.,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104173,The,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104174,mechanisms,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104175,underlying,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104176,the,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104177,effects,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104178,of,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104179,CLA,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104180,are,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104181,still,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104182,moot,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104183,.,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104616,We,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104617,report,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104618,17,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104619,patients,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104620,with,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104621,immediate,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104622,hypersensitivity,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104623,to,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104624,avocado,B,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104625,.,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
105236,Twenty,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105237,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105238,four,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105239,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105240,hour,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105241,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105242,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105243,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105244,dietary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105245,recall,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105246,data,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105247,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105248,24,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105249,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105250,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105251,urinary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105252,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105253,excretion,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105254,data,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105255,from,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105256,Japanese,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105257,participants,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105258,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105259,574,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105260,men,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105261,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105262,571,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105263,women,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105264,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105265,in,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105266,the,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105267,International,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105268,Study,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105269,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105270,Macro,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105271,/,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105272,Micronutrients,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105273,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105274,Blood,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105275,Pressure,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105276,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105277,INTERMAP,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105278,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105279,were,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105280,used,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105281,to,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105282,calculate,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105283,food,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105284,sources,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105285,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105286,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105287,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105288,compare,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105289,food,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105290,consumption,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105291,patterns,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105292,among,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105293,quartiles,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105294,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105295,participants,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105296,categorized,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105297,according,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105298,to,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105299,24,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105300,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105301,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105302,urinary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105303,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105304,excretion,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105305,per,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105306,unit,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105307,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105308,body,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105309,weight,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105310,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105311,UK,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105312,/,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105313,BW,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105314,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105315,.,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105615,Based,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105616,on,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105617,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105618,key,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105619,constituents,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105620,of,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105621,honey,B,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105622,",",O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105623,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105624,paper,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105625,also,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105626,highlights,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105627,polyphenols,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105628,to,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105629,be,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105630,potentially,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105631,responsible,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105632,for,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105633,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105634,health,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105635,benefits,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105636,of,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105637,honey,B,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105638,.,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105655,The,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105656,gluten,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105657,protein,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105658,of,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105659,wheat,B,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105660,triggers,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105661,an,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105662,immunological,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105663,reaction,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105664,in,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105665,some,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105666,gluten,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105667,-,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105668,sensitive,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105669,people,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105670,with,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105671,HLA,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105672,-,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105673,DQ2/8,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105674,genotypes,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105675,",",O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105676,which,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105677,leads,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105678,to,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105679,Celiac,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105680,disease,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105681,(,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105682,CD,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105683,),O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105684,with,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105685,symptomatic,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105686,damage,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105687,in,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105688,the,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105689,small,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105690,intestinal,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105691,villi,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105692,.,O,3675.0,"The gluten protein of wheat triggers an immunological reaction in some gluten - sensitive people with HLA - DQ2/8 genotypes , which leads to Celiac disease ( CD ) with symptomatic damage in the small intestinal villi ."
105809,The,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105810,pseudo,B,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105811,cereals,I,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105812,amaranth,I,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105813,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105814,quinoa,B,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105815,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105816,and,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105817,buckwheat,B,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105818,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105819,are,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105820,promising,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105821,in,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105822,gluten,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105823,-,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105824,free,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105825,diet,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105826,formulation,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105827,.,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
119319,Variation,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119320,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119321,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119322,intakes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119323,of,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119324,fruit,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119325,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119326,vegetables,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119327,and,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119328,sugar,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119329,-,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119330,sweetened,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119331,beverages,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119332,(,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119333,SSB,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119334,),O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119335,across,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119336,consumer,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119337,groups,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119338,contributed,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119339,to,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119340,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119341,largest,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119342,variance,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119343,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119344,DED,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119345,estimates,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119346,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119347,followed,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119348,by,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119349,variation,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119350,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119351,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119352,intakes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119353,of,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119354,potatoes,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119355,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119356,fresh,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119357,meat,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119358,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119359,bread,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119360,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119361,chips,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119362,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119363,ready,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119364,-,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119365,to,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119366,-,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119367,eat,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119368,breakfast,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119369,cereals,I,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119370,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119371,and,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119372,confectionery,B,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119373,.,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119678,Analysis,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119679,of,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119680,variance,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119681,of,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119682,the,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119683,combined,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119684,results,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119685,of,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119686,all,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119687,four,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119688,experiments,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119689,showed,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119690,that,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119691,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119692,in,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119693,comparison,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119694,with,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119695,saturated,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119696,fat,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119697,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119698,olive,B,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119699,oil,I,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119700,lowered,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119701,aortic,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119702,cholesterol,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119703,by,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119704,13,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119705,(,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119706,-9,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119707,-,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119708,30,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119709,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119710,95,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119711,%,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119712,confidence,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119713,interval,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119714,),O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119715,%,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119716,in,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119717,the,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119718,aortic,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119719,arch,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119720,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119721,and,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119722,by,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119723,10,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119724,(,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119725,-10,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119726,-,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119727,26,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119728,),O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119729,%,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119730,in,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119731,the,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119732,thoracic,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119733,aorta,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119734,",",O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119735,which,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119736,was,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119737,not,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119738,significant,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119739,.,O,4171.0,"Analysis of variance of the combined results of all four experiments showed that , in comparison with saturated fat , olive oil lowered aortic cholesterol by 13 ( -9 - 30 , 95 % confidence interval ) % in the aortic arch , and by 10 ( -10 - 26 ) % in the thoracic aorta , which was not significant ."
119863,Controls,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119864,(,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119865,N,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119866,=,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119867,188,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119868,),O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119869,were,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119870,identified,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119871,by,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119872,random,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119873,digit,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119874,dialing,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119875,.,O,4176.0,Controls ( N = 188 ) were identified by random digit dialing .
119941,This,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119942,excess,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119943,risk,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119944,was,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119945,confined,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119946,to,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119947,current,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119948,smokers,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119949,",",O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119950,in,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119951,whom,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119952,the,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119953,odds,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119954,ratio,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119955,was,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119956,3.2,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119957,(,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119958,95,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119959,%,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119960,CI,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119961,1.8,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119962,-,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119963,5.7,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119964,),O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119965,;,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119966,the,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119967,risk,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119968,among,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119969,former,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119970,smokers,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119971,resembled,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119972,that,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119973,in,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119974,those,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119975,who,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119976,had,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119977,never,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119978,smoked,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119979,.,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
120091,Cinnamon,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120092,was,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120093,the,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120094,most,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120095,bioactive,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120096,product,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120097,followed,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120098,by,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120099,witch,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120100,hazel,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120101,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120102,green,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120103,and,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120104,black,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120105,teas,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120106,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120107,allspice,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120108,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120109,bay,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120110,leaves,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120111,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120112,nutmeg,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120113,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120114,cloves,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120115,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120116,mushrooms,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120117,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120118,and,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120119,brewer,B,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120120,'s,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120121,yeast,I,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120122,.,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120340,It,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120341,is,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120342,known,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120343,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120344,bioactive,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120345,metabolites,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120346,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120347,live,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120348,enzymes,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120349,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120350,occur,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120351,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120352,fermentation,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120353,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120354,digestion,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120355,",",O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120356,affect,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120357,the,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120358,health,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120359,positively,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120360,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120361,improving,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120362,gut,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120363,microbiota,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120364,.,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120384,As,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120385,with,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120386,other,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120387,noninfectious,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120388,diseases,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120389,",",O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120390,the,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120391,diet,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120392,has,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120393,an,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120394,important,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120395,effect,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120396,on,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120397,the,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120398,prevention,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120399,and,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120400,treatment,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120401,of,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120402,metabolic,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120403,syndrome,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120404,.,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120759,The,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120760,secular,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120761,trend,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120762,of,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120763,declining,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120764,stroke,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120765,mortality,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120766,was,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120767,parallel,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120768,to,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120769,the,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120770,increase,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120771,in,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120772,the,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120773,consumption,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120774,of,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120775,milk,B,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120776,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120777,meat,B,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120778,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120779,fish,B,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120780,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120781,eggs,B,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120782,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120783,soybeans,B,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120784,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120785,oil,B,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120786,and,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120787,fats,B,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120788,and,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120789,to,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120790,the,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120791,decrease,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120792,in,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120793,rice,B,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120794,consumption,I,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120795,.,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120819,A,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120820,case,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120821,-,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120822,control,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120823,study,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120824,to,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120825,evaluate,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120826,risk,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120827,factors,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120828,of,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120829,gastric,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120830,cancer,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120831,was,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120832,carried,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120833,out,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120834,in,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120835,areas,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120836,with,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120837,contrasting,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120838,incidence,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120839,rates,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120840,in,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120841,Sweden,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120842,.,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
121157,Furthermore,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121158,",",O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121159,gene,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121160,ontology,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121161,(,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121162,GO,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121163,),O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121164,annotation,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121165,and,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121166,Kyoto,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121167,Encyclopedia,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121168,of,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121169,Genes,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121170,and,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121171,Genomes,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121172,(,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121173,KEGG,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121174,),O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121175,pathways,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121176,were,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121177,used,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121178,to,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121179,evaluate,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121180,the,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121181,candidates,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121182,for,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121183,uniquely,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121184,or,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121185,differentially,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121186,expressed,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121187,proteins,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121188,in,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121189,milk,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121190,sEV,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121191,from,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121192,BLV,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121193,-,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121194,infected,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121195,cattle,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121196,.,O,4224.0,"Furthermore , gene ontology ( GO ) annotation and Kyoto Encyclopedia of Genes and Genomes ( KEGG ) pathways were used to evaluate the candidates for uniquely or differentially expressed proteins in milk sEV from BLV - infected cattle ."
121259,GO,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121260,and,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121261,KEGG,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121262,analyses,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121263,indicated,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121264,that,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121265,the,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121266,candidates,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121267,for,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121268,uniquely,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121269,or,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121270,differentially,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121271,expressed,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121272,proteins,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121273,in,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121274,milk,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121275,sEV,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121276,had,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121277,been,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121278,involved,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121279,in,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121280,diverse,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121281,biological,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121282,activities,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121283,including,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121284,metabolic,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121285,processes,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121286,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121287,cellular,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121288,processes,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121289,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121290,respond,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121291,to,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121292,stimulus,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121293,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121294,binding,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121295,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121296,catalytic,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121297,activities,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121298,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121299,cancer,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121300,pathways,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121301,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121302,focal,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121303,adhesion,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121304,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121305,and,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121306,so,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121307,on,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121308,.,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121702,The,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121703,aim,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121704,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121705,this,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121706,review,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121707,was,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121708,to,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121709,compile,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121710,evidence,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121711,on,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121712,the,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121713,effects,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121714,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121715,extracted,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121716,protein,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121717,from,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121718,a,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121719,wide,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121720,range,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121721,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121722,traditional,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121723,and,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121724,novel,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121725,plant,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121726,sources,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121727,on,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121728,glycemic,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121729,responses,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121730,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121731,appetite,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121732,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121733,body,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121734,weight,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121735,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121736,metabolic,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121737,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121738,cardiovascular,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121739,and,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121740,muscle,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121741,health,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121742,.,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
122350,Cancer,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122351,cases,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122352,(,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122353,n,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122354,=,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122355,419,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122356,),O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122357,were,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122358,identified,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122359,through,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122360,the,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122361,Utah,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122362,Cancer,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122363,Registry,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122364,",",O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122365,and,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122366,controls,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122367,(,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122368,n,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122369,=,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122370,889,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122371,),O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122372,were,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122373,obtained,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122374,through,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122375,random,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122376,digit,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122377,dialing,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122378,and,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122379,the,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122380,Health,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122381,Care,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122382,Financing,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122383,Administration,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122384,.,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122792,The,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122793,identified,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122794,dietary,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122795,pattern,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122796,increases,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122797,the,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122798,odds,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122799,of,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122800,type,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122801,2,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122802,diabetes,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122803,in,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122804,urban,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122805,Ghanaians,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122806,",",O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122807,which,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122808,is,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122809,mainly,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122810,attributed,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122811,to,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122812,increased,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122813,serum,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122814,triglycerides,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122815,.,O,4277.0,"The identified dietary pattern increases the odds of type 2 diabetes in urban Ghanaians , which is mainly attributed to increased serum triglycerides ."
122816,This,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122817,cross,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122818,-,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122819,sectional,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122820,analysis,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122821,provides,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122822,up,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122823,-,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122824,to,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122825,-,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122826,date,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122827,information,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122828,about,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122829,dietary,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122830,patterns,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122831,(,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122832,DP,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122833,),O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122834,and,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122835,their,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122836,sociodemographic,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122837,correlates,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122838,in,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122839,European,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122840,elderly,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122841,individuals,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
122842,.,O,4278.0,This cross - sectional analysis provides up - to - date information about dietary patterns ( DP ) and their sociodemographic correlates in European elderly individuals .
123479,First,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123480,",",O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123481,recovery,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123482,experiments,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123483,were,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123484,performed,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123485,on,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123486,salad,B,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123487,dressing,I,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123488,formulated,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123489,with,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123490,0,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123491,to,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123492,1000,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123493,ppm,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123494,mustard,B,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123495,flour,I,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123496,(,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123497,mustard,B,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123498,),O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123499,.,O,4305.0,"First , recovery experiments were performed on salad dressing formulated with 0 to 1000 ppm mustard flour ( mustard ) ."
123604,Acidic,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123605,salad,B,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123606,dressing,I,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123607,matrices,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123608,reduced,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123609,the,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123610,detectability,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123611,of,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123612,mustard,B,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123613,by,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123614,the,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123615,mustard,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123616,ELISA,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123617,probably,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123618,because,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123619,of,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123620,acid,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123621,precipitation,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123622,of,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123623,mustard,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123624,proteins,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123625,that,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123626,renders,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123627,them,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123628,insoluble,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123629,and,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123630,nonextractable,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123631,.,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
124075,There,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124076,are,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124077,various,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124078,factors,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124079,",",O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124080,which,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124081,affect,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124082,the,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124083,formation,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124084,ACE,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124085,-,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124086,I,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124087,peptides,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124088,and,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124089,their,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124090,ability,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124091,to,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124092,reach,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124093,the,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124094,target,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124095,tissue,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124096,in,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124097,active,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124098,form,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124099,",",O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124100,which,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124101,includes,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124102,type,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124103,of,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124104,starters,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124105,(,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124106,lactic,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124107,acid,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124108,bacteria,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124109,(,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124110,LAB,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124111,),O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124112,",",O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124113,yeast,B,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124114,",",O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124115,etc,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124116,.,O,4325.0,"There are various factors , which affect the formation ACE - I peptides and their ability to reach the target tissue in active form , which includes type of starters ( lactic acid bacteria ( LAB ) , yeast , etc ."
124497,Red,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124498,blood,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124499,cell,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124500,count,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124501,and,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124502,erythrocyte,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124503,sedimentation,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124504,rate,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124505,(,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124506,ESR,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124507,;,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124508,both,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124509,The,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124510,role,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124511,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124512,various,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124513,life,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124514,style,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124515,factors,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124516,",",O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124517,including,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124518,dietary,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124519,habits,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124520,",",O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124521,in,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124522,the,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124523,etiology,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124524,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124525,non,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124526,-,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124527,Hodgkin,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124528,'s,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124529,lymphoma,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124530,was,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124531,investigated,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124532,using,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124533,data,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124534,from,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124535,a,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124536,case,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124537,-,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124538,control,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124539,study,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124540,conducted,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124541,in,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124542,the,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124543,northeastern,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124544,part,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124545,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124546,Italy,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124547,.,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124625,The,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124626,consumption,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124627,of,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124628,milk,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124629,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124630,liver,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124631,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124632,butter,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124633,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124634,oil,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124635,(,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124636,chiefly,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124637,polyunsaturated,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124638,oils,I,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124639,),O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124640,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124641,coffee,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124642,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124643,tea,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124644,",",O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124645,and,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124646,cola,B,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124647,was,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124648,positively,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124649,related,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124650,with,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124651,non,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124652,-,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124653,Hodgkin,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124654,'s,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124655,lymphoma,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124656,risk,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
124657,.,O,4346.0,"The consumption of milk , liver , butter , oil ( chiefly polyunsaturated oils ) , coffee , tea , and cola was positively related with non - Hodgkin 's lymphoma risk ."
125041,Red,B,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125042,meat,I,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125043,has,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125044,been,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125045,suggested,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125046,to,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125047,be,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125048,adversely,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125049,associated,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125050,with,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125051,risk,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125052,of,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125053,myocardial,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125054,infarction,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125055,(,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125056,MI,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125057,),O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125058,",",O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125059,whereas,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125060,vegetable,B,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125061,consumption,I,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125062,has,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125063,been,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125064,found,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125065,to,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125066,be,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125067,protective,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125068,.,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125139,Adjusted,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125140,Cox,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125141,proportional,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125142,hazard,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125143,models,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125144,were,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125145,used,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125146,to,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125147,calculate,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125148,hazard,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125149,ratios,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125150,(,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125151,HR,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125152,),O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125153,and,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125154,95,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125155,%,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125156,CI,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125157,for,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125158,MI,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125159,associated,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125160,with,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125161,specified,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125162,food,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125163,substitutions,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125164,of,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125165,150,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125166,g,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125167,/,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125168,week,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125169,.,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125170,During,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125171,a,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125172,median,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125173,follow,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125174,-,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125175,up,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125176,of,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125177,13·6,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125178,years,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125179,",",O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125180,we,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125181,identified,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125182,656,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125183,female,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125184,and,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125185,1694,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125186,male,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125187,cases,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125188,.,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125399,There,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125400,are,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125401,several,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125402,varieties,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125403,of,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125404,sorghum,B,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125405,",",O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125406,whose,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125407,coloration,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125408,varies,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125409,from,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125410,cream,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125411,",",O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125412,lemon,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125413,-,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125414,yellow,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125415,",",O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125416,red,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125417,",",O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125418,and,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125419,even,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125420,black,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125421,.,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125728,When,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125729,fruits,B,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125730,and,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125731,vegetables,B,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125732,were,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125733,examined,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125734,separately,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125735,",",O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125736,those,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125737,who,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125738,consumed,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125739,more,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125740,than,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125741,75,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125742,servings,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125743,per,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125744,month,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125745,of,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125746,fruits,B,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125747,or,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125748,vegetables,B,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125749,had,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125750,multivariate,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125751,relative,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125752,risk,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125753,of,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125754,0.59,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125755,(,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125756,95,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125757,%,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125758,CI,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125759,=,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125760,0.27,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125761,-,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125762,1.25,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125763,),O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125764,and,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125765,0.60,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125766,(,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125767,95,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125768,%,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125769,CI,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125770,=,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125771,0.31,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125772,-,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125773,1.17,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125774,),O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125775,respectively,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125776,",",O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125777,compared,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125778,to,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125779,those,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125780,consuming,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125781,11,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125782,or,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125783,less,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125784,servings,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125785,per,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125786,month,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125787,.,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
126389,Change,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126390,in,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126391,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126392,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126393,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126394,during,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126395,adulthood,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126396,was,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126397,calculated,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126398,by,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126399,subtracting,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126400,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126401,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126402,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126403,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126404,specific,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126405,foods,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126406,or,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126407,food,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126408,groups,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126409,at,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126410,age,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126411,30,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126412,yr,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126413,from,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126414,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126415,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126416,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126417,during,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126418,the,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126419,previous,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126420,year,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126421,(,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126422,recent,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126423,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126424,),O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126425,.,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126627,In,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126628,conclusion,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126629,",",O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126630,irrespective,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126631,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126632,frequency,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126633,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126634,consumption,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126635,at,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126636,age,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126637,30,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126638,yr,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126639,",",O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126640,a,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126641,greater,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126642,reduction,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126643,in,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126644,consumption,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126645,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126646,red,B,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126647,meat,I,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126648,and,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126649,a,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126650,larger,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126651,increase,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126652,in,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126653,consumption,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126654,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126655,vegetables,B,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126656,since,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126657,age,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126658,30,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126659,yr,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126660,were,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126661,associated,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126662,with,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126663,a,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126664,decreased,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126665,risk,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126666,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126667,colorectal,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126668,adenomas,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126669,later,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126670,in,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126671,life,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126672,.,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126739,Since,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126740,different,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126741,types,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126742,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126743,foods,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126744,contain,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126745,differing,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126746,proportions,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126747,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126748,macronutrients,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126749,",",O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126750,the,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126751,present,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126752,study,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126753,investigated,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126754,the,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126755,associations,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126756,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126757,different,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126758,types,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126759,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126760,foods,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126761,ingested,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126762,at,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126763,various,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126764,times,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126765,of,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126766,day,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126767,with,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126768,total,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126769,daily,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126770,and,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126771,macronutrient,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126772,intakes,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126773,.,O,4413.0,"Since different types of foods contain differing proportions of macronutrients , the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes ."
126913,Dietary,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126914,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126915,density,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126916,appeared,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126917,to,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126918,mediate,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126919,the,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126920,associations,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126921,between,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126922,particular,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126923,foods,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126924,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126925,beverages,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126926,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126927,overall,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126928,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126929,intake,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126930,.,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126931,This,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126932,suggests,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126933,that,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126934,eating,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126935,low,B,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126936,-,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126937,density,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126938,foods,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126939,in,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126940,the,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126941,morning,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126942,and,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126943,avoiding,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126944,high,B,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126945,-,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126946,density,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126947,foods,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126948,at,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126949,night,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126950,might,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126951,aid,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126952,in,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126953,reducing,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126954,overall,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126955,intake,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126956,and,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126957,may,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126958,be,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126959,useful,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126960,in,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126961,dietary,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126962,interventions,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126963,for,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126964,overweight,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126965,and,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126966,obesity,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126967,.,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126993,This,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126994,study,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126995,was,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126996,conducted,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126997,to,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126998,identify,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
126999,associations,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127000,between,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127001,total,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127002,sugar,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127003,intake,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127004,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127005,sugar,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127006,intake,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127007,from,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127008,different,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127009,foods,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127010,(,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127011,fruit,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127012,",",O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127013,milk,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127014,",",O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127015,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127016,sugar,B,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127017,-,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127018,sweetened,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127019,beverages,I,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127020,(,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127021,SSBs,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127022,),O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127023,),O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127024,",",O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127025,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127026,adiposity,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127027,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127028,continuous,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127029,metabolic,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127030,syndrome,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127031,scores,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127032,(,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127033,cMetS,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127034,),O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127035,among,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127036,Korean,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127037,children,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127038,and,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127039,adolescents,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127040,using,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127041,cohort,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127042,data,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
127043,.,O,4420.0,"This study was conducted to identify associations between total sugar intake and sugar intake from different foods ( fruit , milk , and sugar - sweetened beverages ( SSBs ) ) , and adiposity and continuous metabolic syndrome scores ( cMetS ) among Korean children and adolescents using cohort data ."
128120,Statistical,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128121,analyses,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128122,disclosed,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128123,that,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128124,the,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128125,groups,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128126,of,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128127,foods,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128128,positively,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128129,associated,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128130,with,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128131,cancer,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128132,death,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128133,were,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128134,as,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128135,follows,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128136,:,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128137,for,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128138,esophageal,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128139,cancer,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128140,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128141,pork,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128142,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128143,oil,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128144,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128145,popular,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128146,-,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128147,grade,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128148,sake,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128149,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128150,and,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128151,green,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128152,tea,I,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128153,;,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128154,for,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128155,stomach,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128156,cancer,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128157,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128158,fresh,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128159,fish,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128160,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128161,salted,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128162,or,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128163,dried,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128164,fish,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128165,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128166,salt,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128167,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128168,and,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128169,special,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128170,-,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128171,grade,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128172,sake,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128173,;,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128174,for,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128175,colon,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128176,cancer,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128177,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128178,bread,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128179,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128180,milk,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128181,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128182,butter,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128183,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128184,margarine,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128185,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128186,ketchup,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128187,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128188,beer,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128189,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128190,and,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128191,salted,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128192,or,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128193,dried,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128194,fish,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128195,;,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128196,for,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128197,rectal,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128198,cancer,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128199,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128200,fresh,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128201,fish,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128202,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128203,salted,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128204,or,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128205,dried,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128206,fish,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128207,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128208,salt,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128209,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128210,and,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128211,popular,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128212,-,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128213,grade,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128214,sake,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128215,;,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128216,for,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128217,cancer,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128218,of,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128219,the,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128220,biliary,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128221,passages,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128222,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128223,pork,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128224,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128225,popular,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128226,-,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128227,grade,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128228,sake,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128229,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128230,and,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128231,green,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128232,tea,I,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128233,;,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128234,and,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128235,for,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128236,pancreatic,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128237,cancer,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128238,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128239,oil,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128240,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128241,mayonnaise,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128242,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128243,fresh,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128244,fish,I,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128245,",",O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128246,and,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128247,salted,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128248,or,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128249,dried,B,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128250,fish,I,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128251,.,O,4458.0,"Statistical analyses disclosed that the groups of foods positively associated with cancer death were as follows : for esophageal cancer , pork , oil , popular - grade sake , and green tea ; for stomach cancer , fresh fish , salted or dried fish , salt , and special - grade sake ; for colon cancer , bread , milk , butter , margarine , ketchup , beer , and salted or dried fish ; for rectal cancer , fresh fish , salted or dried fish , salt , and popular - grade sake ; for cancer of the biliary passages , pork , popular - grade sake , and green tea ; and for pancreatic cancer , oil , mayonnaise , fresh fish , and salted or dried fish ."
128260,Further,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128261,epidemiological,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128262,analyses,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128263,are,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128264,required,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128265,to,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128266,find,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128267,a,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128268,biological,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128269,causal,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128270,relationship,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128271,.,O,4460.0,Further epidemiological analyses are required to find a biological causal relationship .
128415,More,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128416,than,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128417,two,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128418,-,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128419,thirds,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128420,of,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128421,the,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128422,patients,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128423,had,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128424,symptoms,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128425,characteristic,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128426,of,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128427,oral,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128428,allergy,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128429,syndrome,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128430,.,O,4465.0,More than two - thirds of the patients had symptoms characteristic of oral allergy syndrome .
128645,Chocolate,B,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128646,today,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128647,is,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128648,often,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128649,viewed,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128650,as,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128651,a,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128652,food,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128653,or,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128654,snack,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128655,with,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128656,little,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128657,nutritional,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128658,value,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128659,.,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
129551,Cohort,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129552,studies,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129553,are,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129554,equivocal,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129555,regarding,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129556,a,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129557,relationship,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129558,between,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129559,regular,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129560,nut,B,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129561,consumption,I,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129562,and,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129563,reduced,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129564,risk,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129565,of,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129566,type,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129567,2,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129568,diabetes,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129569,mellitus,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
129570,.,O,4505.0,Cohort studies are equivocal regarding a relationship between regular nut consumption and reduced risk of type 2 diabetes mellitus .
130286,Positive,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130287,skin,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130288,test,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130289,reactions,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130290,were,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130291,seen,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130292,almost,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130293,exclusively,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130294,in,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130295,atopics,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130296,.,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130593,Infrared,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130594,thermal,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130595,images,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130596,indicated,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130597,significantly,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130598,greater,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130599,surface,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130600,temperatures,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130601,and,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130602,heat,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130603,loss,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130604,in,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130605,treated,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130606,birds,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130607,following,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130608,external,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130609,oil,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130610,applications,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130611,;,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130612,however,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130613,",",O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130614,measurements,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130615,collected,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130616,by,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130617,coelomically,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130618,implanted,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130619,temperature,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130620,transmitters,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130621,showed,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130622,that,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130623,internal,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130624,body,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130625,temperatures,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130626,were,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130627,stable,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130628,over,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130629,the,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130630,course,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130631,of,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130632,the,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130633,study,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130634,period,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130635,.,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
131055,We,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131056,performed,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131057,an,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131058,open,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131059,",",O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131060,prospective,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131061,",",O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131062,randomized,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131063,",",O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131064,cross,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131065,-,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131066,over,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131067,",",O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131068,controlled,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131069,feeding,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131070,trial,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131071,in,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131072,40,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131073,healthy,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131074,subjects,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131075,who,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131076,randomly,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131077,received,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131078,:,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131079,7.0,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131080,g,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131081,of,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131082,RT,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131083,/,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131084,kg,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131085,of,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131086,body,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131087,weight,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131088,(,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131089,BW,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131090,),O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131091,",",O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131092,3.5,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131093,g,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131094,of,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131095,TS,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131096,/,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131097,kg,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131098,BW,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131099,",",O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131100,3.5,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131101,g,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131102,of,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131103,TSOO,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131104,/,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131105,Kg,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131106,BW,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131107,and,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131108,0.25,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131109,g,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131110,of,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131111,sugar,B,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131112,solved,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131113,in,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131114,water,B,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131115,/,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131116,kg,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131117,BW,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131118,on,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131119,a,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131120,single,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131121,occasion,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131122,on,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131123,four,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131124,different,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131125,days,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131126,.,O,4557.0,"We performed an open , prospective , randomized , cross - over , controlled feeding trial in 40 healthy subjects who randomly received : 7.0 g of RT / kg of body weight ( BW ) , 3.5 g of TS / kg BW , 3.5 g of TSOO / Kg BW and 0.25 g of sugar solved in water / kg BW on a single occasion on four different days ."
131146,The,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131147,results,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131148,indicate,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131149,that,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131150,",",O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131151,compared,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131152,to,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131153,control,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131154,intervention,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131155,",",O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131156,a,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131157,single,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131158,tomato,B,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131159,intake,I,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131160,in,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131161,any,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131162,form,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131163,decreased,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131164,plasma,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131165,total,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131166,cholesterol,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131167,",",O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131168,triglycerides,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131169,and,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131170,several,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131171,cellular,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131172,and,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131173,plasma,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131174,inflammatory,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131175,biomarkers,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131176,",",O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131177,and,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131178,increased,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131179,plasma,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131180,high,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131181,density,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131182,lipoproteins,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131183,(,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131184,HDL,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131185,),O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131186,cholesterol,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131187,and,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131188,interleukine,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131189,(,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131190,IL,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131191,),O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131192,10,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131193,concentrations,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131194,.,O,4559.0,"The results indicate that , compared to control intervention , a single tomato intake in any form decreased plasma total cholesterol , triglycerides and several cellular and plasma inflammatory biomarkers , and increased plasma high density lipoproteins ( HDL ) cholesterol and interleukine ( IL ) 10 concentrations ."
131240,We,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131241,concluded,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131242,that,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131243,tomato,B,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131244,intake,I,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131245,has,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131246,beneficial,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131247,effects,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131248,on,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131249,cardiovascular,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131250,risk,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131251,factors,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131252,",",O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131253,especially,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131254,cooked,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131255,and,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131256,enriched,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131257,with,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131258,oil,B,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131259,.,O,4561.0,"We concluded that tomato intake has beneficial effects on cardiovascular risk factors , especially cooked and enriched with oil ."
131260,Cancer,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131261,initiation,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131262,and,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131263,progression,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131264,are,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131265,the,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131266,result,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131267,of,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131268,genetic,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131269,and/or,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131270,epigenetic,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131271,alterations,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131272,.,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131273,Acetylation,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131274,-,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131275,mediated,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131276,histone,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131277,/,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131278,non,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131279,-,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131280,histone,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131281,protein,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131282,modification,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131283,plays,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131284,an,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131285,important,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131286,role,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131287,in,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131288,the,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131289,epigenetic,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131290,regulation,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131291,of,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131292,gene,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131293,expression,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131294,.,O,4563.0,Acetylation - mediated histone / non - histone protein modification plays an important role in the epigenetic regulation of gene expression .
131417,Natural,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131418,compounds,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131419,of,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131420,plant,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131421,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131422,fungus,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131423,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131424,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131425,actinomycetes,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131426,origin,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131427,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131428,such,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131429,as,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131430,phenolics,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131431,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131432,polyketides,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131433,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131434,tetrapeptide,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131435,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131436,terpenoids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131437,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131438,alkaloids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131439,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131440,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131441,hydoxamic,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131442,acid,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131443,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131444,have,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131445,been,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131446,reported,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131447,to,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131448,show,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131449,potential,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131450,HDAC,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131451,-,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131452,inhibitory,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131453,activity,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131454,.,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131806,Bread,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131807,with,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131808,1.9,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131809,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131810,guar,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131811,gum,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131812,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131813,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131814,/,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131815,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131816,",",O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131817,total,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131818,flour,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131819,basis,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131820,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131821,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131822,5,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131823,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131824,buckwheat,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131825,flour,I,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131826,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131827,of,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131828,all,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131829,flours,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131830,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131831,substitutes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131832,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131833,mimicked,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131834,French,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131835,bread,I,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131836,quality,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131837,attributes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131838,.,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
132165,The,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132166,low,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132167,de,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132168,novo,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132169,diet,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132170,significantly,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132171,increased,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132172,plasma,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132173,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132174,and,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132175,milk,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132176,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132177,content,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132178,",",O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132179,whereas,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132180,dietary,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132181,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132182,level,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132183,did,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132184,not,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132185,in,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132186,itself,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132187,influence,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132188,these,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132189,parameters,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132190,.,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132251,Many,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132252,environmental,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132253,and,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132254,genetic,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132255,factors,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132256,are,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132257,suspected,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132258,to,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132259,play,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132260,an,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132261,important,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132262,role,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132263,in,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132264,the,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132265,development,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132266,of,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132267,the,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132268,disease,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132269,.,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
